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ABSTRACT
Calcium and calmodulin are implicated in mediating the Ca2+-dependent regulation of gap junctions
that are essential for the intercellular transmission of molecules such as nutrients, metabolites, metal ions
and signal messengers (< 1000 Da) through its specialized cell membrane channels and communication
to extracellular environment. To understand the key determinants for calcium and calmodulin regulation
of gap junction, in this study, we identified a calmodulin binding domain in the second half of the
intracellular loop of Cxonnexin50 (the major gap junction protein found in an eye lens) using peptide
fragments that encompass predicted CaM binding sites and various biophysical methods. Our study
provides the first direct evidence that CaM binds to a specific region of the ubiquitous gap junction
protein Cx50 in a Ca2+-dependent manner. Furthermore, two novel CaM binding regions in cytosolic loop
and C-termini of Connexin43 (the most ubiquitous connexin) have been shown to interact with CaM with

different binding modes in the presence of Ca2+ using high resolution NMR. Our results also elucidate the
molecular determinants of regulation of gap junction by multiple CaM targeting regions and provide
insight into the molecular basis of gap junction gating mechanism and the binding of CaM to the cytoslic
region Cx43-3p as the major regulation site. Upon response to the cytosolic calcium increase, CaM binds
to the cytosolic loop to result in the conformational change of gap junction and close the channel. It is
possible for CaM to use an adjacent region as an anchor close to the regulation site to allow for fast
response.

Since a large number of residues in the Cxs mutated in human diseases reside at the highly

identified CaM binding sites in Cxs, our studies provide insights into define the critical cellular changes
and molecular mechanisms contributing to human disease pathogenesis as part of an integrated molecular
model for the calcium regulation of GJs. In addition, we have applied the grafting approach to probe the
metal binding capability of predicted EF-hand motifs within the streptococcal hemoprotein receptor (Shr)
of Streptococcus pyrogenes as well as the nonstructural protein 1 (nsP1) of Sindbis virus and Poxvirus.
This fast and robust method allows us to analyze putative EF-hand proteins at genome-wide scale and to
further visualize the evolutionary scenario of the EF-hand protein family. Further, mass spectrometry has
also been applied to probe modification of proteins such as CaM labeling by florescence dye and 7E15 by
PEG.
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Calmodulin target protein, Protein-protein interaction, Protein grafted approach, Gap junction,
Connexin26, Connexin43, Connexin50

DISSECTING KEY DETERMINANTS FOR CALCIUM AND CALMODULIN REGULATION OF
GAP JUNCTION AND VIRAL PROTEIN

by

YANYI CHEN

A Dissertation Submitted in Partial Fulfillment of the Requirements of the Degree of
Doctor of Philosophy
in the College of Arts and Sciences
Georgia State University
2012

Copyright by
Yanyi Chen
2012

DISSECTING KEY DETERMINANTS FOR CALCIUM AND CALMODULIN REGULATION OF
GAP JUNCTION AND VIRAL PROTEIN

by

YANYI CHEN

Committee Chair:
Committee:

Jenny J. Yang
Charles F. Louis

Richard D. Veenstra
Aimin Liu
Siming Wang

Electronic Version Approved:
Office of Graduate Studies
College of Arts and Sciences
Georgia State University
May 2012

iv

ACKNOWLEDGEMENTS
All of the work in this dissertation is carried out under the direction of Prof. Jenny J. Yang. I am
deeply indebted to Prof. Jenny J. Yang, whose keen help, inspiring suggestions and stimulating
encouragement helped me during the course of my research. The completion of my dissertation and
subsequent Ph.D. has been a long journey. Her patience, flexibility, genuine caring and concern and faith
in me during the dissertation process enabled me to attend to life while also earning my Ph.D. I would
like to express my deepest gratitude to Prof. Richard D. Veenstra, Prof. Charles F. Louis, and Prof. Aimin
Liu who gave me their full support and guidance in performing this research. I would like to express my
sincere gratitude to Dr. Siming Wang for the immeasurable amount of support and guidance she has
provided throughout mass spec. study. This dissertation would not have been possible without the expert
guidance of these esteemed advisors. Many people on the faculty, staff and colleagues of the Department
of Chemistry assisted and encouraged me in various ways during my graduate years. I gladly express my
gratitude to them for all their help, support, interest and valuable hints. Especially I am obliged to Dr.
Yubin Zhou for initiating the project and teaching me almost everything about science and research, to Dr.
Hing-Cheung Wong and Dr. Hsiau-Wei Lee for their hand-to-hand teaching in NMR, to Dr. Shunyi Li for
his help in protein purification, to Dr. Jin Zou for his help in CD and fluoremeter, to Dr. Monica Lurtz for
the cell-based assays, to Xu Qin for the majority of the gap junction experiments along with Dr.Xianming
Lin on the Cx43 and Cx50 projects, to You Zhuo and Juan Zou for working with me in gap junction
project. I would also extend my gratitude to Natalie White and Matthew Cameron for carefully proofreading all the chapters of this dissertation and provided many stylistic suggestions. This work is
supported the grants from National Institutes of Health.
Finally, I am especially grateful to my parents Wansheng Chen and Mingxiang Liu for giving the
opportunity to follow my dreams, to my wife Yangqian Shao and my daughter Amber Chen, for the
patient love to make all of these a reality.

v
TABLE OF CONTENTS
ACKNOWLEDGEMENTS ...................................................................................................................... iv
LIST OF TABLES .................................................................................................................................... ix
LIST OF FIGURES .................................................................................................................................... x
LIST OF ABBREVIATIONS ................................................................................................................. xiv
1.

2.

INTRODUCTION............................................................................................................................... 1
1.1.

Roles of Calcium (Ca2+) in biological systems ..................................................................................... 1

1.2.

The properties of EF-hand motif in Ca2+-binding proteins. .................................................................. 3

1.3.

A grafting approach: exploring the metal binding properties of continuous Ca2+ binding loops. ........ 4

1.4.

Roles of Ca2+/Calmodulin in regulating intracellular signaling. ........................................................... 6

1.5.

Gap junction in cell communication. .................................................................................................... 9

1.6.

Calmodulin-mediated regulation of gap junctions. ............................................................................. 11

1.7.

The objectives of this dissertation. ...................................................................................................... 11

1.8.

Overview of this dissertation. ............................................................................................................. 12

MATERIALS AND METHODS ..................................................................................................... 25
2.1.

Molecular cloning and plasmid construction ...................................................................................... 25

2.2.

Baculovirus vector construction.......................................................................................................... 25

2.3.

Expression and purification of proteins .............................................................................................. 26

2.4.

Peptide design and synthesize ............................................................................................................. 27

2.5.

Nuclear magnetic resonance spectroscopy.......................................................................................... 28

2.6.

Fluorescence spectroscopy.................................................................................................................. 30

2.7.

Circular dichroism spectroscopy......................................................................................................... 33

2.8.

Mass spectroscopy .............................................................................................................................. 33

2.9.

Electrophysiological measurement of junctional conductance ........................................................... 34

2.10. Prediction of protein transmembrane topology and calmodulin binding domains.............................. 34

vi
3.

MOLECULAR INTERACTION AND FUNCTIONAL REGULATION OF CONNEXIN50 BY

CALMODULIN ........................................................................................................................................ 37
3.1.

Introduction ......................................................................................................................................... 37

3.2.

Results................................................................................................................................................. 39

3.2.1.

A putative CaMBD in the single cytoplasmic loop of Cx50............................................... 39

3.2.2.

Ca2+-dependent uncoupling of Cx50 gap junctions requires CaM ...................................... 39

3.2.3.
Ca2+-dependent direct interaction between Cx50 CaMBD and CaM observed by MALDIMS and SDS-PAGE with cross-linking. ............................................................................................. 40
3.2.4.

Ca2+-dependent specific interaction between Cx50 CaMBD and CaM revealed by NMR. 41

3.2.5.

Probing the CaM-Peptide complex state by diffusion NMR .............................................. 43

3.2.6.

Revealing CaM-Peptide interactions with CD spectroscopy .............................................. 43

3.2.7.

Determination of the CaM-Peptide binding affinity by fluorescence spectroscopy ........... 44

3.2.8.

Binding of Cx50p expands the [Ca2+]i sensing range of CaM ............................................ 45

3.3.

3.3.1.

Regulation of Cxs by intracellular Ca2+ and CaM .............................................................. 46

3.3.2.

Comparison of CaM binding affinity with the alpha family Cxs ........................................ 47

3.3.3.

Implications for the factors contributing to the CaM binding affinity to Cxs ..................... 48

3.3.4.

Structural and disease implications ..................................................................................... 50

3.4.

4.

Discussion ........................................................................................................................................... 46

Summary ............................................................................................................................................. 52

EXPLORE MULTIPLE CALMODULIN BINDING SITES IN CONNEXIN43 ....................... 79
4.1.

Introduction ......................................................................................................................................... 79

4.2.

Results................................................................................................................................................. 81

4.2.1.

Design of peptide fragments to probe interactions of Cx43 by CaM.................................. 81

4.2.2.

Monitoring formation of the peptide-CaM complex using Mass spectrometry. ................. 82

4.2.3.
Monitoring the interaction between Cx43 peptides and CaM by NMR (1H, 15N)-HSQC
spectroscopy........................................................................................................................................ 83
4.2.4.
Determining CaM binding mode of holo-CaM-Cx43-2p complex by residue dipolar
coupling. 84
4.2.5.
Determining the binding affinity of Cx43-2p/4p-CaM complex by modified CaM with
fluorescence dye.................................................................................................................................. 85
4.3.

Discussion ........................................................................................................................................... 87

vii

5.

4.3.1.

The binding stoichiometry between CaM and Cx43 peptides ............................................ 87

4.3.2.

The CaM binding modes between CaM and Cx43 peptides. .............................................. 89

4.3.3.

Comparison of CaM binding domains with α-, β-, γ- and δ-family. ................................... 91

4.3.4.

Disease implications in CaM binding domains. .................................................................. 92

4.3.5.

The role of CaM in regulation of Cx43............................................................................... 93

4.4.

Future plan. ......................................................................................................................................... 94

4.5.

Summary and conclusion .................................................................................................................... 95

IDENTIFICATION OF EF-HAND CA2+ BINDING PROTEINS IN VARIOUS BIOLOGICAL

SYSTEMS ................................................................................................................................................ 112
5.1.

Introduction ....................................................................................................................................... 112

5.1.1.

EF-hand Ca2+ binding proteins and protein grafted approach ........................................... 112

5.1.2.

Animalia: Calbindin D9k .................................................................................................. 114

5.1.3.

Bacteria: streptococcal hemoprotein receptor of Streprococcus pyrogenes ...................... 115

5.1.4.

Virus: nsP1 of Sindbis and Pox......................................................................................... 116

5.2.

Results............................................................................................................................................... 117

5.2.1.

Probing metal binding of grafted EF-hand by FRET pair of Trp and Tb3+. ...................... 117

5.2.2.

Revealing Ca2+ dependent conformation change by CD spectroscopy. ............................ 119

5.2.3.
Observing oligomeric stage of CD2 with grafted EF-hand by PFG-NMR measurement and
fluorescence anisotropy. ................................................................................................................... 120
5.3.

6.

7.

Discussion and summary. ................................................................................................................. 122

MASS SPECTROMETRY OF PROTEIN STUDY..................................................................... 139
6.1.

Introduction ....................................................................................................................................... 139

6.2.

Dansylation of CaM and its variants ................................................................................................. 141

6.3.

IAEDANS dye labeling of CaM cysteine variants ........................................................................... 143

6.4.

Protein-protein interaction study of CaM with gap junction peptide. ............................................... 144

6.5.

Dimerization study of engineered proteins with grafted EF-hand motif........................................... 145

6.6.

Determination of chemical PEGylation sites on protein based MRI contrast agent. ........................ 146

6.7.

Summary ........................................................................................................................................... 147

MAJOR FINDING AND THE SIGNIFICANCE OF THIS DISSERTATION ........................ 165

viii
7.1.

Investigating CaM regulation of gap junction proteins..................................................................... 165

7.2.

Identification of continuous calcium binding sites by grafting approach. ........................................ 167

7.3.

The study of protein-protein interactions by mass spectrometry. ..................................................... 168

PUBLICATIONS AND MANUSCRIPTS ............................................................................................ 169
REFERENCES ........................................................................................................................................ 172

ix
LIST OF TABLES
Chapter 1
Table 1. 1 The connexin family. ............................................................................................ 24
Chapter 2
Table 2. 1 Summary of GST fusion protein of CD2 variants. ............................................... 35
Table 2. 2 Common salt for buffer control in different pH. .................................................. 36
Chapter 3
Tabel 3. 1 Electrophysiological measurement. ...................................................................... 75
Tabel 3. 2 Binding affinities to CaM and α-helicity of the Cx peptides................................ 76
Tabel 3. 3 Summary of Change of CaM helicity in different binding modes. ...................... 77
Tabel 3. 4 Effects of Cx peptides binding on the metal-binding properties of CaM. ............ 78
Chapter 4
Table 4. 1 Sequence of CaM binding sites in Cx43 aligned with sequence of peptides from
different CaM binding mode in collapsed subclass. .................................................... 107
Table 4. 2 CaM binding modes and Q factors of the fitting of experimentally measured
RDCs of the Ca2+-CaM-Cx43-2p complex. ................................................................. 108
Table 4. 3 The binding affinities (µM) of Cx43 peptides to CaM (NMR), D-CaM and I-CaM.
..................................................................................................................................... 109
Table 4. 4 Comparison of NMR chemical shift of CaM-Cx43p in identified CaM binding
pockets of SK channel. ................................................................................................ 110
Table 4. 5 Oculodentodigital dysplasia (ODDD) disease mutation overlapping with Cx43
CaMBD. ...................................................................................................................... 111
Chapter 5
Table 5. 1 The secondary structure prediction by DichroWeb. ........................................... 136
Table 5. 2 Hydro dynamic radii (Rhydro) and fluorescence anisotropy (r) of calbindin D9k
grafted proteins. ........................................................................................................... 137
Table 5. 3 The summary of Tb3+ dissociation constants (Kd) in grafted proteins. ............... 138
Chapter 6
Table 6. 1 UV MALDI Matrix list. ..................................................................................... 164

x
LIST OF FIGURES
Chapter 1
Figure 1. 1 Calcium signaling in biological systems. ......................................................................... 14
Figure 1. 2 Calcium signaling in bacteria. .......................................................................................... 15
Figure 1. 3 Ca2+-binding affinities and structures of different classes of Ca2+-binding proteins
(CaBPs). ...................................................................................................................................... 16
Figure 1. 4 Experimental approaches to validate predicted continuous Ca2+-binding motifs. ............ 17
Figure 1. 5 Calcium dependent Ca2+-CaM-protein interaction. .......................................................... 18
Figure 1. 6 Binding modes between CaM and its targets. .................................................................. 19
Figure 1. 7 Classical CaM binding modes. ......................................................................................... 20
Figure 1. 8 Assembly of gap junction proteins. .................................................................................. 21
Figure 1. 9 Schematic representation of the steps that lead to synthesis, assembly, and degradation of
gap junction membrane channels. ............................................................................................... 22
Figure 1. 10 Possible domains of Cx43 involved in interactions with partner proteins...................... 23
Chapter 3
Figure 3. 1 Connexins membrane topology and the putative CaM-binding sites. .............................. 53
Figure 3. 2 Ca2+- and CaM-dependence of Cx50 gap junction uncoupling. ....................................... 54
Figure 3. 3 Mechanistic basis for Ca2+/CaM-dependent Cx50 gap junction uncoupling. ................... 55
Figure 3. 4 Monitoring CaM-Cx50141-166 complex formation by mass spectroscopy. ........................ 56
Figure 3. 5 Cross-linking SDS-PAGE electrophoresis of CaM-Cx50p complex. .............................. 57
Figure 3. 6 Monitoring the interaction between CaM and Cx50 peptides by (1H, 15N)-HSQC
spectroscopy. ............................................................................................................................... 58
Figure 3. 7 Cx50 Scramble peptide eliminates the interaction with holo-CaM by by (1H, 15N)-HSQC.
.................................................................................................................................................... 59
Figure 3. 8 Chemical shift perturbation in CaM induced by addition of 2-fold molar excess of
Cx50p141-166. ................................................................................................................................ 60
Figure 3. 9 The chemical shift change of Gly33 during titration of holo-CaM with Cx50p141-166. ..... 61
Figure 3. 10 Hydrodynamic radii of CaM-Cx50p141-166 complex determination by PFG-NMR. ........ 62

xi
Figure 3. 11 Monitoring the interaction between Apo-CaM and Cx50 peptides by (1H, 15N)-HSQC
spectroscopy. ............................................................................................................................... 63
Figure 3. 12 CD studies of the interaction between CaM and the Cx50141-166 peptide. ....................... 64
Figure 3. 13 CD Studies of the helicity of Cx43, Cx44 and Cx50 peptide. ........................................ 65
Figure 3. 14 CD Studies of Cx50p141-166 in free and complex form. ................................................... 66
Figure 3. 15 Structural basis of the difference in directionality of chemical shift change. ................. 67
Figure 3. 16 The dansyl fluorescence anisotropy................................................................................ 68
Figure 3. 17 The interaction of Cx50141-166 peptide with holo Dansyl-CaM (D-CaM) monitored by
steady-state fluorescence............................................................................................................. 69
Figure 3. 18 The interaction of Cx50141-166 peptide with apo Dansyl-CaM (D-CaM) monitored by
steady-state fluorescence............................................................................................................. 70
Figure 3. 19 pH dependence of Cx50p141-166 and Cx44p129-150 binding to CaM. .................................. 71
Figure 3. 20 N-Domain specific equilibrium Ca2+ titration of CaM (○), and CaM in complex with
Cx50p141-166 (●). ......................................................................................................................... 72
Figure 3. 21 C-Domain specific equilibrium Ca2+ titration of CaM (○), and CaM in complex with
Cx50p141-166 (●). ......................................................................................................................... 73
Figure 3. 22 Comparison of the α family of connexins. ..................................................................... 74
Chapter 4
Figure 4. 1 Connexins membrane topology putative CaM-binding sites of Cx43. ............................. 96
Figure 4. 2 The predicted CaM binding sequences in Cx43. .............................................................. 97
Figure 4. 3 Monitoring CaM-Cx43-2p and CaM-Cx43-4p complex formation by MALDI mass
spectrometry. ............................................................................................................................... 98
Figure 4. 4 Monitoring the interaction between holo-CaM and Cx43-2p peptide by (1H, 15N)-HSQC
spectroscopy. ............................................................................................................................... 99
Figure 4. 5 Monitoring the interaction between holo-CaM and Cx43-4p peptide by (1H, 15N)-HSQC
spectroscopy. ............................................................................................................................. 100
Figure 4. 6 Comparison of the three CaM binding sites of connexin43 in (1H, 15N)-HSQC spectrum.
.................................................................................................................................................. 101
Figure 4. 7 Comparison of the three CaM binding sites of connexin43 in chemical shift. ............... 102

xii
Figure 4. 8 CaM binding mode determination of holo-CaM-Cx43-2p complex by residue dipolar
coupling (RDC). ........................................................................................................................ 103
Figure 4. 9 The interaction of Cx43-2p and Cx43-4p peptide with IAEDANS-CaM (I-CaM)
monitored by steady-state fluorescence. ................................................................................... 104
Figure 4. 10 The interaction of Cx43-2p peptide with Dansyl labeled C lobe of CaM (D-C-CaM)
monitored by steady-state fluorescence (A) and anisotropy fluorescence (B). ......................... 105
Figure 4. 11 Proposed model of Ca2+/CaM regulation of assembling, trafficking, permeability and
degradation in gap junction. ...................................................................................................... 106
Chapter 5
Figure 5. 1. Calcium is involved in multiple steps of virus life cycle. .............................................. 124
Figure 5. 2. The Predicted EF-hand loops in various biological systems. ........................................ 125
Figure 5. 3. Characterization of CD2 grated protein (CD2.Pox.EF) by intrinsic.............................. 126
Figure 5. 4. FRET based Tb3+ titration of the engineered protein from the nsP1 of poxvirus
(CD2.Pox.EF). .......................................................................................................................... 127
Figure 5. 5. Characterization of CD2 grated protein (CD2.Cal1.EF and CD2.Cal2.EF) by intrinsic
Trp fluorescence excitation spectrum (A) and emission spectrum (B). .................................... 128
Figure 5. 6. FRET based Tb3+ titration of the engineered proteins from Calbindin D9k. .................. 129
Figure 5. 7. Probing metal binding properties of predicted EF-hand Ca2+ binding motifs from Shr of
Streptococcus pyrogenes (CD2.Shr.EF) and from the nsP1 of Sindbis virus (CD2.Sin.EF). ... 130
Figure 5. 8. Monitoring Ca2+ dependent secondary structure changes of CD2.Cal1.EF and
CD2.Cal2.EF by far ultra-violet circular dichroism spectra. .................................................... 131
Figure 5. 9. Monitoring Ca2+ dependent secondary structure changes of CD2.Pox.EF and
CD2.Shr.EF by far ultra-violet circular dichroism spectra. ...................................................... 132
Figure 5. 10. Determination of the oligomeric state of CD2.Cal1.EF and CD2.Cal2.EF by PFG-NMR.
.................................................................................................................................................. 133
Figure 5. 11. Determination of the oligomeric state of CD2.Cal1.EF by fluorescence anisotropy. . 134
Figure 5. 12. Determination of the oligomeric state of CD2.Cal2.EF by fluorescence anisotropy. . 135
Chapter 6
Figure 6. 1 Voyager-DETM PRO workstation. ................................................................................. 148
Figure 6. 2 Desorption and Ionization processed in MALDI-MS.................................................... 149

xiii
Figure 6. 3 MALDI-MS spectrum of CaM dansylation in various concentrations.......................... 150
Figure 6. 4 MALDI-MS spectrum of CaM and variants dansylation at various pH. ....................... 151
Figure 6. 5 MALDI-MS spectrum of CaM variant IAEDANS labeling with cysteine mutation or
insertion..................................................................................................................................... 152
Figure 6. 6 The effect of urea on CaM modification with IAEDANS dye. ..................................... 153
Figure 6. 7 MALDI-MS spectrum of CaM and C45 peptide complex. ........................................... 154
Figure 6. 8 Monitoring the interaction between CaM and Cx45 peptides (Cx45p) by (1H, 15N)HSQC spectroscopy. ................................................................................................................. 155
Figure 6. 9 Chemical shift perturbation in CaM induced by addition of 2-fold molar excess of
Cx45p ........................................................................................................................................ 156
Figure 6. 10 MALDI-MS spectrum of CD2.STIM1.EF in the presence of CaCl2. .......................... 157
Figure 6. 11 MALDI-MS spectrum of CD2.STIM1.EF in the presence of EGTA. ........................ 158
Figure 6. 12 MALDI-MS spectrum of CD2.D1 in the presence of CaCl2. ...................................... 159
Figure 6. 13 MALDI-MS spectrum of CD2.D1 in the presence of EGTA. ..................................... 160
Figure 6. 14 Analysis of oligomer status of CD2.STIM1.EF by both MALDI-MS and crosslinking
SDS-PAGE. .............................................................................................................................. 161
Figure 6. 15 MALDI-MS spectrum of MRI contrast agent 7E15 labeling with PEG. .................... 162
Figure 6. 16 The possible PEGylation sites determined by Nano spray ESI-MS. ........................... 163

xiv

LIST OF ABBREVIATIONS
APS

Ammonium persulfate

CaBP

Calcium binding protein

CaM

Calmodulin

CaMBD

Calmodulin binding domain

CD

Circular dichroism

CD2.D1

Domain 1 of Cluster of Differentiation 2

Cx

connexin

DTT

1, 4-dithio-DL-threitol

EGTA

Ethylene glycol tetraacetic acid

ER

Endoplasmic reticulum

ESI

Electrospray ionization

FRET

Fluorescence resonance energy transfer

FPLC

Fast performance liquid chromatography

GST

Glutathione-S-transferase

GA

Golgi apparatus

HSQC

Heteronuclear single quantum coherence

ICP

Inductively coupled plasma

IPTG

Isopropyl-D-thiogalactopyranoside

Kd

Dissociation constant

koff

Off rate

LB

Luria-Bertani medium

MALDI

Matrix-assisted laser desorption/ionization

MS

Mass spectrometry

NMR

Nuclear magnetic resonance

xv
NSP

Nonstructural protein

NOESY

Nuclear Overhauser enhancement spectroscopy

PBS

Phosphate buffer saline

PCR

Polymerase chain reaction

RDC

Residue dipolar couplings

SDS-PAGE

Sodium dodecyl sulfate polyacrylamide gel electrophoresis

SHR

Streptococcal hemoprotein receptor

SIN

Sindbis virus

SPR

Surface plasmon resonance

TFE

Trifluoroethanol

TOCSY

Total correlation spectroscopy

UV

Ultraviolet

1

1. INTRODUCTION
1.1.

Roles of Calcium (Ca2+) in biological systems
Calcium is an essential element in biological systems. Ca2+, one ion with two charges, is the fifth

most abundant dissolved ion in seawater by both mass and molarity. It is chosen by nature through
evolution as one of the most universal and versatile carriers in cellular signal transduction. It functions as
a pivotal regulator of the cell life cycle including cell division, differentiation, apoptosis and death [1-5].
Calcium is also the fifth most abundant element by the total mass in the Earth’s crust (approximately
3.6%); meanwhile its co-crystal form with phosphate and hydroxide ions forms the hardest substance in
human body such as the matrix of tooth enamel and the deposition of the matrix in bone formed by
calcium phosphate. Calcium is very tightly controlled in biological processes [6]., Calcium plays an
important role in both the immobilized form for the support of living organisms and mobilized ion in
nearly every aspect of cellular life.
Ca2+ has a flexible coordination number of 4-8, an irregular coordination geometry and rapid binding
kinetics, which maximizes its potential to interact with various ligands. Ca2+ tends to precipitate both
inorganic and organic anions (at ~mM range) because high Ca2+ concentrations are incompatible with life
and need to be extruded, sequestered or compartmentalized [7]. These unique physio-chemical properties
of Ca2+ make it the only available candidate in the environment to perform both micro (as a messenger)
and macro (e.g., biomineralization) functions in biological systems.
During the evolution from prokaryotes to eukaryotes that began over two billions years ago, the
Fe2+/H2S buffering system in the sea was progressively exhausted, along with the increase of oxygen
supply and prevalence of oxidative reactions [7]. Ca2+ played an important role in facilitating the adaptive
changes of prokaryotes to an oxidative environment, and contributed to the evolution of more advanced
organisms and land colonization [8]. For example, Ca2+ was closely implicated in pivotal evolutionary
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events such as the evolution of cytoskeleton, cell motility, the formation of skeletons and hard-shelled
eggs (biomineralization), and the ability to supply milk.
By mass, Ca2+ represents the most abundant mineral (~1 kg) in the human body, with 99% in the form
of calcium phosphate in bones. In mammals, a specific Ca2+ homeostatic system evolved to set both the
extracellular and intracellular Ca2+ concentrations at proper levels, and produces a steep Ca2+ gradient
(>10,000 times) across the plasma membrane [9, 10]. The external Ca2+, sensed by the extracellular Ca2+
sensing receptor, is maintained at 1.1~1.4 mM through the coordinated actions of three major hormones
(i.e., parathyroid hormone, calcitonin and 1,25-dihydroxyvitamin D3) [11]. Compared to the extracellular
Ca2+ concentration of about 10-3 M, the internal Ca2+ concentration is maintained within the narrow range
of 10-7 to 10-8 M in nearly all living cells. In multi-cellular eukaryotes, Ca2+ levels in different cellular
compartments or organelles are tightly controlled through the molecular choreography of a repertoire of
Ca2+ signaling molecules, including Ca2+ channels, Ca2+ transporters, receptors, Ca2+ buffers, Ca2+responsive proteins (e.g., Ca2+-sensitive enzymes and transcription factors) that are distributed in the
cytoplasm, endoplasmic/sarcoplasmic reticulum (ER/SR), Golgi complex, mitochondria, nucleus or the
extracellular matrix (Fig. 1.1) [12].
In eukaryotic cells, Ca2+ functions as a universal and versatile signal by interacting with hundreds of
proteins over a 106-fold range of affinities (nM to mM) (Fig.1.3A). Inside cells, Ca2+-binding proteins,
such as calmodulin or parvalbumin, have Ca2+-binding affinities in the submicromolar range
corresponding to the resting cytosolic Ca2+ concentrations of ~100 nM. Ca2+ concentrations in organelles
such as the ER, Golgi, and endocytic vacuoles are in the hundreds of μM. By modulating the activities of
these proteins, Ca2+ participates in various biological processes (e.g., hormonal secretion, muscle
contraction, neurotransmission and memory formation) over a wide range of timescale, ranging from as
swift as milliseconds to up to days (Fig. 1.1).
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Viruses also utilize the universal Ca2+ signal to create a specific cellular environment to achieve their
own purposes. Ca2+ plays important roles in viral gene expression, post-translational processing of viral
proteins, virion structure formation, virus entry, and virion maturation and release. The interplay between
viruses and Ca2+ in the infected cell falls generally into three major categories: 1) viral proteins directly or
indirectly disturb Ca2+ homeostasis by altering membrane permeability and/or manipulating key
components of the Ca2+-signaling apparatus; 2) viral proteins directly bind to Ca2+ for structural integrity
or functionality; and 3) critical virus-host interactions depend on cellular Ca2+-regulated proteins or
pathways. Until now, very limited cases of viral calcium-binding proteins were reported in the literature,
possibly due to challenges in the prediction and investigation of Ca2+-binding sites.
In eukaryotes, the importance of calcium is well established. However, the role of calcium in
prokaryotes remains unclear until the interest and evidence for calcium as a regulator in bacteria increased
in recent years [13]. Even in the most primitive prokaryotes, the free cytosolic Ca2+ is maintained at ~10-7
M by using a variety of prokaryotic ion transporters (e.g., Ca2+/H+ antiporter, Ca2+/Na+ antiporter, and
Ca2+ ATPase) or channels (Fig. 1.2) [14-19]. Although bacteria do not possess complex intracellular
organelles and Ca2+ is not extensively used as an intracellular messenger, accumulating evidence indicate
that Ca2+ plays an essential role in the regulation of bacterial movements, chemotaxis, survival reactions
and sporulation [10, 16, 17, 20].
Overall, the Ca2+ signaling system exhibits great versatility in speed, amplitude and spatial-temporal
patterns. In chapter 8, we focus on how integrative studies can be carried out to probe the sophisticated
Ca2+ signaling network in various biological systems.
1.2.

The properties of EF-hand motif in Ca2+-binding proteins.

According to their structural features, Ca2+-binding sites in proteins are classified as either noncontinuous or continuous. In non-continuous sites the Ca2+ ligand residues are located remotely from one
another in the protein sequence. Most of the Ca2+ binding proteins, such as cadherins, C2 domains, Site I
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of thermitase, phospholipase A2, and D-galactose binding protein (GBP) belong to this family.
Continuous Ca2+-binding sites (e.g., EF-hands) have binding pockets formed by a stretch of contiguous
amino acids in the primary sequence.
Based on the arrangement of the Ca2+-binding ligand residues in space, continuous Ca2+ binding
proteins can be divided as EF-hand and non-EF-hand proteins. EF-hand Ca2+-binding proteins with a
continuous helix-loop-helix topology were originally described in the structure of parvalbumin by
Kretsinger (Fig. 1.3) [21]. EF-hand proteins have a conserved Ca2+ binding loop flanked by two helices
[22, 23]. Based on the conserved features of the Ca2+-binding loop, EF-hand proteins have been divided
into two major groups: the canonical EF-hands as seen in CaM and the pseudo EF-hands exclusively
found in the N-termini of S100 and S100-like proteins [22]. Their major difference lies in the Ca2+
binding loop: the 12-residue canonical EF-hand loop binds Ca2+ mainly via side chains (loop positions 1,
3, 5, 12), whereas the 14-residue pseudo EF-hand loop chelates Ca2+ mostly via backbone carbonyls
(positions 1, 4, 6, 9) (Fig. 1.3B). Each type of EF-hand loop has a bidentate Ca2+ ligand (Glu or Asp) that
functions as an anchor at the C-terminal of the binding loop. Among all the structures reported to date, the
majority of EF-hand sites have been found to be paired either within multiple canonical EF-hand motifs
or through the interaction of one pseudo EF-hand motif with one canonical motif [22] (Fig. 1.3). For
proteins with odd numbers of EF-hands, such as the penta-EF-hand calpain, EF-hand motifs are coupled
through homodimerization or heterodimerization [24-26]. The calcium binding proteins with EF-hand
motif play an essential role in cellular signaling such as trigger or sensor proteins calmodulin and troponin
C (Fig. 1.3C), buffering protein parvalbumin and Calbindin D9k (Fig. 1.3D), and stabilizing protein
thermolysin (Fig. 1.3E) [27-31].
1.3.

A grafting approach: exploring the metal binding properties of continuous Ca2+ binding
loops.

Due to the spectroscopically-silent nature of calcium and its physiological abundance, determination of
the calcium binding capability of proteins is challenging. First, most experimental methods such as
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dialysis are only sensitive to the total calcium content. In addition, overcoming the persistent background
contamination of calcium during the preparation of calcium-free sample for proteins with strong calcium
binding affinities is a non-trivial task. Further, since most calcium binding proteins contain multiple
calcium binding sites that cooperatively bind calcium resulting in induced conformational change (e.g.,
CaM) (Fig. 1.3C), obtaining site-specific calcium binding affinity is limited by complication from
contributions from cooperativity and conformational entropy [32]. Hence, understanding the molecular
mechanism of biological function related to calcium is largely hampered by the lack of site specific
information about the calcium-binding properties, especially for the ubiquitous EF-hand calcium-binding
motif. Progress in understanding the molecular mechanism of calcium modulated biological process
requires us to answer several important questions. First, we lack robust prediction algorithms and
effective validating methods. Second, given its physiological abundance and spectroscopic silence,
identification and analyzing Ca2+-binding sites in proteins is not an easy task. Most experimental methods
to determine Ca2+- binding are sensitive to the total Ca2+ concentration. The background Ca2+
concentration, however, is usually hard to control and evaluate. Finally, the binding of Ca2+ to EF-hands
usually induces conformational change of the EF-hands. Therefore, evaluating site-specific Ca2+-binding
affinity is often complicated by the conformational cooperativity in the case of proteins possessing
multiple Ca2+ binding sites (e.g., calmodulin and troponin C) [33].
To overcome the first limitation, we have generated a handful of motif signatures for prediction of
continuous EF-hand or EF-hand-like motifs [34]. Recently, we also developed MUG program to identify
non-EF hand continuous calcium binding pockets [35]. More importantly, we have developed a grafting
approach coupled with luminescence resonance energy transfer (LRET) to evaluate isolated Ca2+-binding
sites from EF-hand Ca2+-binding proteins [36-38]. To circumvent the spectroscopically silent nature of
Ca2+, we use lanthanides to probe Ca2+-binding because of their similar ionic radii (Ca2+, 1.00 Å; Tb3+,
0.92 Å) and metal coordination chemistry [39, 40]. As shown in Fig.1.4A, a putative Ca2+-binding
sequence can be inserted in a flexible loop in the domain 1 of CD2 (CD2.D1) with minimal perturbations

6
to the overall structure. The Trp residue (W32) within CD2.D1 is capable of transferring energy to Tb3+
that binds to the inserted Ca2+- binding loop. We optimized the insertion position and the length of the
glycine linkers to optimize LERT efficiency, and meanwhile, to minimize the perturbation to the host
structure [38]. Insertion of the putative Ca2+-binding sequence between residue Ser52 and Gly53 flanked
by triple glycine linkers proves to be most effective.
A flow chart describing a general approach to probe the Ca2+ binding capability of EF-hand proteins
is outlined in Fig.1.4A. First, putative calcium-binding proteins can be predicted using our developed
calcium-binding sites prediction algorithm [34, 41-44] or using the pattern search server available at
ScanProsite [45, 46]. A total of 93 putative EF-hands or EF-hand like motifs have been found in the viral
genomes, including 80 different viruses that spread in the majority of virus families [47]. The native
structure of host protein CD2.D1 after calcium binding loop insertion is essential for the accuracy of the
metal binding assay. Next, the correct protein folding of engineered proteins is confirmed by both
intrinsic tryptophan fluorescence and circular dichroism spectroscopy. Finally, the site specific Tb3+
binding affinity is obtained by titrating Tb3+ into the sample containing engineered proteins; whereas the
site specific Ca2+-binding affinity is subsequently obtained with competition assay after obtaining sitespecific Tb3+-binding affinity. The calcium binding affinity can be calculated by the apparent dissociation
constant obtained by metal competition assay, in which excess Ca2+ competes with Tb3+ in the binding
pockets. Alternatively, 1D NMR spectrometry also can be used as a way to identify the metal binding
pockets and confirm the native structure of host protein CD2.D1 (Fig. 1.4B).
1.4.

Roles of Ca2+/Calmodulin in regulating intracellular signaling.

As the prototypical EF-hand calcium binding protein, calmodulin (CaM) plays key roles on eukaryotic
cell calcium signal transduction and homeostasis. Calcium is selected by nature because survival requires
the rapid and accurate signaling response by calcium as the appropriate second messenger molecules.
Calcium uses CaM as a calcium sensor and transducer. CaM activity was first discovered in the brain and
heart as an activator of cyclic nucleotide phosphodiesterase in the early 1970s [48, 49]. To reflect the
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multifunctional nature of CaM as a calcium regulatory protein, the name of calmodulin was derived from
calcium modulator protein [50]. Watterson et.al purified CaM in 1976 and reported the first complete
amino acid sequence of CaM in 1980 [51, 52]. Only a single isoform of CaM encoded by three separate
genes in mammalian cells regulates all the metabolic pathways in calcium signaling [53]. In contrast,
plant cells have diverse CaM isoforms to regulate different cellular events in virtually every tissue type
[54, 55]. CaM in yeast has only approximate 60% sequence identity to CaM in mammalian cells and the
fourth EF-hand motifs in yeast CaM lost its ability to binding with calcium [56, 57]. In this study, we
focus on CaM in mammalian cells.
CaM is a small (MW: 16706 Da) and acidic protein (pI = ~4.6) which contains 148 amino acids. Nand C-terminal globular domains in CaM are connected by a flexible central linker and as a result, CaM
binds a total of four calcium ions. Each domain contains two helix-loop-helix Ca2+ binding EF-hand
motifs. Due to 46% sequence identity between its N and C-domains, each of the two domains folds
similarly in both secondary and tertiary structures. Calcium binding to CaM occurs sequentially in a
positively cooperative manner. When calcium concentration increase, two sites in C-domain of CaM are
filled first with a Kd ~ 10-6 M, followed by two sites in N-domain with a Kd ~10-5 M [58, 59]. The binding
of Ca2+ to each site of CaM stabilizes its flexible structure and causes the helical conformation
rearrangement of four EF-hands motifs while the orientation of helix pairs A/D, B/C, E/H and F/G
remains unchanged, as they move from nearly antiparallel orientations in apo-CaM to almost
perpendicular orientation in Ca-CaM [60]. This structure change is often described as moving from a
“closed” form of apo-CaM into an “open” form of Ca-CaM. However, it has been proven by NMR
solution structure that, in the presence of Ca2+, the N-domain is less open than the C-domain [61]. The
central link region of CaM forms a longer helix loop in Ca-CaM and hydrophobic residues in this loop are
exposed to the solvent, which allows other calcium signaling proteins (e.g. smooth muscle myosin light
chain kinase) to bind to Ca-CaM (Fig. 1.5).

8
Through its reversible binding to Ca2+, CaM undergoes conformational changes and interacts with or
releases from more than 150 target proteins [62]. The intracellular calcium concentration range is from
10-7 (resting stage) to 10-5 M (upon signal or mechanical stimulation) and the calcium binding affinities of
CaM in each domain are 10-5 M and 10-6 M, respectively, which makes CaM capable of transducing the
intracellular Ca2+ signal changes into a myriad of divergent cellular events, such as cell proliferation, cell
differentiation and apoptosis [1]. The high number of Met residues in CaM is not common in proteins
[63]. CaM forms nearly half of the hydrophobic binding interface area with its target protein by four Mets
in each domain when calcium is bound [64]. The sulfur atom in Met is ideal for forming Van der Waals
interaction with hydrophobic residues of target proteins [65]. In addition, the other amino acids with long
aliphatic side chains, such as Val, Ile and Leu, contribute to the rest of the hydrophobic binding pockets
which are “sticky” to CaM target proteins [66].
CaM binds to its targets either in a collapsed or an extended confirmation. In the collapsed
conformation of CaM, The sequences in CaM binding domain (CaMBD) are divided into different motifs
based on the distance between key hydrophobic residues such as Phe, Trp, Ile, Leu and Val with bulky
hydrophobic side chains. The target protein with a CaMBD provides at least two hydrophobic anchor
residues that interact with previously mentioned hydrophobic pockets of the N- and C-domains of CaM.
To date, in this class of CaM binding proteins, the structures of five different motifs, 1 – 7, 1 – 10, 1 – 14,
1 – 16 and 1 – 17, have been discovered (Fig. 1.6). Peptide fragments in CaMBD usually have the
propensity to from amphipathic alpha helices with both basic and hydrophobic faces [63, 67]. As shown
in Fig. 1.7, the compactness or tightness of the complex is determined by the spacing between these two
anchor residues in the CaMBD with helical conformation [68]. However, the relationship between the
regulation and the tightness of CaM in the complex remains unclear.
CaM binds to its target proteins either in a Ca2+ dependent or independent manner. Most of CaM
dependent enzymes and channel proteins are inhibited in the absence of CaM and calcium, but are
activated in a Ca2+ dependent manner in the presence of CaM. However, increasing evidence
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demonstrates that calcium-free CaM (Apo-CaM) also binds a number of highly diverse target proteins,
including neuromodulin [69], neurogranin [70] and PEP-19 [71], inducible nitric oxide synthase (iNOS)
[72], cyclic nucleotide PDE [73] and glycogen phosphorylase b Kinase (GbK) [74] as well as many
unconventional myosins [75]. Neuromodulin may function as intracellular CaM storage proteins because
it only binds CaM in the absence of CaM [76]. In some CaM target channel proteins, CaM binds a target
with multiple CaMBDs. The binding between these CaMBDs of certain channel protein (e.g. Ryanodine
receptor [77]) and CaM could be either Ca2+ dependent or independent. Apo-CaM target interaction may
provide a way to concentrate CaM to specific regions of channel proteins with multiple CaMBDs for
rapid response to the Ca2+ stimulus. Sequence analysis of CaMBD of apo-CaM reveals that several share
a common motif known as IQ motif ((FILV)Qxxx(RK)Gxxx(RK)xx(FILVWY)) or IQ like motif
((FILV)Qxxx(RK)xxxxxxxx). Proteins that contain an IQ motif typically bind apo-CaM only but
exceptions exist [75, 78]. Binding of incomplete IQ motifs which lack the second basic residue are Ca2+
dependent [79, 80]. Besides the common CaM binding classes discussed above, novel modes of CaM
binding and activation of target protein have been revealed by structural studies. When CaM binds with
exotoxin edema factor, the N-domain of CaM exists in a calcium free stage like an apo-form, although
saturating calcium levels are used in crystallization condition [81]. In contrast, CaM in the complex with
SK channels is found to have Ca2+ bound only to the N- but not to the C-domain [82, 83]. The structure
and CaM binding modes of a large number of CaM complex remains undetermined. In this dissertation,
CaM binding modes of gap junction proteins have been explored in chapters 3 and 4.
1.5.

Gap junction in cell communication.

Gap junctions (GJs) comprise the intercellular channels that mediate a direct cell-to-cell transfer of small
molecules (< 1 kDa) including metabolites, second messengers and ions between neighboring mammalian
cells [84]. The hydrophilic bridge of GJ channels are formed by head-head docking of two hemichannels
(connexon) each comprised of six connexin (Cx) subunits (Fig. 1.8). Hundreds of gap junction channels
assemble together to form a huge plaque in the barrier between two cells. All the Cxs share a similar
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topology with four highly-conserved transmembrane regions, a short N-terminal cytoplasmic region, one
intracellular and two extracellular loops, and a C-terminal intracellular tail that exhibits the greatest
sequence variation among the Cxs (Fig. 1.8) [85]. Each of two extracellular loops contains three
conserved Cys residues which forms disulfide bonds intramolecularly as shown in the Fig. 1.8C [86]. It is
well known that gap junction proteins are regulated by Ca2+ [87-90]. The increase of cytosolic calcium
concentration triggers gap junction from open to close form (Fig. 1.8D). At least 20 Cx genes have been
identified in the human genome with Cx43 being the most ubiquitous Cxs [91, 92]. Based on their
sequence similarities, Cx can be further grouped into at least five classes, α (e.g. Cxs43, 44, and 50), β
(e.g.Cxs26, 30, and 32), γ, δ and ε (Table 1.1) [93-95].
Assembly of gap junction channels and the delivery of the connexon to the plasma membrane is a
very complicated process. As shown in Fig. 1.8A, gap junction channel can be assembled by different
subunits in various combination, such as homomeric homotypic GJ (same subunits for all), homomeric
heterotypic GJ (same subunits for each connexon, different connexons for GJ), heteromeric homotypic GJ
(different subunits for each connexon, same connexons for GJ) and heteromeric heterotypic GJ (different
subunits for each connexon, different connexons for GJ). Different pathways of gap junction channel
assembly in the β family have been proposed by Ahmad et al. (Fig. 1.8B) [96]. Segretain et al. summarize
all the work about the life of gap junction channel in cell, including synthesis, assemble, trafficking,
insertion into plasma membrane (PM), diffusion to form plaque and degradation (Fig. 1.9) [97]. In brief,
the connexons of Cx26 and Cx32 in β family are assembled in the endoplasmic reticulum (ER); in
contrast, Cx43 in the α family was assembled in the Glogi apparatus (GA) after passing from ER (steps 13); Assembled hemichannels traffic into the plasma membrane with the aid from the microtubules (steps
4-5); gap junction plaques are formed after insertion of hemichannels into the PM and docking of entire
gap junction channels with adjacent cell (steps 8-9); after a 1-5 hours short life time, whole gap junction
plaques are removal from PM and move to the degradation process in either the lysosomes or
proteasomes (steps 10-11).
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The distribution of gap junction proteins depends on the tissue type except Cx43 is the most
ubiquitous Cx protein. Gap junction proteins expressed in different tissues are associated with a large
number of developmental diseases such as deafness (Cx26 and Cx30 in cochlea), Charot-Maire-Tooth
disease (Cx32 in liver and Schwann cells), oculodentodigital dysplasia (Cx43) and congenital cataracts
(Cx43 and Cx50 in lens). However, the specific molecular mechanism of these gap junctions contribute to
these diseases or developmental events is still lacking. Our study provides important insight into the
molecular mechanism of the intracellular calcium regulation of Cxs and the molecular basis for these
diseases.
1.6.

Calmodulin-mediated regulation of gap junctions.

CaM, the Ca2+-sensing subunit of a broad variety of ion channels, has been found in a wide range of
species from Homo to paramecium [98]. Gap junction proteins associate with

a large number of

signaling proteins as parts of multi-protein complexes and the plaque of gap junction channels function as
an “island” in the plasma membrane (Fig. 1.10) [99]. While there is an increasing evidence that CaM
participates in the operation of GJs [100-102], we have shown that the Ca2+-dependent regulation of GJs
Cxs is effected via the association of Ca2+-CaM with the intracellular loop domain of Cx43, and Cx44,
the sheep ortholog of human Cx46. [103, 104]. CaM also been found to co-localize with β-family
connexin Cx32 [105] and directly gates Cx32-containing GJs [106]. In this study, a new CaMBD in
Cx50 was identified and two additional CaMBDs were also explored in Cx43.
1.7.

The objectives of this dissertation.

The objective of this research is to understand how intracellular Ca2+ signaling modulates gap junction
proteins via the calcium sensor protein, calmodulin, and to investigate EF-hand Ca2+-binding proteins
using computational tools and protein engineering. This research focuses on four key objectives:
A. Elucidating the molecular basis underlying the CaM-connexin50 interaction in eukaryotic cells.
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We predicted and identified a CaM-binding region in the second half of intracellular loop of connexin50
(Cx50). The Ca2+-dependent interaction between the Cx50 and CaM was verified in vitro by various
biophysical experiments. In vivo, the CaM-mediated regulatory effect on the conductance of gap junction
formed by Cx50 is investigated in N2a cell through the collaboration with Dr. Richard Veenstra.
B. Investigating the multiple CaM binding sites of connexin43 at the molecular level in
mammalian cells.
We predicted and identified two additional CaM binding sites in Connexin43 (Cx43) using various
biophysical methods, including high resolution NMR and fluorescence. We proposed a model in which
the regulation of Cx43 is mediated by multiple CaM binding sites.
C. Elucidating the metal-binding properties of connexin26 in extracellular loops.
The biological role of a potential calcium binding pocket in extracellular loop of connexin26 (Cx26) will
be investigated by three approaches. 1) Calcium binding prediction algorithm MugSR developed in our lab
was used to predicte calcium binding pockets in the available Cx26 crystal structure. 2) A grafting
approach was applied to investigate the metal binding properties of the isolated calcium binding loop and
disease causing mutant from Cx26. 3) The metal binding properties of Cx26 was investigated by the
whole gap junction channel isolated from rat liver.
D. Investigating the metal-binding properties of EF-hand motifs in various biological systems.
The metal-binding properties of the single isolated EF-hand in virus, bacteria and mammalian proteins
was probed using a grafting approach. In addition, the oligomerization status of the EF-hand II in
Calbindin D9k was examined by a combination of pulse-field gradient NMR and fluorescence anisotropy.
1.8.

Overview of this dissertation.
The CaM-target sequences in the second half of the intracellular loop in Cx50 were synthesized and

their ability to bind CaM was determined using a range of biophysical and electrophysiological
approaches in. We also developed a model of the CaM-mediated regulation of gap junction formed by the
alpha family connexins via a strategy with multiple CaM binding domains.
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Chapter 2 in this dissertation summarizes all the methods and materials used in this study, including
molecular cloning, protein engineering, protein expression and purification, spectroscopic techniques (UV,
circular dichroism, fluorescence, NMR), bio-computational analyses of genomes, homology structure
modeling, and biochemical assays. All mathematical equations used in this study are also listed in this
chapter.
Chapter 3 in this dissertation is focused on the elucidation of the molecular basis underlying the
interaction between Cx50 and CaM. Predicted CaM-target sequences in the second half of intracellular
loop in Cx50 are synthesized and their ability to bind CaM is determined using a range of biophysical
approaches in vitro and electrophysiology in vitro.
Chapter 4 in this dissertation focuses on exploring a model of CaM-mediated regulation of gap
junction protein Cx43 in alpha family via a strategy with multiple CaM binding domains. Heteronuclear
single-quantum coherence (HSQC) NMR, fluorescence and mass spectrometry were used to confirm the
interaction between the peptides from the first half of intracellular loop and C-tail of Cx43. Residual
dipolar coupling (RDC) NMR was used to determine the Cx43-CaM binding mode.
Chapter 5 is devoted to the prediction and identification of EF-hand motifs from various biological
systems by a grafting approach. The calcium binding sites were identified in nonstructural protein 1 (nsP1)
of Sindbis virus and poxviruses, streptococcal hemoprotein receptor (Shr) of Streptococcus pyrogenes.
The metal binding properties of two EF-hand motifs isolated from Calbindin D9k has also been discussed
in this chapter.
Chapter 6 in this dissertation focuses on the mass spectrometry application on protein study. Protein
modification such as dansylation, PEGylation and IAEDANS labeling on protein has been improved by
mass spectrometry. Protein-protein interaction and protein oligomerization also have also been studied by
MALDI-MS in this chapter.
Chapter 7 is a succinct summary of major discoveries of this dissertation.
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Figure 1. 1 Calcium signaling in biological systems.
Calcium ions play key roles through calcium-binding proteins in signaling pathways in eukaryotes cells.
Calciomics study identifies calcium-binding proteins (CaBPs) and the calcium-binding locations in proteins,
which aids in the understanding of protein structures and biological functions.
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Figure 1. 2 Calcium signaling in bacteria.
Intracellular calcium concentration in prokaryotes is tightly regulated in a range from 100 to 300 nM.
In bacteria organisms, calcium ions are involved in the maintenance of cell structure, motility,
transport and cell differentiation processes. Although a number of calcium binding proteins (CaBPs)
have been isolated in several prokaryotic organisms, the role of calcium in prokaryotes is still elusive.
Our study provides a novo and rapid approach to predict and identify CaBPs in prokaryotic system.
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Figure 1. 3 Ca2+-binding affinities and structures of different classes of Ca2+binding proteins (CaBPs).
A, Ca2+ binds to different proteins with affinities varying from nM to mM. B,
cartoon representation of EF-hand Ca2+-binding motif. C, trigger proteins such as
calmodulin (PDB code: 3cln) with four EF-hand Ca2+-binding motifs undergo Ca2+dependent global conformational changes upon association with target proteins. D,
buffer proteins, such as calbindinD9K (PDB code: 1b1g) and parvalbumin, have
been shown to buffer local Ca2+ concentration without significant conformational
changes. E, Ca2+ binding to thermolysin (PDB code: 1clx) stabilizes the protein
structure and confers thermal stability. http://etd.gsu.edu/theses/available/etd11272007-155719/. This figure is from Dr.Yubin Zhou’s dissertation in our lab.
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Figure 1. 4 Experimental approaches to validate predicted continuous Ca2+-binding motifs.
Ca2+-binding sites can be predicted by using the program CaPS (continuous primary protein sequence)
and Mug (crystal structure). A, the predicted Ca2+-binding sequence is subsequently grafted into a
scaffold protein CD2.D1. B, the flow chart of calciomics. After expression and purification of the
engineered protein, Tb3+ titration assay (Tb3+-LRET) is used to confirm the metal binding capability.
Ca2+ competition assay can be further performed based on Tb3+-LRET to obtain Ca2+-binding affinity.
NMR and CD can be used to check whether host protein remain native after loops insertion. If metal
binds to the engineered protein, mutations on the proposed ligand residues can be subsequently
introduced to double confirm the binding event. If the mutagenesis results in a decrease in binding, the
predicted site has a high chance of binding Ca2+. Possible Ca2+-induced conformational changes will
be examined by expressing the protein of interest.
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Figure 1. 5 Calcium dependent Ca2+-CaM-protein interaction.
Calcium activates calmodulin by calcium induced conformational change, which is an essential step to regulate the activity of smooth muscle
myosin light chain kinase (M13).
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Figure 1. 6 Binding modes between CaM and its targets.
Calmodulin can bind to its targets either in a collapsed or an extended conformation. In the collapsed
conformation, the targets will provide 2 hydrophobic anchor residues which interact with the hydrophobic
pockets of the N- and C- terminal domains of calmodulin. These hydrophobic residues usually occur in
the 1-7, 1-10, 1-14, 1-16, or 1-17 positions in the targets sequences. The target usually binds in an
antiparallel fashion, that is, residue 1 interacts with the pocket in the C-lobe, while the second residue
interacts with the pocket in the N-lobe. Calmodulin can also bind in the extended conformation. It can
bind the target only using the C-lobe, both in the holo and apo forms such as with calcium pump or IQ
motif, respectively. It can also bind using both lobes such as with anthrax exotoxin and potassium
channel. It can also induce formation of dimer. It can bind with 1:1, 2:2, and 1:2 stoichiometries. This
figure is derived from Dr. Hing Wong’s drawing.
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Figure 1. 7 Classical CaM binding modes.
In the collapsed conformation, usually, the compactness or tightness of the complex is determined by the spacing of the two anchor residues. The
farther away the two residues, the less compact of the complex obtained. Here we superimposed the first 2 helices of different complexes, and
removing some helices for clearness, we can see as we go from 1-7 to 1-17 (indicated by the color code), helix 7 move farther away. In the
superimposed figure, 1-16 structure is special because the peptide binds in the parallel fashion. The figure on the right shows the positions of
residues on the peptide helix. The most common positions are indicated as red color. All possible positions are clustered together in a region. This
figure is from Dr. Hing Wong based on the report of Mal et al [68].
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Figure 1. 8 Assembly of gap junction proteins.
A, the assemble pattern of different gap junction channels. B, the pathway of gap
junction protein assembly. C, the tropology map of connexin monomer. D, the side view
of hemi-channel in open and close stage. This figure is drawed based on the previous
work [100, 132, 158]
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Figure 1. 9 Schematic representation of the steps that lead to synthesis, assembly, and degradation of gap
junction membrane channels.
Gap junction biosynthesis and degradation involves (1) synthesis of connexin polypeptides at endoplasmic reticulum
membranes, (2) oligomerization into homo- and heteromeric gap junction connexons (hemi-channels), (3) passage
through the Golgi stacks, (4) intracellular storage within trans Golgi membranes, (5) trafficking along microtubules, (6)
insertion of connexons into the plasma membrane, (7) lateral diffusion of connexons in the plasma membrane, (8)
aggregation of individual gap junction channels into plaques, (9) stabilization of peripheral microtubule plus-ends by
binding to Cx43-based gap junctions, (10) internalization of the channel plaque leading to cytoplasmic annular
junctions, and (11) complete degradation via lysosomal and proteasomal pathways. This figure is taken from the review
paper of Segretain and Falk [97].

23

Figure 1. 10 Possible domains of Cx43 involved in interactions with partner proteins.
This figure was modified based on the review paper of Herze, et al [99].
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Table 1. 1 The connexin family.
Family

α

β

γ

δ

ɛ

Human

Mouse

Protein name

Gene name

Protein name

Gene name

Cx43

GJA1

Cx43

Gja1

Cx46

GJA3

Cx46

Gja3

Cx37

GJA4

Cx37

Gja4

Cx40

GJA5

Cx40

Gja5

Cx50

GJA8

Cx33

Gja6

Cx59

GJA9 (GJA10)

Cx50

Gja8

Cx62

GJA10

Cx57

Gja10

Cx32

GJB1

Cx32

Gjb1

Cx26

GJB2

Cx26

Gjb2

Cx31

GJB3

Cx31

Gjb3

Cx30.3

GJB4

Cx30.3

Gjb4

Cx31.1

GJB5

Cx31.1

Gjb5

Cx30

GJB6

Cx30

Gjb6

Cx25

GJB7

Cx45

GJC1 (GJA7)

Cx45

Gjc1

Cx47

GJC2 (GJA12)

Cx47

Gjc2

Cx30.2/Cx31.3

GJC3 (GJE1)

Cx29

Gjc3

Cx36

GJD2 (GJA9)

Cx36

Gjd2

Cx31.9

GJD3 (GJC1)

Cx30.2

Gjd3

Cx40.1

GJD4

Cx39

Gjd4

Cx23

GJE1

Cx23

Gje1

Former names are indicated in parentheses.
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2. MATERIALS AND METHODS
2.1.

Molecular cloning and plasmid construction
Recombinant Rat CaM gene was cloned into pET7 vector between Ndel (5’ end of gene) and BamHI

(3” end of gene) restriction enzyme sites. Recombinant Rat domain 1 of CD2 (CD2.D1) gene was cloned
into PGEX-2T vector between BamHI (5’ end of gene) and EcoRI (3” end of gene) restriction enzyme
sites. The sequence encoding the putative Ca2+-binding domain from extracellular loop I of Cx26 was
inserted between Ser-52 and Gly-53 by using standard PCR methods. In order to maintain the native
structure of inserted Ca2+-binding loop, Gly linker was added at both end of the binding loop peptide
(three Gly at N-temini and two Gly at C-termini). Similarly, predicted and known Ca2+-binding EF-hand
domain from nsP1 of Sindbis virus, nsP1 of POX virus, streptococcal hemoprotein receptor of
Streptococcus pyrogenes, pseudo EF-hand of Calbindin D9k loop 1 and classical EF-hand of Calbindin
D9k loop 2 were inserted into CD2.D1. Disease related mutants and Ca2+-binding elimination mutants
were generated by primer design. Nucleotides replacement was introduced in the middle of forward
primer. The antisense sequence of the reverse primer at 5’ end is next to the forward primer with DNA
polymerase running in the opposite direction.. A mutation generated linear product was ligated by T4
ligase at 16 °C for at least 4 hours. All the sequences were verified by automated sequencing on an ABI
PRISM-377 DNA sequencer (Applied Biosystems) in the Advanced Biotechnology Core Facilities of
Georgia State University.
2.2.

Baculovirus vector construction
Mouse-Cx26 and human-Cx26 gene was inserted into pFastBacTM 1 donor plasmid via BamHI and

HindIII restriction sites. The recombinant was transferred into MAX efficiency DH10BacTM competent
E.coli cells (containing bacmid and helper plasmid). Recombinant bacmid DNA was isolated from
transferred E.coli after overnight growth. Sf9 insect cells were transfected by recombinant Bacmid DNA
using Cellfectin II reagent. Baculovirus contains Cx26 gene was isolated from transfected Sf9 insect cell.
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2.3.

Expression and purification of proteins
CD2 Grafted proteins and their mutants. The engineered CD2 grafted proteins and their mutants

were expressed as GST fusion proteins in Escherichia coli BL21 (DE3) transformed with the plasmid
pGEX2T and grown in LB medium with 100 mg/L of ampicillin and grown at 37 °C. 100 μM of
isopropyl-β-D-thiogalactopyranoside (IPTG) was added when the O.D. 600 reached 0.6 to induce protein
expression for another 3 to 4 hours at 37 °C. The cultures were centrifuged at 7,000 rpm at 4 °C with a
Sorvall centrifuge equipped with a SG-3 rotor. The harvested cell pellets were resuspended in lysis buffer
consisting of 0.2% sarcosine, 1mM DTT, 1 mM AEBSF in PBS, pH 7.4. The resuspended solution was
sonicated 6 times with each time 20 seconds with 80% duty. After centrifugation at 17,000 rpm with a
Sorvall centrifuge equipped with a SS-34 rotor at 4 °C, the clarified supernatant was passed through a
flow-through affinity column loaded with 4-5 mL slurry GS4B beads (GE Healthcare). After a minimum
of 10 bead-volume of washing with PBS, on-column cleavage was performed to remove the GST tag by
adding 20 units of thrombin to each column. The elutant containing the target protein was filtered through
a 0.45 μM filter and injected into a Superdex 75 gel filtration column. The eluted proteins were pooled
together and further purified by Histrap SP cation exchange chromatography. The calculated molecular
weight of CD2 grafted protein and their mutants were also confirmed by MALDI-TOF-MS with sinapinic
acid as matrix in linear fly mode. Their concentration was determined by using the absorption at 280 nm
with an adjusted extinction coefficient according to sequence calculation (r62) in Table 2.1. Isoelectric
point (pI) was also calculated for each CD2 engineering protein with Protein Calculator v3.3 (Table 2.1).
CaM. Recombinant rat CaM in the plasmid pET-7 was expressed in E. coli strain BL21(DE3)pLysS
(r63). pET-7 transformed bacteria were grown in LB medium at 37 °C. All the expression methods
followed the same protocol as grafted CD2 GST fusion protein. Isotope labeled CaM for NMR study was
expressed in SV minimal medium using 0.5 g/L

15

NH4Cl as the only nitrogen source for sole isotopic

labeling. For 15N and 13C double labeling CaM was expressed with anadditional 5g/L glucose (13C6H12O6)
as only carbon source for protein synthesis.

Isotopic

15

NH4Cl and glucose were purchased from
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Cambridge Isotope Laboratories, MA, USA. Recombinant rat CaM was purified by phenyl-Sepharose
(Sigma, MO, USA) chromatography as described previously [104].
CaM modifications. In order to monitor the conformational change of the entire CaM and CaM
domain, several modifications was made in Rat CaM. Five mutants, T26W and Y99W for intrinsic
aromatic group, T34C, T110C and additional an Cys at the C-termini for IAEDANS fluorescence dye
labeling, were introduced into CaM, respectively. Dansyl CaM was prepared according to the method of
Johnson et al with slight modifications [107]. In Brief, rat CaM was dansylated in the dark by mixing 1
ml protein (~500 µM) with a two to five-fold molar excess of dansyl chloride (dissolved in 1:1
acetone/ethanol) in 10 mM Mops, 100 mM KCl, 1 mM CaCl2, pH 6.5 to 7.5 overnight at 4 °C.
IAEDANS labeled CaM (I-CaM) was prepared by following the condition as previously described [108].
Briefly, three CaM mutants with Cys (~ 300 µM) in 10 mM Mops, 100 mM KCl were degased by using a
stirrer and vacuum for 20 mins. High puririty nitrogen gas filled the reaction bottle after adding
IAEDANS (dissolved in DMF) with a two to three-fold molar excess at 4 °C overnight. The reaction
bottle was enclosed with parafilm and aluminum foil to keep reaction in a reduced environment in the
dark. For both D-CaM and I-CaM, the reaction mixture was then extensively dialyzed against 10 mM
Tris, 100 mM KCl at pH 7.4 to remove the free fluorescence dye. The modification conditions of CaM by
dansyl chloride and IAEDANS was improved by checking the reaction product based on the result of
MALDI spectrum. The amount of bound dye was determined using ε335 of 3980 M-1cm-1 for D-CaM
[107] and ε336 of 5700 M-1cm-1 for I-CaM [108]. The concentration of modified CaM was determined
using the BCA assay (Pierce) with CaM as standard. An average of ~0.8 mol of the dansyl and ~0.6 mol
of IAEDANS chromophore was incorporated into per mol of CaM.
2.4.

Peptide design and synthesize
The

Cx50

peptide

Cx50p141-166

(Ac-141SSKGTKKFRLEGTLLRTYVCHIIFKT166-NH2)

was

synthesized by EZ Biolab lnc. and purified by preparative reversed-phase high pressure liquid
chromatography

with

a

purity

of

>87%.

A

scrambled

peptide

SCx50p

(Ac-FKLYKC
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ISFGGTEITTRSHVLTKKRL-NH2), with the same composition of amino acids which shows no
predicted CaM binding capacity, was synthesized with a purity of >90%, and served as a negative control.
The

molecular

weight

of

these

two

peptides

were

determined

by

matrix-assisted

laser

desorption/ionization time-of-flight mass spectrometry (MALDI-MS) in reflectron mode. To mimic the
protein environment and remove extra charges, peptides were acylated at their N termini and aminated at
their C termini.
2.5.

Nuclear magnetic resonance spectroscopy
NMR experiments were performed with a Varian INOVA 600 MHz NMR spectrometer at 37 C. 1H-

15
1

N HSQC data were collected with 2048 complex data points and a spectral width of about 14 ppm in the

H dimension; 128 increments and a spectral width of 33 ppm in the 15N dimension. A sample of 0.26

mM uniformly

15

N-labeled CaM in buffer consisting of 5 mM MES, 10 mM Bis-Tris (pH 6.5), 5 mM

DTT, 0.1 mM NaN3, 10 mM CaCl2 or 10 mM EGTA, and 10% D2O was titrated with peptide stock
solutions (~5 mM) of the CaM binding peptides (CaMBP) such as Cx50p141-166 or scramble peptides such
as SCx50p in the same buffer. NMR data were processed using NMRPipe [109] and analyzed using
Sparky [110].
The pulse-field-gradient diffusion NMR spectra were collected with a modified PG-SLED pulse
sequence [111] on a 600 MHz Varian INOVA spectrometer. 8k complex data points with a spectral width
of ~13 ppm were contained in each FID. The pulse field gradient level (G) was arrayed from ~0.2 to
~31.0 Gauss/cm with a pulse gradient time (δ) of 5 ms and a diffusion time (Δ) of 112.5 ms. The data
were processed using FELIX (Accelrys). The relationship between the NMR signal intensity (A) and the
diffusion constant (D) follows the equation
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Equation 2. 1.
A = A0exp[-(γδG2)(Δ-δ/3)D]
where A0 is the signal intensity when pulse gradient is not used and γ is the gyromagnetic ratio of the
proton. In the data processing, the signal intensity as a function of pulse field gradient level was fitted
with Equation 2 using KaleidaGraph 3.5 (Synergy).

The values discussed in this article were all

determined by fitting with a linear correlation coefficient ≥ 0.999,

Equation 2. 2.
A = A0exp(-CG2)
where C is a constant (equals to γδ(Δ-δ/3)D), the diffusion constant and the hydrodynamic radii R were
obtained by comparing the C values of different molecules measured under identical conditions using the
equations

Equation 2. 3.
D/D0 = C/C0

Equation 2. 4.
R/R0 = C0/C
where D0, R0 and C0 are the diffusion constant, hydrodynamic radius, and the measured C value of
lysozyme. The hydrodynamic radius and diffusion constant of lysozyme have been reported previously
[112]. The gradients were calibrated at 25 C on the residual 1H signal in a sample of 99.9% D2O, using
the published value of 1.902 ± 0.002  10-9 m2 s-1 for the self-diffusion coefficient of HDO at 25 C
[113].
NMR samples contained 0.23 mM CaM in 10% D2O, 100 mM KCl, and 10 mM imidazole at pH 6.5,
with 10 mM Ca2+ for the Ca2+-bound form. The intensities of the protein signals were integrated from the
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methylene and methyl region of ~2 ppm spectral width (-0.2–1.8 ppm). The integrated regions for each
species were carefully selected to avoid or reduce interferences from buffer signals. The integrated
intensities were further normalized to minimize the experimental errors from phase adjustment and
baseline correction during the processing.
Chemical shift perturbations () of the 1H-15N HSQC spectra with and without peptide were
calculated using both 1H and 15N chemical shifts () as shown in Equation 5:

Equation 2. 5.
2

 =

  15N 

( H )  
5


2

2.6.

Fluorescence spectroscopy

1

2

Steady-state fluorescence spectra were recorded using a QM1 fluorescence spectrophotometer
(PTI) in a 1 cm path length cell with a xenon short arc lamp at 25 °C. Intrinsic tryptophan (Trp) emission
spectra were recorded using 2 to 6 µM protein samples in 50 mM Tris-100 mM KCl at pH 7.4. The Trp
fluorescence spectra were recorded from 300 to 400 nm with the excitation wavelength at 282 nm. The
slit widths were set at 4 and 8 nm for excitation and emission, respectively. For Tyr/Trp-sensitized Tb3+
luminescence energy transfer (Tb3+-LRET) experiments, emission spectra were collected from 500 to 600
nm with the excitation at 282 nm and the slit widths were set at 8 and 12 nm for excitation and emission,
respectively. To circumvent secondary Raleigh scattering, a glass filter with a cutoff of 320 nm was used.
The Tb3+ titration experiments were performed by gradually adding 5-10 μl aliquots of Tb3+ stock
solutions (10 mM) into the protein samples (6 µM) in 20 mM PIPES, 100 mM KCl at pH 6.8 to prevent
precipitation. For the Ca2+ competition studies, the solution containing 30 µM of Tb3+ and 1.5 µM of
protein was set as the starting point. The stock solution of 10-100 mM CaCl2 with the same concentration
of Tb3+ and protein was gradually added in the initial mixture. The fluorescence intensity was normalized
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by subtracting the contribution of the baseline slope using logarithmic fitting. The Tb3+-binding affinity of
protein was obtained by fitting normalized fluorescence intensity data using the equation
Equation 2. 6.

([P]T  [M]T  Kd )  ([P]T  [M]T  Kd )2  4[P]T [M]T
f
2[P]T
where f is the fractional change, Kd is the dissociation constant for Tb3+, and [P]T and [M]T are the total
concentrations of protein and Tb3+, respectively. The Ca2+ competition data was first analyzed to derive
the apparent dissociation constant by equation 1. By assuming that the sample is saturated with Tb3+ at the
starting point of the competition, the Ca2+-binding affinity is further obtained by using the equation
Equation 2. 7.

K d ,Ca  K app 

K d ,Tb
K d ,Tb  [Tb ]

where Kd,Ca and Kd,Tb are the dissociation constants of Ca2+ and Tb3+, respectively. Kapp is the apparent
dissociation constant.
The fluorescence emission spectra were acquired between 400 and 600 nm with an excitation
wavelength at 335 nm for D-CaM. The slit widths were set at 4 nm for excitation and 8 nm for emission.
A solution (0.8 ml) containing 0.25-2 µM D-CaM in 10 mM Tris-HCl, 100 mM KCl, pH 7.4, with 5 mM
Ca2+ or 5 mM EGTA was titrated by gradually adding 5-10 µl aliquots of the peptide stock solution (0.250.8 mM) in the same buffer. The binding constant of the synthetic peptide to modified CaM was obtained
with a 1:1 binding model (Equation 2.6) by fitting normalized florescence data as described previously
[114, 115]. pH profile of binding affinity between peptide and D-CaM was determined by various buffer
system listed in Table 2.2.
The fluorescence anisotropy of D-CaM before and after addition of CaMBP was measured with
excitation at 335 nm and emission at 500 nm. An integration time of at least 20 seconds (20 points per
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second) was used to record the fluorescence signal, and all measurements were repeated at least three
times by following established protocols with Equation 2.8 [116, 117].
Equation 2.8.

r

I H  IV
I H  2IV

where the r stands for fluorescence anisotropy and the I terms indicate fluorescence intensity
measurement parallel (IH) and perpendicular (IV) to the incident polarization.
Due to domain specific distribution of phenylalanine and tyrosine in CaM, the equilibrium Ca2+
binding constants for CaM were determined by monitoring fluorescence of intrinsic phenylalanine (λex =
250 nm, λem = 280 nm) for N-domain or tyrosine (λex = 277 nm, λem = 320 nm) for C-domain at 25 °C as
described [118]. For N or C-domain Ca2+ binding constants, 5-8 µM CaM was titrated with 5-10 µl
aliquots of 50 or 15 mM Ca2+ stock solution in Ca2+ equilibrium buffer with 50 mM HEPES, 100 mM
KCl, 5 mM NTA, 0.05 mM EGTA, pH 7.4. The same method was applied for the 1:1 CaM-peptide
mixture. Free Ca2+ at each titration point was determined with the Ca2+ dye Oregon Green 488 BAPTA5N (0.2 µM; Kd = 21.7 ± 2.5 µM) at emission of 520 nm with excitation of 495 nm [115]. The free
concentration was obtained with the equation:
Equation 2. 9.

[Ca2 ] free  K d 

F  Fmin
Fmax  F

Where F is the fluorescence intensity of the dye at each titration point; [Ca2+]free is the concentration of
free ionized calcium in solution; Fmin and Fmax represent the dye fluorescence intensities of Ca2+ -free form
and Ca2+ -saturated dye, respectively. The Ca2+ binding affinity was obtained by fitting to the nonlinear
Hill equation:
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Equation 2. 10.

f 

[Ca 2  ]nfree
K d  [Ca 2  ]nfree

Where f is the fractional change of intrinsic fluorescence intensity; [Ca2+]free is the concentration of free
ionized calcium in solution; Kd represents Ca2+ dissociation constants and n is the Hill coefficient.
2.7.

Circular dichroism spectroscopy
Circular Dichroism (CD) spectra were recorded in the far ultraviolet (UV) (190-260 nm) range on a

Jasco-810 spectropolarimeter at ambient temperature using a 0.1-cm path length quartz cuvette. The
measurements of CaM and CaM-CaMBP complex (10 µM) were made in 10 mM Tris, 100 mM KCl, at
pH 7.5 with 5 mM CaCl2 or 5 mM EGTA. All spectra presented were averaged for at least 15 scans and
the background signal from the buffer was removed from the sample signals. The far UV CD spectra of
the peptide in different percentages of trifluoroethanol (TFE) were obtained using a concentration of 20
µM CaMBP in the same buffer. The secondary structure contents of the peptides were calculated with the
online secondary structure prediction server DICHROWEB [119] The α-helical content of peptides was
predicted using Agadir algorithm [120-122].
2.8.

Mass spectroscopy
The MALDI mass spectrometry analysis was performed on an Applied Biosystems 4800 plus

MALDI TOF/TOF analyzer mass spectrometer (Framingham, MA). The data were acquired in a linear
positive mode with sinapinic acid (SA) as matrix for CaM (50 µM) and CaM- CaMBP complex. The
molecular weight of the CaMBP was also confirmed by MALDI in reflectron positive mode with αCyano-4-hydroxycinnamic acid (CHCA) as matrix. 50 µM CaM and 50 µM CaMBP were mixed in
100mM KCl, 50mM Tris-HCl, at pH 7.5. The reaction was equilibrium at least half an hour. A 1 µl
mixture was added with 10 µl saturated SA solution and then dried on the MALDI plate for the
measurement.
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2.9.

Electrophysiological measurement of junctional conductance
Parental N2a cells were grown to 80% confluency in a 12 well format and were transiently

transfected with 1 µg of the pTracer-Cx50 cDNA plasmid for four hours, lightly trypsinized, and placed
in 35 mm culture dishes overnight. Dual whole cell patch clamp experiments were performed the next day
on GFP-expressing cell pairs to measure gap junction conductance (gj) and the sensitivity to [Ca2+]i was
determined by permeabilizing the cells with 1 μM ionomycin and perfusing with ±1.8 mM external CaCl2
saline solutions. A +20 mV transjunctional voltage (Vj) pulse was applied every 15 sec to monitor gj
during bath perfusion with nominally zero or 1.8 mM external Ca2+ ([Ca2+]o) saline solutions. The gj was
normalized to the initial value (Gj = gj/gj, initial) for each Cx50 cell pair and the results were pooled for each
data set. To examine the effect of CaM inhibitor or the candidate CaM binding peptide on gj, Cx50-N2a
cells were pretreated with 1 µM calmidazolium (CDZ; Calbiochem) for 10-15 min or 1 μM of the
synthetic Cx50 mimetic peptides (Cx50p141-166 or SCx50p) were added to both whole cell patch pipettes.
2.10.

Prediction of protein transmembrane topology and calmodulin binding domains

Based on a hidden Markov model, the topology and orientation of the transmembrane helices of the
mouse Cx50 were predicted using four different programs including TMHMM, MEMSAT, SOSUI and
HMMTOP [123-126]. ClustalW2 was used to align multiple mammalian gap junction polypeptide
sequences in the alpha-family, including Cx43 (accession ID: NP_000156; Gja1 human), Cx44 (accession
ID: AAD56220; Gja3 sheep), Cx46 (accession ID: NP_068773; Gja3 human) and Cx50 (accession ID:
AAF32309; Gja8 human). The candidate CaM binding region in Cx50 was predicted using the CaM
Target Database developed on the basis of over 100 known CaM target sequences [62].
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Table 2. 1 Summary of GST fusion protein of CD2 variants.

Molecular Weight (Da)

pI

ε280nm (M-1·cm-1)

CD2.Cal1a

14832

6.16

12980

CD2.Cal2a

14640

5.05

11700

CD2.Poxb

14616

8.36

14260

CD2.Shrc

14480

7.19

11700

CD2.Sind

14753

8.99

18670

CD2.Sin IId

14721

9.41

18670

CD2.Cx26.EL1e

15763

5.34

19950

CD2.Cx26.EL2e

15763

5.31

19950

CD2.Cx26.EL1 G45Ee

15835

5.17

19950

CD2.Cx26.EL1 D46Ee

15777

5.34

19950

CD2.Cx26.EL1 E47Ke

15762

5.97

19950

CD2.Cx26.EL1 D50Ne

15762

5.57

19950

CD2 Grafted Protein

a) The grafted EF-hand loops are from loop1 (Cal1) and loop2 (Cal2) of calbindin D9k,
respectively.
b) The predicted EF-hand loop from nsP1 of POX virus was grated into CD2 host protein.
c) The predicted EF-hand loop from streptococcal hemoprotein receptor of Streptococcus
pyrogenes was grated into CD2 host protein.
d) The predicted EF-hand loop and calcium binding elimination mutant from Sindbis virus
was grated into CD2 host protein.
e) The predicted calcium binding pockets in extracellular loop1 (EL1) and loop2 (EL2)
from connexin26 was grated into CD2 host protein. Disease mutations, G45E, D46E,
E47K and D50N were introduced as well.
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Table 2. 2 Common salt for buffer control in different pH.

Common

pKa at

Buffer

Name

25°C

Range

Temp Effect
d pH/d T in
(1/K)

Mol.
Weight

Full Compound Name

3{[tris(hydroxymethyl)methyl]amino}
TAPS

8.43

7.7–9.1

−0.018

243.3
propanesulfonic acid

Bicine

8.35

7.6–9.0

−0.018

163.2

N,N-bis(2-hydroxyethyl)glycine

Tris

8.06

7.5–9.0

−0.028

121.14

tris(hydroxymethyl)methylamine

Tricine

8.05

7.4–8.8

−0.021

179.2

N-tris(hydroxymethyl)methylglycine

HEPES

7.48

6.8–8.2

−0.014

238.3

4-2-hydroxyethyl-1-piperazineethanes
ulfonic acid

TES

7.40

6.8–8.2

−0.020

229.20

2-{[tris(hydroxymethyl)methyl]
amino}ethanesulfonic acid
MOPS

7.20

6.5–7.9

−0.015

209.3

3-(N-morpholino)propanesulfonic
acid

PIPES

6.76

6.1–7.5

−0.008

302.4

piperazine-N,N′-bis(2-ethanesulfonic
acid)

MES

6.15

5.5–6.7

−0.011

195.2

2-(N-morpholino)ethanesulfonic acid
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3. MOLECULAR INTERACTION AND FUNCTIONAL REGULATION OF CONNEXIN50 BY
CALMODULIN
3.1.

Introduction
The circulation of current fluid flow through the close packed cells of the lens of the eye is essential

for maintaining lens homeostasis, and is highly dependent on functional cell-to-cell coupling. This is
accomplished by gap junctions, relatively nonselective channels that are permeable to low molecular
weight (<1 kDa) molecules that directly link the cytoplasm of adjacent cells [127-129]. The gap junction
channel formed between two adjacent cells is comprised of two connexon hemichannels, one from each
cell, joined in mirror symmetry. Each hemichannel is composed of six transmembrane connexin (Cx)
proteins embedded in the plasma membrane of the cell. The mammalian lens is comprised of three
different Cx proteins namely Cx43, Cx46 and Cx50 that like all other Cxs have four transmembrane
segments, a short N-terminal cytoplasmic region, one intracellular loop, and two extracellular loops with
a set of highly conserved cysteine residues; the major difference between all connexins is in the sequences
of their cytoplasmic loops and C-terminal tails [129].
Inhibition of cell-to-cell communication in the lens by elevated intracellular Ca2+ concentration
([Ca2+]i) was first demonstrated as an increased internal electrical resistance [130] that was prevented by
pre-incubation with calmodulin (CaM) antagonists. Elevated [Ca2+]i also inhibits cell-to-cell
communication in both bovine [131] and sheep [132] lens primary cell cultures. We have demonstrated
that lens cell-to-cell communication was half-maximally inhibited at ~ 300 nM [Ca2+]i [132] and was
prevented by pre-incubation of lens cultures with CaM antagonists [133]. The rapid onset of this
inhibition (within seconds) suggests that this is mediated by a direct interaction of CaM with one or more
of the lens Cxs rather than being mediated via the action of a CaM-dependent protein kinase. Indeed
Peracchia et al. have demonstrated that CaM directly gates Cx32-containing gap junctions [100], and
Török et al [134] have identified two distinct CaM binding amino acid sequences in Cx32 with the N- and
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C-lobes of CaM showing separate functions, suggesting trans-domain or trans-subunit bridging by CaM
as a possible mechanism of gap junction gating [135]; notably this CaM binding motif in Cx32 is absent
from the three lens Cxs.
To better understand the Ca2+-dependent inhibition of lens gap junctions we identified high affinity
CaM binding sites in the lens connexins Cx43, and Cx44 (the sheep homolog of human Cx46).
Specifically, these domains encompass residues 138-157 in Cx43 [114] and residues 129-148 in Cx44
(corresponding to residues 138-157 in Cx46) [115]. These sequences have conserved hydrophobic residues at
positions 1, 5 and 10 and 14 that matched well with two major CaM binding classes, 1-10 and 1-14, which are
similar to the CaM binding motifs found in calcineurin, nitric oxide synthase, adenylyl cyclase and skeletal
myosin light chain kinase [62, 136]. These CaM binding domains are located at the C-terminal end of the loop
region between the predicted Cx transmembrane regions 2 and 3 [124, 128, 129, 137-139] and are highly
conserved in all three lens Cxs.
The study reported here was conducted to determine whether Cx50, like Cx43 and Cx44, was also
regulated by [Ca2+]i in the μM range, and if so whether this Ca2+ regulation was CaM-mediated. A
bioinformatic analysis [62] of Cx50 resulted in the identification of a candidate CaM binding domain with
high predictive score that was located in the same C-terminal end of the loop region between the predicted
Cx transmembrane regions 2 and 3 of Cx50. This region is highly conserved in all three lens Cxs. A peptide
model, proven to be successful in our studies with Cx43 and Cx44 [114, 115], was then adopted to
demonstrate the physical interaction between the predicted Cx50 CaM binding domain and CaM. Studies
using high-resolution NMR and fluorescence spectroscopy clearly established a high affinity, Ca2+dependent interaction between a domain in the intracellular loop of Cx50 and CaM. Our results provide
important new insight into the molecular mechanism by which altered regulation of intracellular Ca2+
concentration in the lens effects the regulation of lens Cx50 gap junctions.
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3.2.

Results

3.2.1.

A putative CaMBD in the single cytoplasmic loop of Cx50

The CaM binding site predication server, Calmodulin Target Database, was used to identify potential
CaM binding domains within Cx50, by taking into account the hydropathy, alpha-helical propensity,
residue weight, residue charge, hydrophobic residue content and helical class [62]. The highest predictive
score was assigned to a stretch of sequences (residues 141-166; Fig. 3.1) in the C-terminal portion of the
intracellular loop of Cx50. Sequence alignments with previously characterized CaMBDs in rodent Cx43
[114] and sheep Cx44 (human Cx46) [115], and secondary structure prediction, identified common
features among the three alpha-family connexins that included: i) the spacing of hydrophobic residues
with bulky side chains, often used as anchor in CaM-target complexes [140-142], followed a 1-5-10
pattern; ii) all of the domains exhibited strict conservation in positions with positively-charged residues,
which help drive the formation of CaM-target complexes via electrostatic interactions [143]; and iii) the
CaMBDs were predicted to have a predominantly alpha-helical structure. Helical wheel analysis further
suggests the clustering of hydrophobic residues on one side, and the frequent occurrence of charged
residues on the opposite side. A peptide corresponding to the predicted CaMBD was subsequently
synthesized for the functional and biophysical studies described below.
3.2.2.

Ca2+-dependent uncoupling of Cx50 gap junctions requires CaM

To determine whether Cx50 gap junctions like those comprised of Cx43 [114, 144] and Cx46 [115] are
regulated by [Ca2+]i, we first performed dual whole cell patch clamp experiments in Cx50-N2a cells.
Perfusion with saline solution containing 1 µM ionomycin + 1.8 mM [Ca2+]o induced a time-dependent
reduction in Gj (Fig. 3.2A) (Table 3.1); we have shown previously that such treatment effects an
elevation of [Ca2+]i in HeLa cells [145]. Omission of 1.8 mM CaCl2 from the bath saline prevented the
Cx50 gap junction uncoupling response in the presence of 1 µM ionomycin.
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To test whether the Ca2+-dependent decrease in Cx50 Gj produced by addition of 1 μM ionomycin +
2+

1.8 mM [Ca ]o required CaM, Cx50-N2a cell cultures were acutely ( 15 min) treated with
calmidazolium (CDZ) (2 μM), a CaM inhibitor with a dissociation constant (Kd) of ≈1 μM [146].
Pretreatment with CDZ, prevented the Ca2+-dependent decrease in Gj (Fig. 3.2B).
A more specific test for a role of Cx50 CaMBD in mediating the Ca2+-dependent inhibition of this Cx
was to add the 26-mer Cx50 mimetic peptide (Cx50p) corresponding to residues 141-166 of the
cytoplasmic loop to the Cx50-transfected N2A cells. A scrambled peptide containing a randomized
sequence of the same amino acids was also utilized as a control. The addition of the Cx50p, but not the
scrambled peptide, prevented the decline in Gj (Fig. 3.2C). Overall, these electrophysiological data
support the hypothesis that an elevation of [Ca2+]i can uncouple Cx50 gap junctions in a CaM-dependent
manner mediated by the Cx50 141-166 domain.
To examine the molecular basis for the Ca2+-dependent decrease in Cx50 Gj, gap junction channel
recordings were analyzed in two poorly coupled cell pairs. Both experiments exhibited a maximum of
three open channels (N) and their cumulative open probability (N•Po) declined from 1.21 open channels
2+

per unit time to zero upon exposure to 1 μM ionomycin and 1.8 mM [Ca ]o saline (Fig. 3.3A). Unitary
Cx50 gap junction channel currents remained constant (314 ± 18 pS, std, n = 14) during the decline in Po,
indicative of a conformational gating type behavior (Fig. 3.3B).
These experiments in this section were performed by Qin Xu and Dr. Xianming Lin in Dr. Veenstra's
laboratory.

3.2.3.

Ca2+-dependent direct interaction between Cx50 CaMBD and CaM observed by MALDI-MS
and SDS-PAGE with cross-linking.

After confirming the requirement for CaM in the Ca2+-dependent regulation of the Cx50 gap junctions,
we further asked the question whether or not there is a direct interaction between the predicted CaMBD of
Cx50 (or Cx50p) and CaM. The formation of the CaM-Cx50p complex was first confirmed by MALDI
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mass spectrometry (Fig. 3.4). In the presence of Ca2+, a distinct peak representing the CaM-Cx50p
complex (Theoretical MW: 19.93 kDa; Experimental MW: 20.02 kDa.) was detected. The peak intensity
in MALDI spectrum cannot be used as a quantitative method to determine the percentage of complex
because the complex was formed in solution face with hydrophobic interaction and salt bridge while all
the condition was changed when the complex sample was co-crystalized on MALDI plate. The complex
peak in the spectrum only can confirm the direct interaction.
The Ca2+-dependent direct interaction between the peptide including the CaMBD of Cx50 and CaM was
also observed by SDS-PAGE electrophoresis with 0.2 % glutaradehyde as cross-linking reagent (Fig. 3.5).
In calcium loaded solution, the increase of molecular weight of the protein sample demonstrated that
glutaradehyde is able to cross-link Cx50p and Ca2+-CaM. When the peptide concentration increased, more
of the complex was formed in the 1:2 and 1:3 CaM to Cx50p ratio. There was no complex observed in
SDS-PAGE gel in EGTA condition. The dimer form of Ca2+-CaM and complex also can be observed by
cross-linking which shows a band (> 29 kDa). Glutaradehyde is a frequently used amine-reactive
homobifunctional crosslinker reagent with the shortest space arm which only can link the strong binding
with close interaction. After 10 mins reaction at 37°C, the amine groups of lysine residues between
CaM and Cx50p were cross-linked by glutaradehyde. Glutaradehyde contains almost shortest space arm
(~1.8 Å) between two reaction groups. It provides brief estimtion about the distance between CaM and
the gap junction peptide in the complex. The mechanism in chemistry of glutaradehyde remains unclear
[147].
3.2.4.

Ca2+-dependent specific interaction between Cx50 CaMBD and CaM revealed by NMR

To identify residue-specific changes in the conformation of CaM during complex formation with
Cx50p, we carried out (1H, 15N) HSQC NMR experiments. Unlabeled Cx50p peptide stock solution was
gradually titrated into

15

N-labeled CaM. Under Ca2+-loaded condition, the HSQC spectrum of Ca2+-

saturated CaM (holo-CaM) underwent significant changes on addition of 1 molar eq of Cx50p (Fig. 3.6).
The scrambled Cx50 peptide, which is predicted to have no binding affinity to CaM, was similarly added
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to 15N-labeled Holo-CaM. This scrambled peptide failed to induce chemical shift changes in CaM (Fig.
3.7), therefore ruling out the possibility of non-specific interactions between peptide and CaM.
By analyzing the NMR chemical shifts of CaM-Cx50p complexes deposited in the Biological
Magnetic Resonance Bank (BMRB codes: 1634, 4270, 5480, 5770, 5893, 5896, 15470, and 16465), we
identified some significant changes in chemical shifts ((CaM) - (complex) > 1 S.D.) that are common to
all complexes such as the 1H shifts of A57 and M71, and

15

N shift of A128. In the classical CaM-

CaMKII peptide structure with 1-10 binding mode, M71 and A128 are in the hydrophobic pockets of
CaM and are within 5 Å to the Cx50p. A57 occupies the second position of the second Ca2+ binding loop,
suggesting that peptide binding leads to a conformational change in this loop. In the CaM-Cx50p
complex, A57 and M71 have H of 0.29 and 0.05 ppm, respectively, while A128 has N of 0.21 ppm,
consistent with the Cx50p bound to Ca2+-CaM.
Upon formation of a Ca2+/CaM-Cx50p complex, the most significant perturbations, with weighted
average chemical shift changes greater than 0.1 ppm, were observed in both the N-lobe (e.g., S17, T26,
T29, E31, L39, A57) the C-lobe (e.g., E82, D93, L105, R106, A147, K148) and the linker region (e.g.,
D64, F68), indicating that Cx50p causes a global conformation changes in CaM. A detailed residue-toresidue plot of chemical shift perturbation is shown in Fig. 3.8. The overall change of the N-lobe residues
(2.74 ppm) was greater than in the C-lobe residues (1.78 ppm). During the titration, we observed the
simultaneous appearance of two peaks representing the same residue. For example, a progressive
disappearance of the amide signal of residues G33 representing unbound CaM was accompanied by the
concomitant emergence of a new set of peaks from the Cx50p-CaM complex (Fig. 3.9). Such a slow
exchange process, which occurs when the exchange rate of the bound and unbound states is smaller than
the amide frequency difference, often heralds a high affinity protein-protein or protein-peptide association
(i.e. interactions with submicromolar affinities) [115, 148].
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3.2.5.

Probing the CaM-Peptide complex state by diffusion NMR

Pulse-field gradient NMR was performed to determine the diffusion constant of the CaM-Cx50p
complex, enabling us to assess the overall size of this complex in solution. The diffusion constant was
determined to be (12.4 ± 0.4) × 107 cm/s (Fig. 3.10). By assuming a spherical shape of the complex, the
calculated size of the Ca2+/CaM-Cx50p complex was determined to be 17.3 ± 0.6 Å, a value comparable
to the hydrodynamic radii of CaM in complex with well-known targets such as smMLCK (17.9-21.8 Å),
PDE (18.8-22.3Å), and CaMKI (21.2 Å) [149]. The hydrodynamic radius of CaM (22.6 ± 0.6 Å) was
decreased by 23% on formation of the CaM-Cx50p complex. This size conforms to a collapsed structure
of the complex that involves the unwinding of the central helix within CaM to embrace the target peptide.
Further exploring the interaction of apo-CaM with Cx50p using NMR was not possible due to limited
solubility of the peptide in 5 mM EGTA (Fig. 3.11）.
3.2.6.

Revealing CaM-Peptide interactions with CD spectroscopy

CD spectra also confirmed the structural and conformational changes during the formation of the
CaM-peptide complex. As indicated in Fig. 3.12, the addition of the Cx50p to holo-CaM at a 1: 1 molar
ratio resulted in a ~ 6% increase in absolute value of the negative ellipticity at 222 nm. The hydrophobic
environment in the peptide binding pocket of holo-CaM could be the reason for the increase in the
absolute value of negative ellipticity attributed to the peptide itself. In contrast, a 5% decrease at 222 nm
and a 20% decrease at 208 nm in the CD signal intensity were observed after the addition of the Cx50p
peptide to apo-CaM. The data suggested that Cx50p may bind with apo-CaM in different region which is
not the same as holo-CaM. It is not clear why the helical content of the complex decreased in the presence
of EGTA.
We further examined the secondary structure of the Cx50p peptide under different solvent conditions.
TFE is known to induce α-helical formation of peptides and the helical content in the presence of TFE
usually reflects its helical propensity [150]. The Cx50p peptide becomes predominantly helical (> 90%) at
TFE ≥ 30% (v/v) (Fig. 3.13), suggesting that the Cx50p CaM binding sequence readily adopts an α-
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helical configuration. Cx50, Cx44 and Cx43 exhibit 94, 55 and 33% helical conformation, respectively,
in the presence of 30% TFE (Table 3.2). As shown in Fig. 3.1, Cx50p contains both the positive charge
residue R (R for Cx44p and K for Cx43p) and negative charge E (A for Cx44p and R for Cx43p) before
and after hydrophobic residue I at position 1 which may facilitate and stabilize its helical conformation.
The peptide in the absence of CaM has only 7% alpha helix and 72% random coil. The addition of
peptide into CaM resulted in the addition of helicity as shown in Fig. 3.12. Fig. 3.14 shows that our
difference CD spectrum of the CaM in the presence and absence of the peptide exhibits two negative
minima at 208 and 222 nm. To understand the origin of the additional helicity due to the formation of the
CaM-peptide complex, we analyzed the helical contents in the X-ray structure of Ca2+-loaded calmodulin
alone (pdb: 3CLN) and the complex structure of CaM-kinase II peptide (pdb:1CDM) since our chemical
shift studies suggest that CaM binds to Cx50p in a similar binding mode as to the peptide of CaM-kinase
II (Fig. 3.15). CaM secondary structure almost remains the same in its helical content upon formation of
the complex with a helicity about 62% (Table 3.3). Therefore, the complex induced helicity (about 20%
helical calculated by DICHROWEB based on peptide spectrum after subtraction of CaM signal) is
attributed to the conversion of peptide after binding with Ca2+-CaM. Table 3.3 summaries the helicity
change of CaM upon formation of the complex in different CaM binding modes. The maximum helical
content change of CaM complex is equal or less than 4% compare to CaM itself (62%) despite the
increase or decrease. Thus, about 20% helical change introduced by adding Cx50p is mainly from the
peptide itself even considering other different CaM binding Mode.
3.2.7.

Determination of the CaM-Peptide binding affinity by fluorescence spectroscopy

Dansyl-labeled calmodulin (D-CaM) has been frequently used to determine the binding affinity of
CaM-peptide interaction due to its sensitivity to the changes in the surrounding chemical environment and
its ease of preparation [151]. The dansyl moiety has an emission maximum at ~500-510 nm, a range in
which the signals from intrinsic aromatic residues (Phe, Tyr and Trp) are negligible. We first examined
the dansyl fluorescence anisotropy changes to confirm the formation of complex in the low micromolar
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range. Fluorescence anisotropy is dependent on the rotational correlation time of fluorophore in the
sample, and is often used to reflect the hydrodynamic properties of biomolecules [152]. The increase in
anisotropy often arises from slower tumbling of the fluorophore and thus reports the formation of a larger
complex. Indeed, upon addition of 1 molar eq of Cx50p, the anisotropy of the dansyl moiety within DCaM increased from 0.083 to 0.125, suggesting the association of Cx50p with Ca2+-CaM (Fig. 3.16).
We then carried out the titration of peptide with D-CaM by monitoring the fluorescence emission
between 400 nm and 600 nm. In the presence of Ca2+, D-CaM showed a fluorescence maximum at 500
nm. With the addition of Cx50p, the dansyl fluorescence emission maximum blue-shifted to 474 nm with
a concomitant enhancement of its fluorescence intensity (Fig. 3.17) implying that the dansyl group
entered a more hydrophobic environment upon complex formation with peptide. In contrast, in the
presence of EGTA (Fig. 3.18), although the dansyl fluorescence intensity also increased, the fluorescence
maxima changed less than in the presence of Ca2+. The data confirms the CD signal change on the
addition of peptide to apo-CaM. By fitting the titration curve with a 1:1 binding mode, we obtained a
dissociation constant (Kd) of 4.9 ± 0.6 nM for the interaction between Ca2+-CaM and Cx50p and
thousands times lower Kd for the interaction between apo-CaM and Cx50p (Table 3.2).
To further investigate the possible role of pH on CaM-peptide association, the effect of varying pH on
the binding affinity of CaM for Cx50p was also examined. As shown in Fig. 3.19, the binding affinity
(represented as –log Kd) exhibited a pH-dependent change between pH 5.0 to pH 10.0. The highest
binding affinity was obtained at pH 6.5 and the binding affinities from pH 6 to 9 almost remain the same
level. The observed pH-dependence of the interaction between CaM and Cx50p indicates that electrostatic
interactions are likely the main force driving CaM-Peptide complex formation.
3.2.8.

Binding of Cx50p expands the [Ca2+]i sensing range of CaM

We next performed the Ca2+ equilibrium titration of CaM to obtain macroscopic Ca2+-binding
constants for both the N- (phenylalanine) and C-lobes (tyrosine) of CaM by monitoring domain-specific
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fluorescence changes as described previously [117, 118]. The decrease in phenylalanine fluorescence (λex
= 250 nm, λem = 280 nm) and the increase in tyrosine fluorescence (λex = 277 nm, λem = 320 nm) report
Ca2+ binding to the N-lobe and the C-lobe of CaM, respectively. This allows us to examine the effect of
peptide binding on the domain-specific Ca2+ sensing capability of CaM. As shown in Fig. 3.20, Fig. 3.21
and summarized in Table 3.4, the addition of Cx50p led to a right shift of the titration curve representing
the Ca2+ binding to the N-lobe, and concomitantly caused a left shift of the titration curve reflecting the
Ca2+ binding to the C-lobe of CaM. Specifically, the Ca2+ affinity of the N-lobe of Cx50p-bound CaM
decreased by 2 fold, whereas the Ca2+ affinity of the C-lobe increased by ~20%. As a result of Cx50p
binding, CaM responses to subtle changes in [Ca2+]i over a broader range of calcium concentrations.
3.3.

Discussion

3.3.1.

Regulation of Cxs by intracellular Ca2+ and CaM

The results reported here demonstrate that intracellular calcium is important in the regulation of Cx50
gap junctions [145].

Furthermore, using the CaM inhibitor CDZ as well as a peptide fragment

encompassing the predicted CaM binding region, we are able to demonstrate that this Ca2+-dependent
inhibition of Cx50 gap junctions is mediated by the ubiquitous intracellular Ca2+-receptor CaM. Thus
CaM appears to mediate the Ca2+-dependent regulation of all three major alpha connexins in the lens, i.e.
Cx43, Cx46 and Cx50. Our results also demonstrate that this inhibition of Cx50 gap junction channels by
Ca2+ is due to a decrease in channel open time probability as opposed to a reduction in single channel
conductance (Fig. 6.3AB). These records provide the first direct evidence for the gated closure of
individual connexin gap junction channels by Ca2+-CaM. The average observed γj value of 314 pS is
indicative of Cx50 since it is at least double the observed γj for Cx40, Cx43, or Cx45 gap junctions in our
N2a cell cultures and consistent with the reported 210-290 pS values from reconstituted lens fiber cell
membranes or exogenously expressed Cx50 gap junction channels [153-158].
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The possible role of CaM in the chemical gating of the beta family Cxs was first proposed by
Peracchia and colleagues [159]. CaM colocalizes with Cx32 [134] and directly gates Cx32-containing GJs
[160]. Török et al. [134] reported that fluorescent labeled CaM derivatives bind to synthetic peptides
spanning most of the cytoplasmic sequences from two regions of Cx32: an N-terminal sequence
comprising residues 1-21 (Kd = 27 nM) or residues 1-19 (Kd = 1.1 µM); and a C-terminal sequence
comprising residues 216-230 (Kd = 2.1 µM) or residues 208-226 (Kd = 3.5 µM). Both exhibit Ca2+dependent CaM-binding properties [134, 135]. They also identified two distinct CaM binding amino acid
sequences in Cx32 within the N- and C-lobes of CaM showing separate functions, suggesting transdomain or trans-subunit bridging by CaM as a possible mechanism of GJ gating [160]. In addition,
Ahmad et al using in vitro translation approaches have shown that oligomerization of Cx32 is CaMdependent [161] since CaM interacts with Cxs at an early stage of GJ assembly [100, 134]. The Cterminal tail of the CaM binding site of Cx32 is likely involved in the assembly of Cxs and is Ca2+
dependent [100].

Furthermore, Blodow et al reported that CaM antagonists suppress gap junction

coupling of Cx26 in isolated Hensen cells of the guinea pig cochlea [162]. Taken together, [Ca2+]i and
CaM play vital roles in regulating gap junctions mediated by both the alpha and beta family of Cxs.
3.3.2.

Comparison of CaM binding affinity with the alpha family Cxs

Using high resolution NMR, CD and fluorescence studies, we have shown using a peptide model that
CaM interacts with the predicted cytosolic CaM binding region of Cx50. Our current studies, as well as
previous studies, have clearly shown that CaM exhibits a Ca2+ dependent interaction of all three peptide
fragments encompassing the intracellular loop regions of all three lenses Cxs. Fluorescence spectroscopy
revealed conformational changes of both the peptide and CaM following formation of the CaM-Cx
peptide complex. NMR studies demonstrated that the peptide binds to CaM with a 1:1 stoichiometry. It
also indicated that the peptide induces structural changes in both the N- and C-terminal domains, as well
as in the linker region of CaM and the binding of Cx peptides to CaM reflects a classical embracing mode
of interaction. Overall for these three connexins, binding of the peptide to CaM decreases the apparent Kd
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of Ca2+ for CaM, and the Hill Coefficient (nHill) increased. In addition, for the peptide from the
intracellular loop, Cx43 exhibit weaker affinity for CaM than either Cx50 or Cx44.
Consistent with the CaM-Cx peptide binding affinity studies using fluorescence spectroscopy, our
NMR chemical shift analysis also supports a lower affinity for the CaM-Cx43 peptide complex. The
addition of Cx43 and Cx50 peptides results in similar changes in the CaM spectra as shown in Fig. 3.22.
For most signals, the directionalities of the changes are the same, reflecting the same 1-5-10 binding
mode of these peptides to CaM. However, we have observed the slow exchange process for residue
Gly33 in CaM shown in Fig. 3.9. A similar scenario was observed for residues T29, A57 and T117 for the
CaM-Cx44 peptide complex [115]. Such a slow exchange process occurs when the exchange rate of the
bound and unbound states is smaller than the amide frequency difference, and often heralds a high affinity
protein-protein or protein-peptide association (i.e. interactions with submicromolar affinities) [148] that is
consistent with the CaM binding affinity to Cx50p and Cx44p peptides. In contrast, the NMR signals of
CaM upon addition of Cx43 peptide exhibits a gradual change in chemical shifts characteristic of the fast
exchange regime, suggesting a weaker binding affinity.
3.3.3.

Implications for the factors contributing to the CaM binding affinity to Cxs

There are several positive charged residues such as K147, R149 and R156 in Cx50 that are conserved
in all alpha family members. To identify the key factors responsible for the binding affinity of CaM to
Cxs, we have determined the CaM binding affinity of the Cx50 peptide to CaM as a function of pH. The
peptide binding affinity is decreased at pH values lower than 5.5 and greater than 8.5. This trend is very
similar to our previous results reported for Cx44 [115]. Both Cx44 peptide and Cx50 peptide behave
similarly when pH is varied, but CaM binding to the Cx50 peptide is ~ 1 order of magnitude stronger than
to the Cx44 peptide. Such a similar pH dependence suggests that electrostatic interactions following the
protonation of Asp and Glu and deprotonation of Lys are important for this complex formation.
The difference in CaM binding affinity of Cx50 and Cx44 peptides may be originate from the
intrinsic sequences encoded in the CaM binding regions of different Cxs. As shown in Fig. 3.1, there are
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several differences in the predicted regions especially with variations between conserved residue positions
1 and 5. Cx43 contains two flexible Gly instead of the helical forming residues in Cx44 and Cx50. Such
sequence variation reflects their ability to form α-helices that are important for their interaction with CaM
[62]. As shown in Fig. 3.13 and Table 3.2, Cx43 peptide has the lowest α-helical formation capacity. The
addition of TFE (> 60%) induces the highest α-helical content in the Cx50 and Cx44 peptides. In Fig.
3.13, the α-helicity of Cx50 peptide is higher than that of the Cx43 and Cx44 peptides reported previously
[114, 115]. The calculated α-helical content of peptides in TFE exhibits the rank order Cx50p > Cx44p >
Cx43p. Interestingly, negatively charged E151 located close to R149 in Cx50 may stabilize the α-helical
conformation of this peptide. In contrast, Cx43 has a positive charged R at the same location that may
disable α-helical conformation.

The observed α-helical content of the CaM binding peptides are

consistent with the trend for the CaM binding affinity results from our fluorescence experiments (Table
3.2). Both Cx44 and Cx50 peptides also bind CaM in the absence of Ca2+ as revealed by fluorescence data.
The CaM binding affinities to Cx44 and Cx50 in EGTA are 100- and 1000-fold weaker than those in the
presence of Ca2+, respectively. The apo-form of CaM does not interact with the Cx43 peptide which has
the least α-helical content. Therefore, our results reveal that the α-helicity of the CaM binding peptide is
an important factor in predicting the CaM binding affinity of these Cxs.
Our detailed NMR analysis has also revealed the differential interactions of CaM with the Cx50 and
Cx43 peptides. We observed that in general the N-lobe of CaM-Cx50p has larger chemical shift changes,
while the C-lobe has smaller changes than those of CaM-Cx43p although such interactions belong to a
similar 1-5-10 binding mode. In addition, chemical shifts of residues such as F12, K13, K94, L116, I130,
and M145 of CaM-Cx50p changed in different directions compared with those of CaM-Cx43p (Fig. 3.22).
Among these residues, K94 and I130 are on the third and fourth Ca2+ binding loops respectively, and
these loops could be flexible and adopt different conformations, leading to different directions of change
in chemical shifts. In the structure of CaM-CaMKII (pdb code 1CDM), L116 interacts with K298,
which corresponds to K146 in Cx43 and R149 in Cx50. Similarly, M145 interacts with K300, which
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corresponds to R148 in Cx43 and E151 in Cx50 (Fig. 3.15). Such changes in directions of the chemical
shifts of CaM are likely due to the intrinsic properties such as the α-helical propensity of the sequences in
the CaM binding regions of Cxs.
3.3.4.

Structural and disease implications

The intracellular region regulated by CaM has been reported to be involved in several disease related
mutations. Oculodentodigital dysplasia (ODDD) is caused by mutations in Cx43 such as G138R, G138S,
G143S, G143D, K144E, V145G, M147T, R148G, R1481, T154A and T154N [163], overlapping with
CaM binding region identified previously [114]. There have been no reports of point mutations in the
CaM binding domain of Cx50 associated with cataract formation. However, Beahm and Hall (57) have
reported that the Cx50 H161N mutant does not form detectable hemichannels but forms gap junctions
indistinguishable from wild type. Interestingly, Toloue (58) identified three nonfunctional mutations in
Cx50, T157C, H161C, and E169C, that failed to function homotypically or in heterotypic pairings with
wt Cx50. The threonine at position 157 is highly conserved and this residue has been shown previously to
be functionally essential for all connexins tested, including Cx26, Cx43, and Cx50 [164]. Mutation of a
conserved threonine in the third transmembrane helix of alpha- and beta-connexins creates a dominant
negative closed gap junction channel [164]. It is possible that such mutations may compromise the
regulation of this Cx by CaM. The testing of such mutational effects on Cx50 function is currently
underway in this laboratory. The difficulty of testing these mutations is they could produce "dead" gap
junctions by not trafficking to the membrane or forming nonfunctional channels.
The molecular scenario of CaM-mediated regulation of the alpha-class of gap junctions seems to be
quite different from the beta-class, probably due to the fact that the alpha-class connexins lack the Nterminal glycine hinge and possess longer intracellular loops and C-termini than the beta-class Cxs.
Indeed, the CaM targeting sequences in the alpha-class connexins, such as rodent Cx43, sheep Cx44 (or
human Cx46), and mouse Cx50 as revealed in this work, are in the cytoplasmic loop connecting TM2 and
TM3, in close proximity to the CL-TM3 interface. The apparent juxtaposition of the Cx32 N-terminal
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CaMBD to TM1 and of the Cx43 CL CaMBD to TM3 may facilitate the closing of the connexin channel
pore since both TM1 and TM3 are suggested to be involved in forming the transmembrane pore while the
N-terminus loops back to form a pore cytoplasmic vestibule.
The recently determined 3D structure of the connexin 26 gap junction channel at 3.5 Å resolution
provides insights into the gating mechanism of the beta-class of gap junction at atomic resolution [165].
In this tsuzumi (Japanese drum)-shaped structure, the permeation pathway is mainly defined by the short
N-terminal helix (NTH, residues 2-10) that lines the pore funnel of gap junction channel, and the first
transmembrane domain (TM1) that constitutes the pore-lining helix. This structure suggests that the
molecular identity of the channel “plug” observed under electron microscopy [166] is likely the Nterminal helix. However, due to the invisibility of both the cytoplasmic loop and the C terminus in the
crystal structure, both of which play important roles in the chemical gating of gap junction [167], it is still
too premature to explain the chemical gating mechanism with the current structure.
Given that the N-terminal CaMBD in Cx32 overlaps with the NTH that is believed to form the
channel “plug” in beta-class gap junction, it is conceivable that the Ca2+-dependent binding of CaM to
NTH might function as “cork” to block the channel by the complex per se or by inducing conformational
changes in NTH. However, since the NTH is lined interior to the channel to form a funnel, its
accessibility to CaM in the assembled channel still remains to be confirmed.
Despite the absence of X-ray structural information about the intracellular loop of Cxs [165], we have
provided detailed structural information about the association of CaM with all three alpha connexins
members. Our results provide the first direct evidence that CaM binds to a specific region of the lens gap
junction connexins Cx43, Cx44 and Cx50 in a Ca2+-dependent manner [114, 115]. Our data suggests a
common conformational gating mechanism by which the Ca2+- dependent inhibition of the α-class of gap
junction proteins is mediated by the direct association of an intracellular loop region of these proteins
with Ca2+-CaM [132, 133, 144, 145].
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3.4.

Summary

Connexin 50 (Cx50), a member of the α family of gap junction proteins expressed in the lens of the eye,
has been shown to be essential for normal lens development. In the present study, we identified a
calmodulin (CaM) binding domain (CaMBD, residues 141-166) in the intracellular loop of Cx50.
Elevations in intracellular Ca2+ concentration effected a 95% decline in junctional conductance (gj) of
Cx50 in N2A cells that is likely mediated by CaM, because inclusion of the CaM inhibitor,
calmidazolium, prevented this Ca2+-dependent decrease in gj. The direct involvement of the Cx50
CaMBD in this Ca2+/CaM-dependent regulation was further demonstrated by inclusion of a synthetic
peptide encompassing the CaMBD in both whole cell patch pipettes, which effectively prevented the
intracellular Ca2+-dependent decline in gj. Biophysical studies using NMR and fluorescence spectroscopy
further reveal that the peptide stoichiometrically binds to Ca2+/CaM with an affinity of ~5 nM. The
binding of the peptide expanded the Ca2+ sensing range of CaM by increasing the Ca2+ affinity of the Clobe of CaM, while decreasing the Ca2+ affinity of the N-lobe of CaM. Overall, these results demonstrate
that the binding of Ca2+/CaM to the intracellular loop of Cx50 is critical for mediating the Ca2+-dependent
inhibition of Cx50 gap junctions in the lens of the eye.
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Figure 3. 1 Connexins membrane topology and the putative CaM-binding sites.
The α-class of connexins are composed of four transmembrane (TM) segments, two
extracellular loops, one cytoplasmic loop, a short N-terminus and a much longer Cterminal tail. The predicted CaM binding sites are located in the second half of the
intracellular loop between TM2 and TM3. The numeric score (1-9) represents the
probability of an accurate prediction of high affinity CaM binding sites. The identified
CaM-binding sequences in the α-class connexins are similar to the Ca2+-CaM-dependent
kinase II (CaMKII). All the aligned sequences fit the 1-5-10 CaM-binding mode subclass,
where each number represents the presence of a hydrophobic residue. m, mouse; h,
human; s, sheep; r, rat; #, hydrophobic residues (highlighted in gray); B, basic residues
(underscored).
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Figure 3. 2 Ca2+- and CaM-dependence of Cx50 gap junction uncoupling.
A, Cx50-N2a cell pair superfusion with 1 µM ionomycin bath saline ± 1.8 mM CaCl2
demonstrates a time-dependent uncoupling of Cx50 gap junctions that requires 1.8 mM
extracellular [Ca2+]. B, pretreatment with 2 mM calmidazolium for 10-15 min prior to
patch clamp analysis completely prevented the 1.8 mM [Ca2+]o-dependent uncoupling
response. C, Inclusion of 1 µM Cx50p141-166 peptide in both whole cell patch pipettes
prevented 80% of the Ca2+/CaM-dependent decline in Cx50 Gj. In contrast, experiments
performed with the scrambled control SCx50p peptide prevented only 20% of the 1.8 mM
[Ca2+]o-CaM-dependent reduction of Cx50 Gj. The average initial gj ± SEM values for all
experimental groups are displayed in Table 3.1. These experiments were performed by
Qin Xu and Dr. Xianming Lin in Dr. Veenstra's laboratory.
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Figure 3. 3 Mechanistic basis for Ca2+/CaM-dependent Cx50 gap junction uncoupling.
A, The product of the number of open channels (N) and open probability (Po) from two poorly coupled Cx50-N2a
cell pairs is plotted as a function of time and 1 µM ionomycin + 1.8 mM [Ca2+]o superfusion. N x Po declined from
an average control value of 1.21 open channels to zero within two minutes of ionomycin/CaCl2 saline superfusion.
B, Cx50 gap junction channel current recordings from one experiment are shown for the time points indicated by
the circles in panel A. The number and duration of the open channels declined progressively to zero without any
apparent reduction in the single channel conductance (314 pS), indicative of closure of a Ca2+-CaM-dependent gate
without a block of the ion permeation pathway. These experiments were performed by Qin Xu and Dr. Xianming
Lin in Dr. Veenstra's laboratory.
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Figure 3. 4 Monitoring CaM-Cx50141-166 complex formation by mass spectroscopy.
The MALDI-MS spectra of the free form of Ca2+-CaM (~17 kDa) and the complex form of CaM-Cx50141-166 (~20 kDa).
The inset showed the molecular weight of the Cx50141-166 peptide (~3 kDa). [Cx50p] stands for Cx50141-166 peptide.
Sinapic acid (10 mg/ ml) was mixed with protein sample as matrix.
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A

B

Glutaradyhyde, space arm 1.8 Å
Figure 3. 5 Cross-linking SDS-PAGE electrophoresis of CaM-Cx50p complex.
A, SDS-PAGE results of CaM-Cx50p complex with cross-linking. B, the structure of
glutaradehyde. 100 µM CaM (20 mM Mops, pH 7.4) in 1mM calcium chloride or 1
mM EGTA was mixed with Cx50p141-166 as ratio 1:1. 1:2 and 1:3 respectively. Crosslinking reagent, 0.2% (final concentration) glutaradehyde was added and incubate at
37 °C for 10 mins. 1 µl 1 M Tris-HCl with large amount of amine group, pH 8.0 was
added into each sample to stop reaction. In calcium loaded solution, the increase of
molecular weight of protein sample demonstrate that glutaradehyde is able to crosslink Cx50p141-166 and Ca2+-CaM. There is no complex observed in SDS-PAGE gel
with calcium free condition. The dimer form of Ca2+-CaM and complex also can be
stabilized by cross-link which shows a band (> 29 kDa).
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Figure 3. 6 Monitoring the interaction between CaM and Cx50 peptides by (1H, 15N)-HSQC spectroscopy.
An overlay of HSQC spectra of holo-CaM (red) with the spectrum of the holo-CaM-Cx50p141-166 (green). The
black box indicates residue in CaM with dramatic change in chemical shift such as G33, T29, A57 and D64.
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Figure 3. 7 Cx50 Scramble peptide eliminates the interaction with holo-CaM by by (1H, 15N)-HSQC.
An overlay of the HSQC spectra of holo-CaM (red) with the spectrum of the holo-CaM-SCx50p (green).
Comparing holo-CaM spectrum, no chemical shift change can be observed after adding Cx50 scramble
peptide. The result indicates that the certain sequence order of Cx50 CaMBD is specific for the interaction.
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Figure 3. 8 Chemical shift perturbation in CaM induced by addition of 2-fold molar excess of Cx50p141-166.
The weight average chemical shift change (∆δ) was calculated using Equation 2.5. Residues with ∆δ > 0.1 ppm
(highlighted in red) were mapped to the three dimensional structure of holo-CaM (Protein Data Bank code: 3cln).
The C-termini exhibits less conformational change than N-termini by calculated chemical shift. The highlighted
residues in red color was considered as potential interaction face between CaM and Cx50p141-166.
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Figure 3. 9 The chemical shift change of Gly33 during titration of holo-CaM with Cx50p141-166.
The disappearance of the peak (free form) was accompanied by the appearance of the corresponding
peak (bound form) at a new position. The observation for the disappearance and the appearance of
the peaks in 1 :0.4 and 1: 1 indicates the slow exchange during the binding process. The strong
binding between CaM and Cx50p141-166 was confirmed by the slow exchange of chemical shift for
Gly33 in CaM..
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Figure 3. 10 Hydrodynamic radii of CaM-Cx50p141-166 complex determination by PFG-NMR.
The NMR signal decay of Holo-CaM (○) and Holo-CaM-Cx50p141-166 complex (●) as a function of
field strength. The calculated hydrodynamic radii of the CaM and complexes are indicated on the
top. The decrease of hydrodynamic radii of the complex indicates the compact binding mode in
which peptide could be embraced by both N-lobe and C-lobe of CaM.
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Figure 3. 11 Monitoring the interaction between Apo-CaM and Cx50 peptides by (1H, 15N)-HSQC spectroscopy.
An overlay of HSQC spectra of apo-CaM (red) with the spectrum of the apo-CaM-Cx50141-166 (green). White heavy
precipitation was observed in NMR tube after adding high concentration (5 mM) Cx50 peptide. The solubility of the
peptide is much better in 5 mM CaCl2 than in 5 mM EGTA. The intensity of CaM in the HSQC spectrum (Green) was
decreased but no chemical shift can be observed because CaM may precipitate as well.

64

Figure 3. 12 CD studies of the interaction between CaM and the Cx50141-166 peptide.
Far UV CD spectra of CaM in the presence of 5mM EGTA (○ Apo-CaM) or CaCl2 (□
Holo-CaM), and a CaM-Cx50p141-166 (1:1) mixture with 5mM EGTA (● Apo-CaMCx50141-166) or CaCl2 (■ Holo-CaM-Cx50141-166).
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Figure 3. 13 CD Studies of the helicity of Cx43, Cx44 and Cx50 peptide.
Far UV spectra of the synthetic peptide Cx50p141-166 with addition of TFE
(0% - 80%). The inset shows calculated α-helical content as a function of
TFE concentration for the peptides Cx50141-166 (■), Cx44129-150 (▲) and
Cx43136-158 (●).
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Figure 3. 14 CD Studies of Cx50p141-166 in free and complex form.
Far UV spectra of the synthetic peptide Cx50141-166 with (●) or
without (○) addition of CaM. The Cx50p became helical upon
binding in the hydrophobic core of CaM.
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Figure 3. 15 Structural basis of the difference in directionality of chemical shift change.
The structure of CaM-CaMKII complex (pdb code: 1CDM) was shown with the peptide
(inside) and the CaM residues (outside). L116 and M145 of CaM are within 5 Å to K298p
and K300p of the peptide, respectively. These peptide positions correspond to K146p and
R148p for Cx43, and R149p and E151p for Cx50, as can be seen in the superposition of their
sequences. In Cx50, E151p may be pulled away from M145 by K147p. On the contrary, in
Cx43, R148p may be pushed toward M145 by K144p. These differences in peptide
sequences can cause changes of chemical shifts in different directions.
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Figure 3. 16 The dansyl fluorescence anisotropy.
D-CaM (1 µM) was titrated with Cx50141-166 in 100mM KCl, 5mM CaCl2, 50mM
Tris-HCl at pH 7.5. The fluorescence anisotropy were measured at λex = 335 nm
and λem = 495 nm with an integration time of 20s. The inset shows the
anisotropy change for D-CaM (free), and the complex of D-CaM-Cx50p (bound).
All experiments were repeated in triplicate.
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Figure 3. 17 The interaction of Cx50141-166 peptide with holo Dansyl-CaM (D-CaM)
monitored by steady-state fluorescence.
The titration curve of D-CaM (2 µM) with Cx50p141-166 in the presence of 5mM Ca2+ in a
buffer consisting of 100mM KCl, 50mM Tris, pH 7.5. The inset shows the fluorescence
spectrum of D-CaM in the absence (dashed line) of in the presence (solid line) of an
equivalent molar concentration of Cx50p141-166. X axis on the top line indicates the ratio of
Cx50p141-166 over CaM and the bind ratio is 1:1 according to the fitting curve (at 498 nm).
A clear blue shift of the fluorescence emission spectrum of holo D-CaM caused by adding
Cx50p141-166 indicates the conformation change of D-CaM introduced by the interaction.
All experiments were repeated in triplicate.
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Figure 3. 18 The interaction of Cx50141-166 peptide with apo Dansyl-CaM (D-CaM)
monitored by steady-state fluorescence.
The titration curve of D-CaM (2 µM) with Cx50p141-166 in the presence of 5mM EGTA
in a buffer consisting of 100mM KCl, 50mM Tris, pH 7.5. The inset showed the
fluorescence spectrum of D-CaM in the absence of (dashed line) in the presence of (solid
line) an equivalent molar concentration of Cx50p141-166. In the Ca2+ free solution, although
the dansyl fluorescence intensity also increased, the fluorescence maxima changed less
than in the presence of Ca2+ and the binding is much weaker indicated by the dissociation
constant in Table 3.2. The data confirms the CD signal change on the addition of peptide
to apo-CaM. All experiments were repeated in triplicate.
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Figure 3. 19 pH dependence of Cx50p141-166 and Cx44p129-150 binding to CaM.
The binding affinities were derived from the peptides titration curves of D-CaM
at various pH. All experiments were repeated in triplicate. The binding affinity
(represented as –log Kd) exhibited a pH-dependent change between pH 5.0 to pH
10.0. The highest binding affinity was obtained at pH 6.5 for Cx50p141-166 and
7.5 for. Cx44p129-150.
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Figure 3. 20 N-Domain specific equilibrium Ca2+ titration of CaM (○), and CaM in complex
with Cx50p141-166 (●).
The intrinsic phenylalanine fluorescence (λex = 250 nm, λem = 280 nm) was monitored to report
the equilibrium Ca2+-binding constants of the N-lobe of CaM. The free ionized Ca2+
concentration was measured using the Ca2+ indicator dye Oregon Green 488 BAPTA-5N. All
experiments were repeated in triplicate in 100 mM KCl, 5 mM NTA, 0.5 mM EGTA, 50 mM
HEPES, pH 7.5. The Ca2+ affinity of the N-lobe of Cx50p-bound CaM decreased by 2 fold.
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Figure 3. 21 C-Domain specific equilibrium Ca2+ titration of CaM (○), and CaM in
complex with Cx50p141-166 (●).
The intrinsic tyrosine fluorescence (λex = 277 nm, λem = 320 nm) was monitored to
report the equilibrium Ca2+-binding constants of the C-lobe of CaM. The free ionized
Ca2+ concentration was measured using the Ca2+ indicator dye Oregon Green 488
BAPTA-5N. All experiments were repeated in triplicate in 100 mM KCl, 5 mM NTA,
0.5 mM EGTA, 50 mM HEPES, pH 7.5. Upon binding with Cx50p141-166, the Ca2+
affinity of the C-lobe of CaM increased by ~20%.
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Figure 3. 22 Comparison of the α family of connexins.
An overlay of the HSQC spectra of holo-CaM (yellow), holo-CaM-Cx50p141-166 (green), and holo-CaMCx43p136-158 (violet). Arrows indicated that most signals shifted to the same direction due to identical
binding mode, while rectangles highlighted some exceptions.

75

Tabel 3. 1 Electrophysiological measurement.
Experiment

Initial gj (ns)

SEM (nS)

N

1.8 mM CaCl2

9.90

2.90

5

0 mM CaCl2

14.74

6.51

4

2 mM CDZ

16.79

2.95

4

Cx50p141-166

7.05

2.53

7

SCx50p

3.36

1.80

6

gj = Ij/Vj (Ohm's Law, junctional current divided by transjunctional voltage).
nS = nanoSiemens, S = inverse Ohm (g = 1/R).
SEM = standard error of the mean.
N = number of cell pairs recorded from each data set.
Data collected by Qin Xu and Xianming Lin in Dr. Veenstra’s labrarory.
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Tabel 3. 2 Binding affinities to CaM and α-helicity of the Cx peptides.
Dissociation constants (Kd, nM)#
Peptide

α-helicity

5mM Ca2+

5mM EGTA

Prediction* CD (%)§

Cx50p141-166

4.9 ± 0.6

> 8000

1.11

94

Cx44p129-150

49 ± 3.0

> 5000

1.20

55

Cx43p136-158

860 ± 20

nd

0.52

33

All the experiments were repeated at n = 3.
nd, not detectable.
#

Dansyl-CaM fluorescence in 50 mM Tris-HCl, 100 mM KCl, pH 7.5.

*Prediction of the helical content of peptides using Agadir algorithm.
§

Far UV CD measurement with 30% TFE in 10 mM Tris, 100 mM KCl, at pH 7.5.
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Tabel 3. 3 Summary of Change of CaM helicity in different binding modes.

PDB. ID

Peptide in Complex

Binding Mode

Number of Helical Residue in CaM

CaM Helicity (%)

3CLN

nd

nd

96 ± 4

62 ± 3

2HQW

NR1C1

1-7

88 ± 8

59 ± 5

2F3Y

cardiac Ca(v)1.2

1-10

94 ± 7

58 ± 5

1CDM

CaM Kinase II

1-10

84 ± 7

62 ± 5

1MXE

CaM Kinase I

1-14

96 ± 8

64 ± 5

1QS7

RS20

1-8-14

95 ± 8

65 ± 6

1QTX

RS20

1-8-14

89 ± 8

60 ± 5

1IQ5

CaM Kinase Kinase

1-16

90 ± 8

60 ± 6

2BCX

RyR

1-17

86 ± 7

58 ± 5
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Tabel 3. 4 Effects of Cx peptides binding on the metal-binding properties of CaM.
N-domain (sites I and II)*

C-domain (sites III and IV)#

Kd (µM)

nHill

Kd (µM)

nHill

None

12.0 ± 0.2

1.4 ± 0.1

3.78 ± 0.03

2.14 ± 0.03

Cx50p141-166

22.7 ± 0.6

0.8 ± 0.1

3.18 ± 0.03

2.74 ± 0.07

Cx44p129-150

11.6 ± 0.1

1.5 ± 0.1

0.93 ± 0.02

2.20 ± 0.10

Cx43p136-158

14.5 ± 0.1

1.6 ± 0.2

1.16 ± 0.02

2.10 ± 0.10

Peptide

All the experiments were repeated at n= 3.
Kd and the Hill coefficient (nHill) were obtained by fitting the titration curve with Eq.7.
*Phenylalanine fluorescence (λex = 250 nm; λem = 280 nm) reports the Ca2+ binding to the N-domain of
CaM.
#

Tyrosine fluorescence (λex = 277 nm; λem = 320 nm) reports the Ca2+ binding to the C-domain of CaM.
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4. EXPLORE MULTIPLE CALMODULIN BINDING SITES IN CONNEXIN43
4.1.

Introduction
Gap junctions (GJs) comprise the intercellular channels that mediate the cell-to-cell transfer of small

molecules (< 1 kDa) including metabolites, second messengers and ions between neighboring mammalian
cells [84]. GJ channels are formed by head-head docking of two hemichannels each comprised of six
connexin (Cx) subunits. At least 20 Cx genes have been identified in the human genome with Cx43 being
one of the most ubiquitous Cxs [91, 92]. Cx46 and Cx50 are mainly expressed in the lens [168-171].
Based on their sequence similarities, Cx can be further grouped into at least five classes, α (e.g. Cx43, 44,
and 50), β (e.g. Cx26, 30, and 32), γ, δ and ε [93] (Table 1.1). All the Cxs share a similar topology with
four highly-conserved transmembrane regions, a short N-terminal cytoplasmic region, one intracellular
and two extracellular loops, and a C-terminal intracellular tail that exhibits the greatest sequence variation
among the Cxs (Fig. 4.1) [85].
It is well known that gap junction proteins are regulated by Ca2+ [87-90]. Modulation of the
cytoplasmic Ca2+ concentration is a ubiquitous mechanism by which cells transduce external signals into
biological responses. The signaling cascade initiated by the rise in intracellular Ca2+ concentration ([Ca2+]i)
is often mediated via Ca2+-binding proteins such as CaM [172, 173]. Upon Ca2+ binding, CaM undergoes
a large conformational change, exposing hydrophobic patches that are important in its binding to more
than 500 target proteins in various pathways [174]. CaM uses either its N- or C-domain to differentiate
between local and global [Ca2+]i changes and to regulate a diverse group of membrane channels/pumps
[175-177] to adjust [Ca2+]i. Depending on the properties of protein targets, CaM uses different binding
modes to regulate different biological processes. For example, CaM prefers to interact with 12-30
continuous amino acid with amphipathic helical regions containing hydrophobic residues spaced at 1-5-10,
1-8-14 or 1-16 and interspersed with positively charged residues (≥+3) [62, 178].
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While there is increasing evidence that CaM participates in the operation of GJs [100-102], we have
shown that the Ca2+-dependent regulation of GJs Cxs is effected via the association of Ca2+-CaM with the
intracellular loop domain of the Cx43, Cx44, the sheep ortholog of rodent Cx46, and Cx50 [103, 104,
179]. Similar to the previously reported CaM-binding sequences [62, 178], we have reported that CaM
binds to the second half of the intracellular loop region of Cx43 via a 1-5-10 hydrophobic residue motif
[104]. The same binding mode was also reported in other well-characterized CaM targeting proteins such
as CaM Kinase I [180], CaM Kinase II [181], MARCKS [141] and synapsin [140]. CaM binds to Cterminal domain of Cx36 in δ-family [182] and binds to N and C-terminal regions of Cx32 in β-family
[183-185]. However, the detailed structural mechanism for CaM to regulate Cxs in all families is not clear.
To date, multiple regions of CaM interaction for alpha family has not been reported.
In this chapter, we report our identification of two additional potential CaM binding sites on the first
half of the intracellular loop (CL) and the C-terminal loop region (CT) in Cx43 (Fig. 4.1). As shown in
Fig. 4.1, we define two CaM binding regions in the cytosolic loop as Cx43-2p and Cx43-3p, and define
the one at C-terminal as Cx43-4p. The CaM biding domain like Cx43-2p has never been discovered
before. Our predicted CaM-binding regions in Cxs encompass the disease-rich cytosolic regions of Cxs
that harbor several disease-linked mutations in Cx43 such as oculodentodigital dysplasia (ODDD) [186].
Using high resolution NMR and peptide model, we have shown that CaM interacts with different regions
using different binding modes. This study provides important insight into the molecular mechanism of
intracellular calcium regulation of Cxs and provide a novo model how CaM involve in gap junction
assemble, traffic and calcium dependent regulation.
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4.2.

Results

4.2.1.

Design of peptide fragments to probe interactions of Cx43 by CaM.

The CaM binding sequences of Cx43 in Fig. 4.2A were predicted using the CaM target database [62]
with the prediction for each residue scored on a scale from 0 (no binding) to 9 (high affinity binding). The
predicted CaM binding region highlighted by the blue line in Fig. 4.2A has been reported in our previous
paper [104]. Based on the conserved hydrophobic residue positions and spacing (Fig. 4.1), the key
conserved hydrophobic residues in Cx43-2p have a spacing similar to RyR13614-3643 with a binding mode
of 1-17 (box 2), while reported Cx43-3p has a 1-5-10 mode of calmodulin kinase II (box 3). However, the
binding mode in Cx43-4p region cannot be aligned with peptide sequences from collapsed CaM binding
mode subclass (Table 4.1). The predicted CaM binding sequences of Cx43 and Cx32 in the C-tail (box 4)
share the most similarity. The CaM binding mode of Cx32 in this region has not been determined.
Two other peptide fragments of Cx43 (green and purple line in Fig. 4.2A) were designed based on the
following considerations. First, peptides encompassing the predicted high affinity CaM binding sequences
were selected for synthesis. Second, the direct comparison of the CaM binding capability of these
sequences allowed us to precisely define the interacting regions. In addition, scrambled peptides with an
identical composition of amino acids yet different sequence order and low predictive score for CaM
binding were also synthesized as negative controls. Third, all chemically synthesized peptides are longer
than 20 amino acid residues based on the common length of CaM binding peptides, and to ensure their
ability to adopt secondary structure in solution. Fourth, all of the designed peptides were blocked with an
acetyl group at their N-termini and an amide group at their C-termini to mimic their protein environment
and remove extra charges [187]. The Cx43 peptide, Cx43-2p, in the first half of the intracellular loop
region (Ac-86SVPTLLYLAHVFYVMRKEEKLN107-NH2) and the other in the C terminus region, Cx434p, (Ac-224NIIELFYVFFKGVKDRVKGRSDPY247-NH2) was synthesized by EZ Biolab lnc. and purified
by preparative reversed-phase high pressure liquid chromatography with purity of >87%.
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CaM binding peptides usually form a helical conformation in the hydrophobic environment provided
by CaM. Three Cx43 CaM binding domains with highest scores (18 residues) are presented in the helical
wheel (Fig. 4.2B). In the helical wheel of Cx43-3p, the hydrophobic residues in 1-5-10 binding mode,
M147, L151 and I159 stay close in one side of the helix; while two positive charged residues R148 and
K144 were inserted in between each of them. In another side of the helix, the positively charged residues
such as H142, R153 and K146 stay together. In the helical wheels of Cx43-2p, hydrophobic residues (F84,
M100) in 1-17 CaM binding mode are separated into both ends and hydrophilic residues such as P88 and
H95 are close to F84. In the helical wheel of Cx43-4p, the hydrophobic (I225, I226, F229, F232, and
F233) and charged residues (D227, K234, D238 and K241) are distributed on opposite ends of the helix.
4.2.2.

Monitoring formation of the peptide-CaM complex using Mass spectrometry.

Fig. 4.3AB shows the MALDI-MS spectra of the peptide, Cx43-2p and Cx43-4p (inset) and the
mixture of CaM incubated with these two peptides in the presence Ca2+. CaM (50 µM) was mixed with 50
µM Cx43 peptides (1:1 ratio) in 50 mM Tris-HCl, 100 mM KCl, and 1 mM CaCl2 at pH 7.5. The reaction
remained at equilibrium for at least half an hour. The data were acquired in a linear positive mode with
sinapinic acid (SA) as matrix for CaM and CaM-Cx43-2p/4p complex. A 1 µL mixture was added with
10 µL saturated SA solution and then dried on the MALDI plate for the measurement. Mass over charge
(m/z) of protein and peptide in MALDI-MS spectrum usually equal to their mass because they only take 1
charge with proton from matrix. Peptides Cx43-2p/Cx43-4p produced a major peak with the molecular
mass of 2693.4/2933.7 that is close to the calculated mass value of 2693.2/2933.4 ([M+H]+). The
molecule mass after subtracting the adduct (Na+, K+) and binding Ca2+ from the major peaks at 16.9 kDa
is consistent with the calculated mass of CaM, 16.7 kDa. The additional peak with molar mass of ~20
kDa is consistent with the expected value of the CaM-peptide complex. The error occurred in calculation
is from the slat adduct to the large molecule such as protein. Under this condition, CaM complexes with
Cx43-2p and Cx43-4p in 1 to 1 binding ratio were observed.
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4.2.3.

Monitoring the interaction between Cx43 peptides and CaM by NMR (1H, 15N)-HSQC
spectroscopy.

Using

15

N labeled CaM purified as previously described [188], we have examined the possible

interactions of peptides Cx43-2p and Cx43-4p with CaM in the presence of Ca2+. In the presence of 5
mM Ca2+ (zoom region in Fig. 4. 4A), T29, I27, G33, D64 and N137 in CaM exhibit further downfield
shift after adding Cx43-2p peptide, while A57 has its proton and nitrogen in further upfield shift. As
shown in Fig 4. 4B, addition of Cx43-2p resulted in the appearance of a new set of chemical shifts such as
G33 while the intensities of the existing set of resonances decreases. The induced chemical shift changes
by peptide suggesting it is in the slow exchange regime. Fig. 4.4C displays the chemical shift perturbation
in CaM induced by addition of 3-fold molar excess of Cx43-2p. The weight average chemical shift
change (∆δ) was calculated using Equation 2.5. E helix and H helix of C-lobe of CaM has higher
chemical shift than the entire N-lobe of CaM.
Fig. 4.5 shows that the addition of Cx43-4p also results in the change of chemical shifts of the
residues of CaM. Although the 3-fold molar excess of Cx43-4p were added into CaM solution, the
complex cannot reach to saturation as shown in Fig. 4.5A (spectrum with purple color) due to the limited
peptide solubility in the presence of 5 mM Ca2+. In this NMR spectrum, there are two sets of peaks
correlated to the free form and complex form for most of amino acids in CaM. Interestingly, the chemical
shifts of these residues G33 (Fig. 4.5C) and M145 (Fig. 4.5D) were initially small upon the addition of a
small amount of peptide Cx-4p with a ratio of CaM to peptide 0-1.0. It becomes significantly greater
when peptide concentration is further increased from ratio to 1.5 to 3.0. Both fast (D78 and T146) and
slow exchanges (G33 and M145) of chemical shifts were observed in the enlarged spectrum (Fig. 4.5D).
Fig. 4.5B depicts the chemical shift perturbation in CaM induced by addition of 3-fold molar excess of
Cx43-4p. Although the average chemical shift changes in C-lobe CaM is bigger than N-lobe CaM, B
helix and Ca2+ binding loop II in N-lobe of CaM has bigger chemical shift change compare to all helixes
in C-lobe of CaM.
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Fig. 4.6 summarizes the overall chemical shift changes of CaM upon addition of the three peptide
fragments from Cx43. Clearly, residues have significant chemical shift changes spread from both N- and
C- termini domain of CaM similar to that of Cx43-3p (Fig. 4.6B). Fig. 4.6A also confirms the result of
peptide sequence analysis that the different CaM binding modes exist in these CaM-peptide complexes
because they exhibit different change processes and chemical exchange behaviors.
4.2.4.

Determining CaM binding mode of holo-CaM-Cx43-2p complex by residue dipolar coupling.

Residual dipolar coupling (RDC) [189] has been used to assist in characterization of molecular
binding processes, determination of relative domain orientations in proteins with multiple domains, and
homology modeling [190, 191]. RDC measurements were performed on a Varian 800 MHz spectrometer
using a 0.8 mM 15N-labeled holo-CaM in complex with the Cx43-2p (1:2) in 5 mM MES, 10 mM BisTris, 0.1% NaN3, 5 mM CaCl2 and 10% D2O at pH 6.5. First, the 1H-15N isotropic couplings of the
complex were measured by a TORSY-based J-modulation experiment [192]. The dipolar coupling
between nitrogen and protein nuclei in the backbone for each amino acid depends on the distance between
them, and the angel of this bond between them is relative to the external magnetic field provide by NMR
instrument. It occurs when the protein molecule in solution exhibit a partial alignment with addition of
align medium such as Pf1 phage we used in this study. Upon completion of the experiment, Pf1 phage (70
mg/mL) in the same buffer was added to the complex sample such that the HDO signal was split to a
doublet (no window function applied and tn = “lk”) with a coupling of 10 ~ 13Hz. The final concentration
of Pf1 phage in the aligned sample is around 12.5 mg/ml. Pf1 phage is negatively charged in buffer
conditions and could interact with a positively charged sample. CaM is an acidic protein and should be
negatively charged at pH 6.5. However, the iso-electric point of Cx43-2p is 9.74, and it therefore takes
positive net charge ~1.1 at pH 6.5. Fortunately, precipitation was not observed when PF1 phage was
added into the sample containing high concentration of Cx43-2p peptide possibly because the positively
charged residues form a salt bridge with negatively charged residues of CaM in the binding interface. A
second J-modulation experiment with aligned sample was performed. Then RDC values were obtained by
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subtracting the isotropic couplings from the values measured in the phage alignment experiment. RDC
data were analyzed with CaM complex structures in different binding modes deposited in the protein data
bank (PDB). The missing proton information in the X-ray crystal structure was generated by SYBYL 6.7
(Tripos Inc.). The calculated RDC values based on known structures were fit to the experimentally
measured couplings using the program REDCAT [193].
Recently, RDC has also been applied to investigate the CaM and Cx43 binding mode with limited
structure information [68, 191, 194, 195], using the measured RDCs (CaM-Cx43-2p) with calculated
values in the PDB (Table 4.2). Both collapsed (PDB codes 2HQW, 1CDM, 1CDL, 1SY9, 1NIW, 1IQ5,
and 2BCX) and extended (PDB codes 1CFF, 1G4Y, 1K93, 2IX7 and 1NWD) CaM binding mode have
been examined. In collapsed CaM binding modes (1-7, 1-10, 1- 14, 1-16 and 1-17), both N lobe and C
lobe of CaM embrace the peptides in CaM binding domains. More than one peptide can bind CaM in its
extended binding mode (PDB codes 1G4Y, 1K93 and 1NWD). We also compared the data with the
structure of holo-CaM (PDB code 3CLN). The quality of the fit between calculated RDC and
experimental measured RDC is determined by the Q-factor and the agreement between domain
orientations. As listed in Table 4.2, the best correlation of measured and calculated RDCs (lowest Qfactor, 0.149) were calculated when the RDCs were fitted using the structure of gating domain from small
conductance K+ channel (SK channel, PDB codes, 1G4Y) [83]. Schumacher et al reported that the CaM
binding domain in SK channel forms a dimer in extended conformation with a CaM molecule (Fig 4.7A
inset). As shown in Fig 4.7 and Table 4.2, 33 RDCs were used in the CaM binding mode fitting. The
residues used for 33 RDCs fitting are almost evenly distributed with the exception of the linker region and
helix E (Fig 4.7B).
4.2.5.

Determining the binding affinity of Cx43-2p/4p-CaM complex by modified CaM with
fluorescence dye.

Dansyl-labeled CaM (D-CaM) and IAEDANS-labeled CaM (I-CaM) have been frequently used to
determine the binding affinity of CaM-peptide interaction due to its sensitivity to the changes in the
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surrounding chemical environment and its ease of preparation [108, 151, 196]. The dansyl moiety has an
emission maximum at ~500-510 nm, a range in which the signals from intrinsic aromatic residues are
negligible. However, as we report before, no significant fluorescence changes were observed for the
titration of D-CaM with Cx43-2p and Cx43-4p peptides [104]. Another fluorescence dye, IAEDANS, was
introduced to instate Cys at C-terminal of CaM to detect the CaM conformation change after binding with
these two peptides. As seen in Fig 4.9, I-CaM (2 µM with 1 mM Ca2+) showed a fluorescence maximum
at 484 nm. With the addition of Cx43-4p (Fig. 4.8A), the IAEDANS fluorescence emission maximum
blue-shifted to 473 nm with a concomitant enhancement of its fluorescence intensity (Fig. 4.8A) implying
that the IAEDANS group entered a more hydrophobic environment upon complex formation with peptide.
However, no significant fluorescent changes were seen upon the addition of the Cx43-2p peptide to ICaM probably because the Cx43-2p peptide binds to N-lobe of CaM which is far away to the dye
conjugated in the C-lobe of CaM By fitting the titration curve with hill equation (modified Equation 2.
6), we obtained a dissociation constant (Kd) 23.3 µM for the interaction between Ca2+-CaM and Cx43-4p
(Fig. 4.8B and Table 4.3). This is based on the assumption of that free peptide concentration is equal to
total peptide concentration when it is much higher than I-CaM (2 µM). The titration curve and hill
number (2) suggests the binding stoichiometry is more than 1 peptide per CaM molecule.
We also engineered and purified the C lobe of CaM with dansyl-labeled (D-C-CaM) to capture the
conformational change of CaM upon addition of Cx43-2p peptide. We first examined the dansyl
fluorescence anisotropy changes to confirm the formation of complex in the low micromolar range.
Fluorescence anisotropy is dependent on the rotational correlation time of fluorophore in the sample, and
is often used to reflect the hydrodynamic properties of biomolecules [152]. The increase in anisotropy
often arises from slower tumbling of the fluorophore and thus reports the formation of a larger complex.
Indeed, upon addition of 100 μM of Cx43-2p into 1 μM D-C-CaM, the anisotropy of the dansyl moiety
within D-C-CaM increased from 0.081 to 0.296, suggesting the association of Cx43-2p with Ca2+-CaM
(Fig. 4.9B inset). We then carried out the titration of peptide with D-C-CaM by monitoring the
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fluorescence emission between 400 nm and 600 nm. In the presence of Ca2+, D-C-CaM showed a
fluorescence maximum at 508 nm. With the addition of Cx43-2p (Fig. 4.9A inset), the dansyl
fluorescence emission maximum blue-shifted to 490 nm with a concomitant enhancement of its
fluorescence intensity (Fig. 4.9A) implying that the dansyl group entered a more hydrophobic
environment upon complex formation with peptide. By fitting the titration curve with a 1:1 binding mode
(Equation 2. 6), we obtained a dissociation constant (Kd) of 13 ± 4 µM (fluorescence anisotropy) and 77
± 5 µM (static fluorescence) for the interaction between Ca2+-CaM and Cx43-2p (Table 4.3).
4.3.

Discussion

4.3.1.

The binding stoichiometry between CaM and Cx43 peptides

Since the gap junction channel is a hexamer embedded into the membrane, to further understand the
regulation of gap junction by CaM, it is important to clarify the stoichiometry between CaM and these
three Cx43 peptides. As we reported previously [104], both NMR and fluorescence titration experiment
suggested that Cx43-3p peptide binds with CaM in a molar ratio of 1 to 1. In the HSQC-NMR spectrum,
peaks of G25, G33, A57, G61, D64, K94 and K148 in CaM were selected to indicate the global
conformational change of CaM upon addition of Cx43-3p peptide from 0 to 2 in a molar ratio. The
chemical shifts of these residues are clearly observed to stop moving after the peptide to CaM ratio
reaches to 1 to 1. In this study, however, it seems that the binding stoichiometry between Cx43-2p or
Cx43-4p peptide and CaM is greater than one. As shown in Fig. 4.4B, the bound form of G33 in CaM did
not appear until adding more than 1 molar ratio peptide and the free form of G33 in CaM disappears only
when Cx43-2p peptide to CaM ratio reaches to 3 to 1. Similarly, as shown in Fig. 4.5C, between the mix
ratios from 0 to 1-fold molar excess of Cx43-4p, G33 in CaM went through fast exchange when
interaction occurred. After adding Cx43-4p peptide to CaM solution at increasing ratios from 1.5 to 3, the
decrease of the peak intensity of G33 was accompanied by an increase in the corresponding peak intensity
(bound form) at a new position (N, 8.95 ppm and H, 107.0 ppm). The concentration of the peptides was
calculated by weight, purity, dissolving volume and molecule weight and it was confirmed by UV
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absorbance of tyrosine (two Tyr for each peptide). The NMR experiments for both peptides interacting
with CaM have been repeated in both 600 MHz and 500 MHz NMR in our lab. In addition, when the
RDC data was collected in 800 MHz at University of Georgia, the CaM-Cx43-2p complex HSQC
spectrum could not reach saturation at a ratio of two peptides per CaM because peaks in two components
were observed. We conclude that more than one Cx43-2p or Cx43-4p peptide binds with CaM based on
the evidence from NMR experiment.
As shown in Fig. 4.9B, the binding curve for I-CaM titrated with Cx43-4p peptide only can be
fitted by the Hill equation. The Hill number is 1.99, which indicates more than 1 Cx43-4p peptide binding
with CaM and the cooperative binding between them. However, I-CaM did not show any fluorescence
change upon addition of Cx43-2p peptide. In MALDI-MS spectrum, we also observed the complex
molecule with two peptides and one CaM for both peptides (in the higher range of m/z and data not
shown in Fig. 4.2). It could be matrix artificial effect (Sample co-crystallization with matrix and matrix
may facilitate the complex formation) and ESI-MS monitoring the interaction in solution interface will be
used as another control to demonstrate the complexes of multiple peptides with CaM in solution phase.
It is also important to clarify the differences of binding affinities between these three peptides and
CaM. As shown in Table 4.3, the dissociation constants determined by fluorescence are Cx43-3p > Cx434p > Cx43-2p. However, in the HSQC-NMR spectrum (Fig. 4.4 & 4.5), the binding affinities between
CaM and all the peptides are in the different manner because the chemical exchange rates from fast to
slow are Cx43-3p > Cx43-4p > Cx43-2p. The possible reasons for the inconsistent results are, 1) the 1 to
1 binding equation used in the fluorescence experiments may not be optimal because more than 2 to 1
stoichiometry was observed in NMR experiment; 2) upon addition of Cx43-2p, the fluorescence of both
dansyl and IAEDANS group in CaM does not change and dissociation constant is only available from
dansyl labeled half-CaM which is not equal to the entire CaM molecule. Further study of the binding
affinity measurement requires additional experiments such as surface plasmon resonance (SPR) which
could provide both dissociation constants and kinetic information with more accuracy. Fluorescence and
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anisotropy fluorescence data, somehow, at least indicate that the binding between them is confirmed and
CaM should interact with all peptides in different regions.
4.3.2.

The CaM binding modes between CaM and Cx43 peptides.

CaM was reported to bind with more than 150 target proteins in different binding modes [62]. More and
more proteins, especially channel proteins and enzymes like protein kinases, have been reported to bind
CaM with more than one binding sites. The multiple roles of CaM in regulation of certain proteins require
multiple interaction domains. In 1988, Ladant identified two separated CaM binding domains (CaMBD)
in Bordetella pertussis adenylate cyclase [197]. Two years later, Trewhella et al. studied the solution
structure of CaM complexes with two peptides, PhK5 (342-366) and PhK13 (301-326) from the catalytic
subunit of phosporylase kinase [198]. They discovered that binding of PhK5 to CaM induces a compact
formation of CaM while CaM remains extended upon binding of PhK13. But in the presence of both
peptides (PhK5 and PhK13), CaM still keeps the extended conformation [198]. The other enzymes such
as adenylyl cyclase type I and II, synapsin I, plant glutamate decarboxylase and caldesmon have also
been found to have multiple regions that bind CaM [199-202]. Interaction of CaM with multiple binding
sites of the olfactory and rod cyclic nucleotide-gated channels, the plasma membrane Ca2+ pump, TRP
channels, Cav1.2 Ca2+ channels and ryanodine receptor has also been reported [77, 203-206].
According to the structure of CaM in the binding complex, CaM binding modes can be classified
as two major groups, collapsed and extended conformation. In our previous report, Cx43-3p in cytosolic
loop region of Cx43 has been suggested to bind with CaM in the 1-10 binding mode, in which CaM is in
a collapsed conformation and embraces the peptide in its central loop region [104]. The 1-10 motif refers
to a group of sequences whose key hydrophobic residues are spaced 9 residues apart as it was first
reported for the CaM binding domain in CaM dependent kinase I and II [68, 207].
Based on extensive studies using various approaches such as proteinase digestion [208, 209], several
CaM binding regions within the RyR1 primary sequence such as RyR11975-1999 and RyR13614-3643, have
been identified by Hamilton and co-workers [210, 211]. As shown in Fig. 4.1 and Table 4.1, the
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sequence of Cx43-2p fits very well with RyR13614-3643 as the 1-17 CaM binding mode. They both contain
the key hydrophobic residues at positions 1 and 17 in the binding interface with CaM and a positively
charged arginine right after position 17. As shown in Table 4.2, calculated RDC values for the CaMCx43-2p complex are similar to the CaM-RYR1 complex (PDB code: 2BCX) in a 1-17 CaM binding
mode (31 residues with Q = 0.198). However, the best aligned structure with calculated RDC values is
CaM with peptide fragments from the gating domain of the potassium channel (SK channels) (33 residues
with Q = 0.149). As shown in Fig. 4.7B, 33 residues with RDC values in binding mode determination are
almost evenly distributed in CaM with the exception of the linker region and helix E. Unlike gap junction
proteins, small-conductance Ca2+-activated K+ channels (SK channels) are independent of voltage and
gated only by intracellular Ca2+ [212, 213]. Schumacher et al. solved a crystal structure of CaM complex
which provides an evidence of both Ca2+-dependent and

-independent CaM interaction with SK

channel CaMBD [83]. It this structure, a pocket (pocket 1) in N-lobe and 3 pockets in C-lobe of holoCaM have been identified to interact with the SK channel CaMBD. A complementary hydrophobic
binding pocket in Ca2+ CaM N-lobe is created by Phe 12, Phe 19, Val 35, Met 36, Leu 39, Phe 68, Met 71
and Met72. In CaM C-lobe, three additional pockets, pocket 2 with Met 124, Phe 141 and Met 144,
pocket 3 with Phe 89, Phe 92, Leu 105 and Met 109, and pocket 4 with Val 91 and Phe 92, has also been
located in this paper [83] . Table 4.4 summarizes all chemical shift changes between the Ca2+-CaMCx43-2p Complex and Ca2+-CaM in HSQC-NMR spectrum. It is clear that all the key residues in the SK
channel CaMBD binding pockets have larger chemical shift changes in our complex. The changes for
most of them are greater than 0.1 ppm, which is large enough to be considered as a possible binding
interface. However, the incomplete assignment limits the agreement such as the unavailable Val 91 and
Phe 92 in pocket 4. According to the RDC data and the comparison of chemical shift changes, we can
conclude that the CaM binding mode of Ca2+-CaM-Cx43-2p Complex is similar as the manner in SK
channels. The interaction is involving multiple CaM binding regions and CaM is in an extended mode
which is quite different as we proposed for Cx43-3p previously [103, 104, 179].
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4.3.3.

Comparison of CaM binding domains with α-, β-, γ- and δ-family.

CaM binding domains (CaMBD) of the connexin proteins in different gap junction subfamilies have been
reported previously. The vertebrate connexin family has been summarized and defined as four major
groups, which are group I (β-family), group II (α-family), group IIIa (δ-family) and group IIIb (γ-family)
[94, 214]. Cx56 in α-family, the primary gap junction protein in chicken lens, is the first CaM binding
connexin protein in a Ca2+-dependent manner identified in 1982 [215]. In mammal lens fiber cells,
inhibition of cell-to-cell communication by elevated [Ca2+]i was first demonstrated as an increased
internal electrical resistance [216] that was prevented by pre-incubation with CaM antagonists[217-219].
The rapid onset of this inhibition (within seconds) suggests that this is mediated by a direct interaction of
CaM with one or more of the Cxs. Our lab has reported that CaM interact with the second half of the
intracellular loop of three major Cxs in α-family, Cx43, Cx44 (sheep homologue of human Cx46) and
Cx50 in lens fiber cells [103, 104, 179]. The CaM binding modes for these regions has been suggested to
be like CaM-CaMKII having the 1-5-10 subclass [103, 104, 179]. Our preliminary data also indicates that
the same region of cytosolic loop of the γ-family Cx45 also interacts with CaM and the proposed binding
mode is similar to the α-family.
CaM has also been found to co-localize with Cx32 in the β-family [105] and directly gates Cx32containing GJs [106]. Török et al. [185] reported that fluorescently labeled CaM derivatives bind to
synthetic peptides covering most of the cytoplasmic sequences of Cx32 and they identified two regions,
one at the N-terminus, and another at the C-terminus, showing Ca2+-independent CaM-binding properties
[185]. Dodd et al. also identified two distinct CaM-binding amino acid sequences in Cx32 within the Nand C-lobes of CaM showing separate functions, suggesting trans-domain or trans-subunit bridging by
CaM as a possible mechanism of GJ gating [184]. Using in vitro synthesis approaches, we have shown
that oligomerization of Cx32 is CaM-dependent [161] suggesting CaM interacts with Cxs at an early
stage of GJ assembly [100, 185]. Blodow et.al reported that CaM antagonists suppress GJ coupling of
Cx26 in isolated Hensen cells of the guinea pig cochlea [162]. However, there is still no clear evidence
for the direct interaction of CaM with Cx26. Interestingly, the same CaMBD of Cx34.7, Cx35 and Cx36
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in δ-family also has been reported [182]. The CaM interaction in these three δ-family gap junction
proteins is in concentration and Ca2+-dependent manner with rapid kinetics. Two possible binding sites,
with a high affinity (~ 72 nM) and a low affinity (~2.4 µM), have been identified in SPR measurement
with two-component model. The weaker dissociation constants of CaM with Cx43-2p or Cx43-4p by
fluorescence could be due to the same reason. The average dissociation constants we observed in these
experiments may contain both weaker and strong binding processes. The possibility of CaM binding with
intracellular loops of these Cxs has been eliminated in this paper as well [182]. The sequence of binding
region at C-terminal of Cx43 (Cx43-4p) can be aligned well with the same region in Cx32 (β-family) and
Cx36 (δ-family) (Fig. 4.1). However, CaM binding modes for both β-family and δ-family have not been
reported previously. The RDC experiment for determining the CaM binding mode of Ca2+-CaM-Cx43-4p
is under preparation. Cx43, the most ubiquitous connexin in mammal, should contain the unique CaM
binding properties crossing all the gap junction families.
4.3.4.

Disease implications in CaM binding domains.

Three CaM binding regions in Cx43 are highly conserved in the alpha family. Germ line mutations in
nearly 50% of the genes that encode 21-member Cxs are linked to one or more human diseases including
deafness, Oculodentodigital dysplasia (ODDD), cataract and Charcot-Marie-Tooth disease [186, 220].
Congenital cataracts are attributed to mutations in the genes encoding Cx46 and Cx50 [221, 222]. While
some of these disease causing mutations are autosomal recessive, some are autosomal dominant [223].
For example, autosomal dominant mutations in GJA1 genes encoded Cx43 cause the mild developmental
disorder, oculodentodigital dysplasia (ODDD). While it is difficult to establish how these genotypic
changes lead to disease outcomes, given the broad and overlapping distributions of Cxs in a wide range of
tissues, we have noticed that quite a few disease-linked mutations reside within the intracellular loop
regions, which we have shown are important for the regulation of these Cxs. Table 4.5 summarizes all the
ODDD disease mutations which overlap with the CaM binding regions we reported here and previously
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[104, 186]. It implicates that CaM binding regions in Cx43 are the potential therapeutic target which
could prevent ODDD diseases.
4.3.5.

The role of CaM in regulation of Cx43.

CaM accessibility within the assembled channel is a major consideration because all the predicted and
identified CaMBD in Cx43 involves transmembrane domains (TM). The Cx43-2 site is predominantly
located within the TM2. Pro 88 (Pro 87 in β-family) is highly conserved and critical for gating [224, 225].
This locus is also in the middle of the TM2 domain that probably ends within the FYV sequence of this
predicted sequence (the RKEE is certainly cytoplasmic). The Cx43-4 site probably also contains ~34.8%
transmembrane region since the TM4 domain likely ends with the FYVFF sequence. Accessibility to
cytosolic CaM is a major question with this site within the assembled channel. However, the reported
Cx36 C-terminal CaMBD also involves TM4 (~ 34.8%). In addition, CaMBD located at TM in the pore
lining surface may be exposed to the solvent and become accessible to CaM. Even the pore is open
widely enough to provide the binding surface for CaM since we propose the CaM binds with Cx43-2p in
an extended mode which only require N-lobe or C-lobe of CaM (Fig. 4.7).
Protein-protein interaction plays an essential role in channel localization and activity and gap
junction protein are involved in different cellular functions by interacting with many other proteins. For
example, the C-terminal tail of Cx43 has been reported to bind with SH2 and SH3 domains of sarcoma ,
PDZ domain of zonula occludes-1, N-cadherin, protein kinase C, CaM, CaM dependent protein kinase II
and microtubules [99, 226]. Identified microtubule binding region at the C-terminal of Cx43 overlaps
with our reported CaM binding region here (Cx43-4p) [227]. Shaw et al. reported that delivering Cx43
hemi gap junction channel into plasma membrane requires microtubule proteins [228]. However, both
groups did not mention the role of CaM and the possibility of CaM being involving in this cellular event
cannot be eliminated. The CaM and microtubule binding domains are localized to overlapping regions at
N-terminus of p35 (the neuronal activator of Cdk5) [229]. Ca2+-CaM inhibits p35 association with
microtubules, suggesting p35 may be involved in the Ca2+-CaM mediated inhibition of microtubule
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assembly [229]. CaM has also been also reported to bind with microtubule-associate proteins 2 and 6
which facilitate microtubule assembly and stabilize tubulin structure [230, 231]. Passareiro et al. reported
that two structure domains of calmodulin interact with mature and immature rat brain microtubules [232].
Ahmad et al. also suggested that CaMBD in the C-terminal tail of Cx32 likely regulates connexin
oligomerization [233]. Therefore, our hypothesis is that CaM involved in the hemi-gap junctional
trafficking into plasma membrane through microtubules and CaMBD at C-terminus of Cx43. In the
proposed model (Fig. 4.11), CaM binding to Cx43-4p region induces connexon hexamer assembly of the
hemi gap junction channel in Golgi apparatus. With help from CaM at Cx43-4p region, gap junction
hemi-channels traffic through microtubule proteins into plasma membrane. After formation of functional
channels with adjacent cell, CaM sticks at the Cx43-2p region in the cytosolic calcium concentration.
CaM starts to bind to the additional region Cx43-3p when local Ca2+ concentration increases. CaM
binding to Cx43-3p region in the presence of Ca2+ regulates the closure of the channel. The
phosphorylation of Cx43 in the C-terminal tail may trigger its internalization and degradation. CaM
binding to Cx43-4p region may protect gap junction from CaM kinase II (CaMKII) phosphorylation
which also function as a hexamer. There is no clear evidence to support that CaM involve in gap junction
protein degradation. Further investigation into the function of CaM induced gap junction trafficking is
required.
4.4.

Future plan.

a. Peptide competition experiment in CaM binding sites of Cx43 by HSQC NMR.
b. CaM binding modes determination of CaM-Cx43-3p and CaM-Cx43-4p complex by RDC NMR
measurement.
c. Binding affinities measurement and stoichiometry between CaM and three Cx43 peptides by SPR and
ESI-MS.
d. Proposed functional studies (Dr. Richard Veenstra)
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4.5.

Summary and conclusion

Gap junction, allowing the intercellular transmission of molecules through its specialized cell membrane
channels, plays a major role in intercellular calcium signaling between adjacent cells. Connexin43 (Cx43),
the most ubiquitous connexin, belongs to α family of gap junction proteins expressed in heart where are
essential for normal heart development. Calmodulin (CaM) has been implicated in mediating the Ca2+dependent regulation of gap junctions. We have reported CaM binding site in the second half of
intracellular loop of Cx43. In this study, two additional CaM binding regions in cytosol loop and Ctermini of Cx43 have been identified by biophysical studies. Our results indicate that in the presence of
Ca2+, synthesized Cx peptide fragments, Cx43-2p and Cx43-4p, encompassing predicted CaM binding
regions are able to bind with high affinity to CaM using NMR spectroscopy. Unlike Cx43-3p, the
suggested stoichiometry of these new discovered peptides binding with CaM is greater than one. The
NMR RDC result suggests that the CaM binding mode of Cx43-2p to CaM is similar as CaMBD in SK
channel in an extended mode. Our results elucidate the molecular level of regulation of Cx43 by multiple
CaM targeting regions and provide a proposed model about how CaM regulate gap junction assemble,
trafficking and gating.
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Figure 4. 1 Connexins membrane topology putative CaM-binding sites of Cx43.
The integral α-class of connexins are composed of four transmembrane (TM) segments, two extracellular loops, one cytoplasmic loop (separated
as the green box 2 and the blue box 3), a short N-terminus (the black box 1) and a much longer C terminal tail (the purple box 4). Three potential
CaM binding sites of Cx43 illustrated in the intracellular region of connexins from 1 to 4 are listed in the table box colored with corresponding
regions. Two of them named as Cx43-2p and Cx43-3p are located in the intracellular loop between TM2 and TM3; Cx43-4p is located in the Cterminal tail. The numeric score (1-9) represents the probability of an accurate prediction of high affinity CaM binding sites. The sequence of
Cx43-2p is aligned very well with peptide (3619-3643) from Ryanodine receptor 1 (RyR1) which fits 1-17 CaM binding mode subclass. The
aligned sequence of Cx43-3p fit the 1-5-10 CaM-binding mode subclass. The identified CaM-binding sequences from the α-class connexins in the
second half of intracellular loop (box 3) are similar to the Ca2+-CaM-dependent kinase II (CaMKII). Each number represents the presence of a
hydrophobic residue in blue color. The predicted CaM Binding sequences of Cx43 and Cx32 in the C-tail (box 4) share the most similarity. The
CaM binding mode of Cx32 in this region has not been determined. h, human; m, mouse; r, rat; s, sheep; B, basic residues (red); A, acidic
residues; #, hydrophobic residues (blue); ?, the potential hydrophobic residue which could determine the binding modes.
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Figure 4. 2 The predicted CaM binding sequences in Cx43.
A, the primary sequence of Cx43 (NP_000156.1).The predicted high affinity CaM binding site (136-158
highlighted above green line, box 3 in Fig.1) of highest predicted score (13) is located in the second half
of the intracellular loop between TM2 and TM3. Two other regions (86-107 highlighted above blue line,
box 2 in Fig.1; 224-247 highlighted above purple line, box 4 in Fig.1) with lower scores are also
predicted. B, helical wheel displays of the CaM binding sites, Cx43-2p, Cx43-3p and Cx43-4p (Helical
Wheel
Projections
created
by
Don
Armstrong
and
Raphael
Zidovetzki
http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). Circles, hydrophilic residues; diamonds, hydrophobic
residues; triangles, negative charged residues; pentagons, positive charged residues. Hydrophobicity is
decreasing proportionally to the amount of green color. The most hydrophobic residue is green and zero
hydrophobicity coded as yellow. Hydrophobicity is based on the whole residue interface scale.
Hydrophilic residues are coded red and the residues with charge are light blue. 18 residues of each CaM
binding domain with highest scores are presented in the helical wheel.
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Figure 4. 3 Monitoring CaM-Cx43-2p and CaM-Cx43-4p complex formation by MALDI mass
spectrometry.
The MALDI-MS spectra of the free form of CaM (~17 kDa) and the complex form of CaM-Cx43-2p (A)
and CaM-Cx43-4p (B) (~20 kDa). The inset shows the molecular weight of the Cx43-2p (A) and Cx43-4p
(B) peptides. 50 µM CaM was mixed with 50 µM Cx43 peptides (1:1) in 50 mM Tris-HCl, 100 mM KCl,
1 mM CaCl2 at pH 7.5. The reaction was equilibrium for at least 30 minutes. The data were acquired in a
linear positive mode with sinapinic acid (SA) as matrix for CaM and CaM-Cx43-2p/4p complex. A 1 µL
mixture was added with 10 µL saturated SA solution and then dried on the MALDI plate for the
measurement. The molecular weight of the Cx43 peptides was confirmed by MALDI in reflectron
positive mode with α-Cyano-4-hydroxycinnamic acid (CHCA) as matrix.
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Figure 4. 4 Monitoring the interaction between holo-CaM and Cx43-2p peptide by (1H, 15N)-HSQC
spectroscopy.
A, an overlay of HSQC spectra of holo-CaM (red) with the spectrum of the holo-CaM-Cx43-2p
(blue).The Cx43-2p peptide is from the first half of intracellular loop (highlighted in red color in the top
cartoon) in Cx43. As indicated in the zoom in graphs, T29, I27, G33, D64 and N137 in CaM exhibit
further downfield shift after adding Cx43-2p peptide; while A57 has its proton and nitrogen in further
upfield shift. B, the chemical shift change of Gly33 during titration of holo-CaM with Cx43-2p. The
disappearance of the peak (free form) was accompanied by the appearance of the corresponding peak
(bound form) at a new position. C, chemical shift perturbation in CaM induced by addition of 3-fold
molar excess of Cx43-2p. The weight average chemical shift change (∆δ) was calculated using Equation
5. E helix and H helix of C-lobe CaM has higher chemical shift compare to N-lobe CaM.
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Figure 4. 5 Monitoring the interaction between holo-CaM and Cx43-4p peptide by (1H, 15N)-HSQC
spectroscopy.
A, an overlay of HSQC spectra of holo-CaM (red) with the spectrum of the holo-CaM-Cx43-4p
(purple).The Cx43-4p peptide is from the C-terminal tail (highlighted in red color in the inset) in Cx43. B,
chemical shift perturbation in CaM induced by addition of 3-fold molar excess of Cx43-4p. The weight
average chemical shift change (∆δ) was calculated using Equation 2.5. Although the average chemical
shift changes in C-lobe CaM is bigger than N-lobe CaM, B helix and Ca2+ binding loop II in N-lobe CaM
has bigger chemical shift change compare to all helixes in C-lobe CaM. C, the chemical shift change of
Gly33 during titration of holo-CaM with Cx43-4p. Between the mix ratios from 0 to 1-fold molar excess
of Cx43-4p, G33 went through fast exchange when interaction occurred. After adding Cx43-4p peptide
from to 1.5 to 1 ratio, the decrease of the peak intensity of G33 was accompanied by the increase of the
corresponding peak intensity (bound form) at a new position. D, D78 and T146 in CaM-Cx43-4p
interaction behaves as fast exchange; while M145 has similar binding pattern as G33.
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Holo‐CaM + Cx43‐2p
Holo‐CaM + Cx43‐3p
Holo‐CaM + Cx43‐4p

Figure 4. 6 Comparison of the three CaM binding sites of connexin43 in (1H, 15N)-HSQC spectrum.
An overlay of the HSQC spectra of holo-CaM-Cx43-2p complex (cyan), holo-CaM-Cx43-3p complex (yellow), and holo-CaM-Cx43-4p complex
(violet). Due to dramatic differences in these three spectrum, they are not the same CaM binding mode. E6 residue was selected to align all three
spectrum because it did not move during the peptide titration.
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Figure 4. 7 Comparison of the three CaM binding sites of connexin43 in chemical shift.
An overlay of chemical shift perturbation in CaM induced by addition of Cx43-2p (cyan), Cx43-3p (yellow), and Cx43-4p (violet).
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Figure 4. 8 CaM binding mode determination of holo-CaM-Cx43-2p complex by residue dipolar coupling (RDC).
A, correlations between experimentally determined 1H-15N RDCs of the holo-CaM-Cx43-2p complex and the best fit RDC values calculated using
the structure of holo-CaM-K+ channel complex (pdb code: 1G4Y, the inset is the cartoon picture of its structure). CaM (purple) binds to the Ca2+
activated K+ channel (blue) with a 2 to 2 binding ratio in an extended mode. The quality factor (Q) of the fitting is 0.149. B, the distribution of
CaM residues used in structure comparison. Top panel is CaM (14GY) cartoon structure drawing with PyMOL (red, residues in CaM used in RDC
value calculation; grey, CaM; green, Ca2+). 33 residues (red dots) from CaM were used in binding mode determination. (bottom panel). They are
almost evenly distributed with exception of the linker region and helix E.
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Figure 4. 9 The interaction of Cx43-2p and Cx43-4p peptide with IAEDANS-CaM (I-CaM) monitored by steady-state fluorescence.
A, the fluorescence spectrum of I-CaM (2 µM) in the absence of (dash lined with hollow dots) and in the presence of (solid line with solid dots)
Cx43-4p in a buffer consisting of 1 mM Ca2+, 100 mM KCl, 50 mM Tris-HCl, 10 mM DTT at pH 7.4. The inset shows the fluorescence spectrum
of I-CaM (2 µM) with and without Cx43-2p in the same condition. B, the titration curve of I-CaM (2 µM) with Cx43-4p in the presence of 1mM
Ca2+.
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Figure 4. 10 The interaction of Cx43-2p peptide with Dansyl labeled C lobe of CaM (D-C-CaM) monitored by steady-state fluorescence
(A) and anisotropy fluorescence (B).
A, the fluorescence titration curve of D-C-CaM (1 µM) in the presence of 1mM Ca2+ with Cx43-2p in a buffer consisting of 1 mM Ca2+, 100 mM
KCl, 50 mM at pH 7.4. The inset shows the fluorescence titration spectrum before (broken line with hollow dots) and after (continuous line with
solid dots) adding Cx43-2p peptide into D-C-CaM. B, the anisotropy fluorescence titration curve of D-C-CaM (1 µM) with Cx43-2p in the same
condition. The inset shows the anisotropy change for D-C-CaM (free, light gray bar), and the complex of D-C-CaM-Cx43-2p (bound, dark gray
bar).
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Figure 11
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Figure 4. 11 Proposed model of Ca2+/CaM regulation of assembling, trafficking, permeability and
degradation in gap junction.
In the proposed model, Cx43 was synthesized at endoplasmic reticulum membrane (ER, double circle in
blue color, yellow color inside indicates the high calcium concentration at 10-4 M). CaM binding to Cx434p (black ellipsoid) region induce the hemi-channel formation of gap junction hexamer (grey cylinder and
circle) at Golgi apparatus (GA) With help of CaM in Cx43-4p region, gap junction hemi-channels traffic
through microtubule proteins (green bar) into plasma membrane (PM). Purple dots stand for lipids and
light yellow color indicates the increase of local Ca2+ concentration. After formation of functional
channels with adjacent cell, CaM sticks at Cx43-2p region (green ellipsoid) in the cytosolic calcium
concentration. CaM starts to bind to the additional region Cx43-3p (red ellipsoid) when local Ca2+
concentration increase. CaM binding to Cx43-3p region in the presence of Ca2+ regulates the closure of
the channel. The phosphorylation of Cx43 in the C-terminal tail may trigger its internalization and
degradation. CaM binding to Cx43-4p region (black ellipsoid) may protect gap junction from CaM kinase
II phosphorylation as well. However, there is no clear evidence to support that CaM involve in gap
junction protein degradation. ER, endoplasmic reticulum membrane; GA, Golgi apparatus; PM, plasma
membrane.
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Table 4. 1 Sequence of CaM binding sites in Cx43 aligned with sequence of peptides from different CaM binding mode in
collapsed subclass.
Binding
Mode

1 – 7
NMDA
receptor
NR1 C1

Cx43-2p

FVSVPTLLYLAHVFY-VMRKEEKLN- 24
-KKKATFRAITSTLASSFKRRRSSK- 24
. .*: :: .:
:::... :

1 – 10
CaMKII

FVSVPTLLYLA-HVFYVMRKEEKLNK 24
LKKFNARRKLKGAILTTMLATRNFS– 24
: .. :
*
:: .*
.::.

1 – 14
CNG
channel

IFVSVPTLLYLAHVFYVMRKEEKLN-K- 26
-QQRRGGFRRIARLVGVLREWAYRNFR- 26
: :*::. *:*:
* :

1 – 16
CaMKK

IFVS-VPTLLYLAHVFYVMRKEEKLNKK 27
RFPNGFRKRHGMAKVL-ILTDLRPIVRV 27
* . . .
:*:*: :: . . : :

1 – 17
RyR1

IFVSVPTLLYLAHVFYVMRKEEKLN 19
VWHKLLSKQRRRAVVACFRMTPLYN 19
:: .: :
*. :*
*

Cx43-3p

FKYGIEEHGKVKMRGGLLRTYIIS 23
KKKATFRAITSTLASSFKRRRSSK 23
* . . . .: ..: *
.

FKYGIEEHGKVKMRGGLLRTYIISI--- 25
LK---KFNARRKLKGAILTTMLATRNFS 25
:*
: :.: *::*.:* * : :

KFKYGIEEHGKVKMRGGLLRTYIIS-I- 26
QQRRG--GFRRIARLVGVLREWAYRNFR 26
: : *
. ::
*:** :
:

KFKYGIEE-HGKVKMRGGLLRTY--IISIL 27
RFPNGFRKRHGMAKVL--ILTDLRPIVRV- 27
:* *:.: ** .*:
:*
*: :

KKFKYGIEEHGKVKMRGGLLRTYIISILFK 29
KSKKAVWHKLLSKQRRRAVVACFRMTPLYN 29
*. *
.: . : * .:: : :: *::

Cx43-4p

NIIELFYVFFKGVKDRVKGRSDPY 23
KKKATFRAITSTLASSFKRRRSSK 23
:
* .: . : . .* * ..

LNIIELFYVFFKGVKDRVKGRSDPY- 25
LKKFNARRKLKGAILTTMLATRN-FS 25
*: ::
: .:
: . : :

LNIIELFYVFFKGVKDRVKGRS-DPYH 25
QQRRGGFRRIAR-LVGVLREWAYRNFR 25
:
* : : : . :: :
::

LNIIELFYVFFKGVKDRVKGRSDPYHA- 27
-RFPNGFRKRHGMAKVLILTDLRPIVRV 27
.: : *
. .* :
*

LALNIIELFYVFFKGVKDR-VKG--RSDPYHAT 29
--KSKKAVWHKLLSKQRRRAVVACFRMTPLYN- 29
.
::: ::. : * * . * * :
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Table 4. 2 CaM binding modes and Q factors of the fitting of experimentally measured RDCs of the Ca2+-CaM-Cx43-2p complex.

Pdb

Target protein

Binding Mode

Q-factor

RMSD

No. of RDC

2HQW

Glutamate NMDA receptor subunit zeta 1

1‐7

0.184

2.07

34

1CDM

CaMKII

1‐10

0.175

2.11

40

1CDL

CaMKII alpha chain

1‐10

0.183

2.21

38

1NIW

Endothelial nitric‐oxide synthase

1‐14

0.172

2.06

37

1SY9

Cyclic‐nucleotide‐gated olfactory channel

1‐14

0.170

2.02

38

1IQ5

Ca2+/calmodulin dependent kinase kinase

1‐16

0.179

2.03

38

2BCX

Ryanodine receptor I

1‐17

0.198

2.24

31

1CFF

Ca2+ pump

Extended

0.258

2.55

27

1G4Y

Gating domain of K+ channel

Extended

0.149

1.72

33

1K93

Adenylate cyclase domain of anthrax
edema factor

Extended

0.215

1.81

24

2IX7

Myosin 5A

Extended

0.235

2.23

27

1NWD

Plant glutamate decarboxylase

Partially
extended dimer

0.242

2.63

24

3CLN

Calcium‐bound CaM

N.A

0.2496

2.05

21
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Table 4. 3 The binding affinities (µM) of Cx43 peptides to CaM (NMR), D-CaM and I-CaM.

CaM-Cx43

Cx43-2p

D-CaM

77 ± 5

I-CaM
b

NMR

Cx43-3p

Cx43-4p

0.86 ± 0.02

NA

ND

NA

23.3

slow

fast

slow and fast

a

a, data obtained from dansyl labeled C-lobe of half CaM
b, chemical shift of slow exchange in NMR usually indicates strong binding (~ 10-8 M );
chemical shift of fast exchange in NMR usually indicates relative weak binding (~ 10-6 M );
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Table 4. 4 Comparison of NMR chemical shift of CaM-Cx43p in identified CaM binding pockets of SK channel.

CaM-Cx43-2p

Pocket 1

Pocket 2

Pocket 3

Pocket 4

AA , Δ NH-H (ppm)

Phe 12 (0.128), Phe 19 (N.A.),
Val 35 (0.146), Met 36 (N.A.),
Leu 39 (0.049), Phe 68
(0.062),
Met 71 (0.120), Met 72 (N.A.).

Met 124 (N.A.),
Phe 141 (0.158),
Met 144 (N.A.).

Phe 89 (0.149),
Phe 92 (N.A.),
Leu 105 (0.121),
Met 109 (N.A.).

Val 91 (N.A.),
Phe 92 (N.A.).

AA, amino acid;
N.A. not available due to incomplete assignment.
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Table 4. 5 Oculodentodigital dysplasia (ODDD) disease mutation overlapping with Cx43 CaMBD.

Cx43 CaMBD

Cx43-2p

Cx43-3p

Cx43-4p

ODDD disease
mutations

L90V, H95R,
V96M, V96E,
V96A, Y98C,
K102N, L106P.

G138R, G138S, G143S,
G143D, K144E,
V145G, M147T,
R148G, R148Q,
T154A, T154N.

Y230
Truncation*

* The Y230 Cx43 ODDD mutations alters 6 amino acids before truncating the protein after 236.
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5. IDENTIFICATION OF EF-HAND CA2+ BINDING PROTEINS IN VARIOUS
BIOLOGICAL SYSTEMS
5.1.

Introduction

Cells maintain a Ca2+ concentration in a gradient of 20,000-fold between their intracellular (~ 100 nM
free) and extracellular (mM) regions. Hundreds of cellular proteins have been identified to bind Ca2+
over a 106-fold range of affinities (nM to mM) (Fig. 1.3A). Ca2+ binding has been shown to be
essential for stabilizing proteins as well as maintaining physiological cellular free Ca2+ concentrations
as seen in buffer proteins such as calbindin D9k in mammalian intestinal epithelial cells (Fig. 1.3D).
Depending on the nature of the Ca2+-modulated event, some of these cellular proteins have been
adapted to buffer Ca2+ concentration in low levels and others have been adapted to trigger cellular
events by affecting Ca2+ concentration change. As shown in Fig. 1.2, Bacterial cells also have a wellregulated cytosolic free Ca2+ concentration (approximately 0.1-2 M) that is significantly lower than
that observed in the extracellular medium (mM) due to Ca2+ transporters and channels [234-237].
Viruses, on the other hand, utilize the universal Ca2+ signal to create a specific cellular environment to
increase their viability

(Fig. 5.1). Ca2+ plays important roles in viral gene expression, post-

translational processing of viral proteins, virion structure formation, virus entry, and virion maturation
and release.

5.1.1.

EF-hand Ca2+ binding proteins and protein grafted approach

Ca2+ binding sites in proteins are classified as either non-continuous or continuous. For the protein
with a continuous Ca2+ binding loop, a helix-loop-helix structure domain with Ca2+ binding capability
was named as EF-hand motif because it is like the spread thumb and forefinger of the human hand, in
which the Ca2+ ions are coordinated by the ligands within the loop. The term of EF-hand motif was
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first used by Kretsinger to describe the Ca2+ binding by parvalbumin which is also a Ca2+ buffer
protein in fast-contracting muscles [29]. Based on the conserved features of the Ca2+ binding loop,
EF-hand proteins have been divided into two major groups: the canonical EF-hands as seen in CaM,
and the pseudo EF-hands exclusively found in the N-termini of S100 and S100-like proteins [22].
At present, more than 1000 protein with EF-hand motifs have been found in prokaryotes and
eukaryotes and they can be classified into 77 distinct subfamilies [238-240]. However, there are likely
numerous Ca2+ binding proteins which contain an EF-hand motif in bacterial and viral genomes have
not been discovered. The role of calcium in bacteria and virus is still elusive. The cooperativity and
conformational changes of coupled EF-hand motifs in the well-known EF-hand protein, calbindin
D9k, have to be further clarified with our grafting approach (Fig. 1.4). To understand the role of Ca2+
in biological systems, we have predicted and analyzed potential EF-hand and EF-hand like Ca2+
binding

motifs

on

a

genome-wide

scale

using

our

developed

bioinformatic

tool

(http://www.chemistry.gsu.edu/faculty/Yang/Calciomics.htm). Proteins from bacteria and virus such
as Streprococcus pyrogenes, Sindbis virus and pox virus have been predicted and identified with our
grafted approach as clarified in Chapter 1.3. As shown in Fig. 5.2, the single EF-hand motif grafted
into CD2.D1 (CD2.Shr.EF) from Shr has a significant homology to that of CaM with all the conserved
Ca2+ binding ligand residues and two flanking helices (Fig. 5.2). Similarly, the other two predicted EF
hand motifs in virus and two well-known EF-hand motifs were grafted into CD2.D1 as well. As
indicated in Fig 5.2, all the loops in the canonical EF-hands family can be aligned well with the EFhand loop III in the calcium modulated protein, calmodulin. The structure of CD2.D1 (blue) was draw
by PyMOL with PDB 1hng. LRET or FRET occurs between aromatic Trp residues (orange) in
CD2.D1 and Tb3+ (green) ion in grated EF-hand loops (Magenta). The binding ligands at positions 1, 3,
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5, 7, 9, 12 for canonical EF-hands and at positions 1, 3, 5, 7, 11, 14 for pseudo EF-hands are
highlighted in red color.

5.1.2.

Animalia: Calbindin D9k

Calbindin refers to several calcium-binding proteins including Calbindin D9k and Calbindin D28k.
Both are Vitamin D-dependent calcium binding proteins present in intestinal epithelial cells
(enterocytes) of mammalians or birds, respectively. Calbindin D9k can also be found in the kidney
and uterus in some mammalian species. Calbindin D9k mediates the transport of calcium across the
enterocytes from the apical side, where entry is regulated by the calcium channel TRPV6, to the
basolateral side, where calcium pumps such as PMCA1 utilize intracellular adenosine triphosphate to
pump calcium into the blood [241]. The transport of calcium across the enterocyte cytoplasm appears
to be rate-limiting for calcium absorption in the intestine; the presence of calbindin increases the
amount of calcium crossing the cell without raising the free concentration [242]. Calbindin D9k may
also stimulate the basolateral calcium-pumping ATPases. Expression of calbindin D9k, like that of
calbindin-D28k, is stimulated by the active vitamin D metabolite, calcitriol although the precise
mechanisms are still controversial [243]. Calbindin D9k, a small Ca2+ binding protein (75 residues,
MW 8,600) with two EF-hand motifs bundled together, is one of the primary model systems in the
S100 protein family for the studies of Ca2+ binding properties of proteins [244]. It carries two distinct
EF-hands: a canonical EF-hand at the C terminus and a pseudo EF-hand motif at the N-terminus.
These two EF-hands were grated into CD2.D1 (CD2.Cal1.EF and CD2.Cal2.EF) in order to determine
their metal binding affinity with cooperativity elimination between them. The oligomerization status
of the engineered protein introducing by EF-hand insertion was studied by anisotropy fluorescence.
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5.1.3.

Bacteria: streptococcal hemoprotein receptor of Streprococcus pyrogenes

Although bacterial cells do not have complex subcompartments or organelles, there is strong evidence
that Ca2+ plays an essential role in bacterial signaling, communication and stability similar to that
observed in eukaryotic cells (Fig. 1. 2) [234-237, 245]. Bacterial cells also have a well-regulated
cytosolic free Ca2+ concentration (approximately 0.1-2 M) that is significantly lower than that
observed in the extracellular medium (mM) due to Ca2+ transporters and channels [234-237]. Similar
to the eukaryotic systems, P-type ATPase Ca2+ efflux pumps have been characterized from
Synechococcus and Flavobacterium. A Ca2+ transporter of S. pneumoniae is involved in Ca2+-DNA
uptake, lysis, and competence [246, 247]. Uptake of Ca2+ and other divalent cations can also
accompany uptake of phosphate by the phosphate transport system of E. coli. Furthermore, it has been
reported that bacteria contain Ca2+ binding proteins that are essential for cell adhesion and
communication [248-251].
Streptococcus pyogenes is a spherical, Gram-positive bacterium that is the cause of group A
streptococcal infections. Streptococci are catalase-negative. In ideal conditions, S. pyogenes has an
incubation period of approximately 1–3 days. It is an infrequent, but usually pathogenic, part of the
skin flora. It is estimated that there are more than 700 million infections each year and over 650,000
cases of severe, invasive infections that have mortality rate of 25 % [252]. The streptococcal
hemoprotein receptor (Shr) from Streprococcus pyrogenes is a surface protein with a role in iron
uptake that has no significant homologues in other bacteria but shares partial homology with
eukaryotic receptors such as Toll and G-protein dependent receptors (gi 15675635, GeneBank).
Additional sequence analysis identified a leucine-rich repeat domain, an EF-hand Ca2+ domain, and
two NEAT domains [253].
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5.1.4.

Virus: nsP1 of Sindbis and Pox

As shown in Fig. 5.1, the interplay between viruses and Ca2+ in the infected cell falls generally into
three major categories: 1) viral proteins directly or indirectly disturb Ca2+ homeostasis by altering
membrane permeability and/or manipulating key components of the Ca2+-signaling apparatus; 2) viral
proteins directly bind to Ca2+ for structural integrity or functionality; and 3) critical virus-host
interactions depend on cellular Ca2+-regulated proteins or pathways. EF-hands have been found
abundantly in eukaryotes and bacteria. However, literature reporting EF-hand or EF-hand like Ca2+binding motifs in virus proteins is scarce, possibly due to lack of accurate prediction methods and
robust validating methodologies. With our developed method, the 93 putative EF-hand or EF-handlike motifs are found in the genomes of almost 80 different viruses, spreading throughout the majority
of virus families [254]. The Ca2+-binding capabilities of these sequences from virus such as Sindbis
Virus and Vaccinia virus (poxvirus family) have been experimentally verified in this chapter.
Sindbis Virus (SINV) is a member of the Togaviridae family, in the alphavirus subfamily. The virus
causing fever in humans is transmitted by mosquitoes. The symptoms include arthralgia, rash and
malaise. The virus was first isolated in 1952 in Cairo, Egypt and SINV has been linked to Pogosta
disease in Finland recently [255]. SINV induces apoptosis in many vertebrate cells and apoptosis of
neuroblastoma cells induced by SINV is dependent on viral replication but not dependent on a rise in
intracellular Ca2+ [256]. However, apoptosis occurred more rapidly in the absence of extracellular
Ca2+ and the mechanism remains unknown because the Ca2+ binding domain in SINV remains to be
indentified.
Vaccinia virus (VACV or VV) belongs to the poxvirus family, a large complex of double-strand DNA
viruses that replicate in the cytoplasm of the infected cell in a highly regulated manner [257]. Western
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Reserve A38L protein from the vaccinia virus represents the first example of a virus protein which
directly or indirectly promotes the influx of extracellular Ca2+ [258].
Nonstructural protein (nsP) encoded by a viral genome that are produced in the organisms they infect,
but not packaged into the virus particles. Some of these proteins may play roles within the infected
cell during virus replication or act in regulation of virus replication or virus assembly. We grafted two
predicted 29-residue EF-hand motifs, from the nonstructural protein 1 (nsP1) of SINV (CD2.Sin.EF)
and poxvirus (CD2.Pox.EF) , into CD2.D1 to examine their Ca2+ binding capability by using aromatic
residue-sensitized Tb3+ luminescence resonance energy transfer (Tb3+-LRET).

5.2. Results

5.2.1.

Probing metal binding of grafted EF-hand by FRET pair of Trp and Tb3+.

CD2.Pox.EF.
Engineered proteins with grafted EF-hand motifs were generated as described in Chapter 2.1 and
proteins were expressed and purified following the method in Chapter 2.3. Before studying the metal
binding properties of these engineered proteins, the native structure of domain 1 of CD2 had to be
confirmed. As shown in Fig. 5.3A, the structural integrity of the engineered protein with grated EFhand from poxvirus is confirmed by the fluorescence emission peaks at 315 nm and 330 nm. The Trp
emission peak at 330 nm (W32) of CD2.Pox.EF exhibits a blue shift from 350 nm which is the same
as CD2 without insertion. The Trp emission peak at 315 nm is from the inserted E-helix of calcium
binding loop. It indicated the hydrophobic environment of Trp residues and the correct folding of the
engineered protein. Circular Dichroism (CD) spectroscopy also was employed as a way to confirm the
structural integrity of the engineered protein by monitoring the secondary structure. As seen in Fig.
5.3B, the major secondary structure contents of CD2.Pox.EF and CD2.WT are β sheet which has a
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negative peak at 218 nm. The negative shoulder peaks of CD2.Pox.EF at 224 nm and 202 nm indicate
the helical and random coil contribution from the inserted loop. The average molar ellipticity for both
the wild type and engineered protein are almost the same (Fig. 5.3B). The noise indicating in the CD
spectrum below 200 nm is mainly from Cl- in the buffer (100 mM KCl, 10 mM Tris-HCl, pH 7.2).
After confirmation of native structure of the engineered protein, FRET based Tb3+ titration of the
engineered protein from the nsP1 of poxvirus (CD2.Pox.EF) has been tested. As shown in Fig. 5.4A,
2 to 5 µM CD2.Pox.EF was prepared in 10 mM PIPES, 100 mM KCl at pH 6.8. Intrinsic Trp residues
close to grated EF-hand loop was excited at 280 nm. If Tb3+ binds to the predicted loop from pox
virus, the fluorescence signal from Trp by FRET at 545 nm will increase until it reaches saturation.
The inset is the fluorescence signal from free Tb3+ ion which also can be excited at 280 nm. The
contribution of fluorescence signal from Tb3+ ion was subtracted from Tb3+ signal in protein. As
shown in Fig. 5.4B, the fluorescence signal decreased by adding calcium into 2 µM CD2.Pox.EF preincubated with 30 µM TbCl3 because Tb3+ was competed out from the binding pocket. The
dissociation constant of calcium (258 ± 12 µM) was calculated by Equation 2.7 with apparent
dissociation constant fitted in the inset.
CD2.Cal1.EF and CD2.Cal2.EF.
3 µM CD2.Cal1.EF or CD2.Cal2.EF was prepared in 10 mM PIPES, 100 mM KCl at pH 6.8. The
inserted loops in CD2.D1 of these two proteins are from calcium binding EF hand motif 1 and 2 of the
calcium buffer protein Calbinidin D9k. CD2.Cal1.EF contains the pseudo EF-hand with 14 residues in
the binding loop while CD2.Cal2.EF has the classical EF-hand with 12 amino acids in the binding
loop. Except the intensity differences, the excitation spectrum for both protein are almost same when
fix emission wavelength at 340 nm for CD2.Cal1.EF and at 332 nm for CD2.Cal2.EF (Fig. 5.5A). As
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shown in Fig. 5.5B, CD2.Cal2.EF folds better than CD2.Cal1.EF because the peak with the maximum
intensity for CD2.Cal2.EF in the emission spectrum shifts further to the lower wavelength than
CD2.Cal1.EF and fluorescence intensity higher when two protein concentrations in the measurement
are the same (3 µM). As shown in Fig. 5.6AB, when the Tb3+ signal reached saturation after titration,
the final fluorescence intensity are similar for both grafted EF hand motifs. However, the total Tb3+
required to reach saturation for CD2.Cal1.EF is more than 14 folds higher than CD2.Cal2.EF. The
dissociation constants of Tb3+ for CD2.Cal1.EF (174 µM) and CD2.Cal2.EF (1.2 µM) was obtained by
fitting F/F0 of Tb3+ signal with 1 to 1 binding equation (Equation 2. 6).
CD2.Shr.EF and CD2.Sin.EF.
Two predicted 29-residue EF-hand motifs, one from the Shr of S. pyrogenes (CD2.Shr.EF) and the
viral nsP1 of Sindbis virus (CD2.Sin.EF), were grafted into CD2.D1 to examine their Ca2+ binding
capability by using aromatic residue-sensitized Tb3+ luminescence resonance energy transfer (Tb3+LRET) (Fig. 5.7). As indicated in Fig. 5.7A, both engineered proteins fold well by monitoring
intrinsic Trp fluorescence. Circular dichroism studies of both engineered proteins showed a notable
trough at ~216 nm which is characteristic of β-sheet structure. More negative signals were observed
below 240 nm due to the contribution from the insertion of the helix-loop-helix sequences (Fig. 5.7B).
Both proteins were able to bind the Ca2+ analog, Tb3+, with affinities of 25.1 μM for CD2.Shr.EF and
16.4 μM for CD2.Sin.EF (Fig. 5.7CD). The biological relevance of these EF-hand Ca2+-binding
motifs will be further investigated in the virus transfected system.

5.2.2.

Revealing Ca2+ dependent conformation change by CD spectroscopy.

Far UV CD spectrometry of CD2.Cal1.EF in aqueous solution yields a spectrum with minima at 202
nm and a maximum at 194 nm in both Ca2+ free and Ca2+ loaded condition (Fig. 5.8A). As shown in
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Fig. 5.8B, far UV CD spectrometry of CD2.Cal2.EF in apo form yields a spectrum with minima at
209 nm and a maximum at 196 nm. After adding Ca2+, far UV CD spectrometry of CD2.Cal2.EF in
holo form yields a spectrum with minima at 219 nm and a maximum at 195 nm, characteristic of a
protein with substantial ß–sheet secondary structure. Fig. 5.8C summarizes the secondary structure
content for CD2 WT and CD2 engineered proteins predicted by DichroWeb based on experimental far
UV CD spectrum. The predicted major secondary structure for domain 1 of CD2 (CD2.WT) is ß–
sheet (40.3% in Table 5. 1), which is in good agreement with the secondary structure contents
determined by X-ray crystallography [259]. The engineered proteins with grafted EF hand motifs
from calbindin D9k increase their ß–sheet content and decrease α-helical content after addition of 2
mM Ca2+. For CD2.Pox.EF and CD.Shr.EF, the secondary structure remains almost the same between
the EGTA form and Ca2+ loaded form (Fig. 5.9). CD2.Cal2.EF has the largest average molar ellipticity
and reveals dramatic Ca2+ depend secondary structure conformation change comparing to other
engineered proteins.

5.2.3.

Observing oligomeric stage of CD2 with grafted EF-hand by PFG-NMR measurement and
fluorescence anisotropy.

Next, the oligomeric state of the grafted EF-Hand motifs from calbindin D9k was examined by two
different techniques: pulsed-filed gradient NMR (PFG-NMR) and fluorescence anisotropy. PFG NMR
has been widely used to study the molecular motion, effective dimensions and oligomeric states of
proteins in solution [111]. The size of proteins can be estimated by measuring the diffusion constants
and the hydrodynamic radius is calculated with Equation 2.2 to 2.4 with reported lysozyme size as a
reference.
The diffusion constants of CD2 grated protein CD2.Cal1.EF and CD2.Cal2.EF were measured under
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Ca2+-saturated and Ca2+-depleted conditions to determine where the isolated EF-hand motifs from
calbindin D9k undergo dimerization on metal binding. As shown in Fig. 5.10, NMR signal decay when
the field strength was increased from 0.2 to 31 G·cm-1. The calculated hydrodynamic radius of the
CD2 monomer (19.4 Å) was close to the one (19.6 Å) reported previously [112]. Table 4.2
summarizes all the calculated hydrodynamic radii value. The calculated hydrodynamic radii of
CD2.Cal1.EF are 21.1 ± 0.2 Å for apo form and 20.4 ± 0.3 Å for Ca2+-loaded form (Fig. 5.10A);
the calculated hydrodynamic radii of CD2.Cal2.EF are 27.4 ± 0.3 Å for Ca2+-loaded form (Fig.
5.10B). According to calculations using the spherical shape of macromolecules, the hydrodynamic
radius of the protein will increase by 27% on formation of the dimer [260]. The increase in size for
CD2.Cal2.EF in 10 mM CaCl2 is 41% to CD2 monomer and 34% to CD2.Cal1.EF monomer,
indicating that it exists as a dimer in solution in the presence of Ca2+.
Fluorescence anisotropy was also used to determine the oligomeric status of the engineered protein in
the absence of in the presence of Ca2+. As shown in Fig. 5.11, the fluorescence anisotropy of
CD2.Cal1.EF remains at the same value (~0.08) when protein concentration varies from 2 to 10 µM
and binding with metal also does not alter the value. On the contrary, the fluorescence anisotropy of 5
µM CD2.Cal2.EF increased from 0.076 (0.079 in 10 µM) in 300 µM EDTA to 0.084 (0.086 in 10 µM)
in 5 mM CaCl2 (Fig. 5.12). However, there is no obvious change for 2 µM CD2.Cal2.EF. The
anisotropy value is related to the molecule tumbling rate in the aqueous solution. The bigger
fluorescence anisotropy value, the slower the molecule tumbling rate and the bigger the protein size.
The data suggests that CD2.Cal2.EF forms a dimer in a Ca2+-dependent and concentration dependent
way while CD2.Cal1.EF does not.
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5.3. Discussion and summary.
Table 5.3 summarizes the Tb3+ dissociation constants for all the engineered proteins studied in this
chapter. The negative charge of amino acids in the EF-hand binding loops plays a key role in the
metal binding affinities. CD2.Cal2.EF, CD2.Shr.EF and CD2.Sin.EF contain 4 negative charged
residues in the loop (Fig. 5.2). They also have higher Tb3+ binding affinities than CD2.Pox.EF which
has only 3 negative charged amino acids at the conserved positions. The correct folding is also
important to study the side-specific metal binding properties by grafted approach. From both far-UV
spectrum and Trp fluorescence, CD2.Cal1.EF does not fold very well, thus forming the improper
arranged binding pockets with relative low binding affinities. When the final Tb3+ concentration in the
fluorescence titration cuvette is getting very high, the unspecific binding to CD2 host protein will
occur which also affects the accurate estimation of metal binding affinities in the grafted proteins. The
biological relevance of these EF-hand Ca2+-binding motifs are necessary to understand the role of
calcium in both bacterial and viral systems.
Shaw et al. [261] first reported that an isolated EF-hand III from skeletal troponin C dimerizes in the
presence of Ca2+. EF hands from parvalbumin and calbindin D9K have also been shown to exhibit
Ca2+-dependent dimerization [262-264]. Wojcik et al. [239] have shown that the isolated 12-residue
peptide from calmodulin (CaM) EF-hand motif III does not dimerize in the presence of Ca2+, but
dimerizes to form a native-like structure in the presence of Ln3+, which has a similar ionic radius and
coordination properties to Ca2+. They concluded that local interactions between the EF-hand Ca2+binding loops alone could be responsible for the observed cooperativity of Ca2+ binding to EF-hand
protein domains. To examine the key determinants for Ca binding and Ca-induced conformational
change, peptides or fragments encompassing the helix – loop – helix motif produced by either
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synthesis or cleavage are common methods. With our lab developed grafting approach, the isolated
calcium binding loop 2 from calbindin D9k has been determined to form dimer in a Ca2+ and
concentration dependent way (Table 5.2). The Ca2+ binding to CD2.Cal2.EF could induce large
conformational change in the EF-hand helix – loop – helix motif. Upon binding to Ca2+,
CD2.Cal2.EF behaves more like CD2.WT in the secondary structure maybe because the glycine linker
is getting close induced by metal binding in the EF-hand motif and disruption of host protein is
getting less.
Overall, based on sequence homology, a straightforward and fast method has been developed to detect
linear Ca2+-binding motifs from genomic information. Experimentally, we have also developed a
robust and reliable grafting approach to study Ca2+-binding properties of continuous Ca2+ binding sites.
This novel approach has been successfully used to dissect site-specific Ca2+ binding affinity and
cooperativity among the four canonical EF-hands in the prototypical Ca2+-binding protein, calmodulin.
The combination of these two approaches is expected to enable us to explore more Ca2+ binding sites
that are underrepresented due to the limitation of available methodology. In addition, PFG-NMR and
fluorescence anisotropy provide both accurate and fast measurement for the native protein size
determination in solution.
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Virus and Calcium
Attachment and
penetration

Un-coating

Replication and
SP translation

Assembly
Budding

NSP translation

Self-cleavage

Figure 5. 1. Calcium is involved in multiple steps of virus life cycle.
The virus life cycle can be divided into several steps, attachment, penetration, un-coating,
replication, assembly, release and budding. Each step is controlled tightly by calcium through
calcium binding proteins.
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Figure 5. 2. The Predicted EF-hand loops in various biological systems.
The entire EF-hands (E-helix, loop and F-helix) from predicted proteins were grated into CD2
domain 1 (CD2.D1) as host protein. The structure of CD2.D1 (blue) was draw by PyMOL
with PDB 1hng. LRET or FRET occurs between aromatic Trp residues (orange) in CD2.D1
and Tb3+ (green) ion in grated EF-hand loops (Magenta). All the loops in canonical EF-hands
family can be aligned well with EF-hand loop III from calcium modulated protein,
calmodulin. The binding ligands at positions 1, 3, 5, 7, 9, 12 for canonical EF-hands and at
positions 1, 3, 5, 7, 11, 14 for pseudo EF-hands are highlighted in red color.
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Figure 5. 3. Characterization of CD2 grated protein (CD2.Pox.EF) by intrinsic
Trp fluorescence emission spectrum (A) and circular dichroism spectroscopy (B). A, the structural integrity of the engineered protein with grated EF-hand
from poxvirus is confirmed by the fluorescence emission peaks at 315 nm and 330 nm. The solid line with solid square stands for grated protein CD2.Pox.EF;
the dashed line with hollow square stands for the domain 1 of CD2 (CD2.WT). The blue shift of the emission peak from 350 nm indicated the hydrophobic
environment of Trp residues and the correct folding of the engineered protein. B, the major secondary structure contents of CD2.Pox.EF (●) and CD2.WT (○)
are β sheet which has a negative peak at 218 nm.
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Figure 5. 4. FRET based Tb3+ titration of the engineered protein from the nsP1 of poxvirus (CD2.Pox.EF).
A, 2 to 5 µM CD2.Pox.EF was prepared in 10 mM PIPES, 100 mM KCl at pH 6.8. Intrinsic Trp residues close to grated EF-hand loop was excited at 280
nm. If Tb3+ binds to the predicted loop from pox virus, the fluorescence signal from Trp by FRET at 545 nm will increase until it reaches saturation. The
inset is the fluorescence signal from free Tb3+ ion which also can be excited at 280 nm. The contribution of fluorescence signal from Tb3+ ion was
subtracted from Tb3+ signal in protein. B, the binding constant of Tb3+ (86 ± 2 µM) was obtained by fitting F/F0 of Tb3+ signal with 1 to 1 binding
equation (Equation 2. 6). The fluorescence signal decreased by adding calcium into 2 µM CD2.Pox.EF with pre added 30 µM TbCl3 because Tb3+ was
compete out from the binding pocket. The dissociation constant of calcium (258 ± 12 µM) was calculated by Equation 2.7 with apparent dissociation
constant fitted in the inset.
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Figure 5. 5. Characterization of CD2 grated protein (CD2.Cal1.EF and CD2.Cal2.EF) by intrinsic Trp fluorescence excitation spectrum (A) and
emission spectrum (B).
A, the fluorescence excitation spectrum of the engineered protein with grated EF-hand motifs (CD2.Cal1.EF, red line with solid dots and CD2.Cal2.EF,
black line with solid dots) from Calbindin D9k. B, the structural integrity of the engineered proteins are confirmed by the fluorescence emission peaks at
332 nm (CD2.Cal1.EF, red line with hollow dots) and 340 nm (CD2.Cal2.EF, black line with solid dots). The blue shift of the emission peak from 350
nm indicated the hydrophobic environment of Trp residues and the correct folding of the engineered protein. All the fluorescence measurements were
taken in 10 mM PIPES,100 mM KCl at pH 6.8 with 3 µM proteins.
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Figure 5. 6. FRET based Tb3+ titration of the engineered proteins from Calbindin D9k.
2 to 5 µM CD2.Cal1.EF (A) or CD2.Cal2.EF (B) was prepared in 10 mM PIPES, 100 mM
KCl at pH 6.8. Intrinsic Trp residues close to grated EF-hand loop was excited at 282 nm. If
Tb3+ binds to the grafted loops, the fluorescence signal from Trp by FRET at 545 nm will
increase until it reaches saturation. The contribution of fluorescence signal from Tb3+ ion was
subtracted from Tb3+ signal in protein. The binding constants of Tb3+ for CD2.Cal1.EF (174
µM) and CD2.Cal2.EF (1.2 ± 0.1 µM) was obtained by fitting F/F0 of Tb3+ signal with 1 to 1
binding equation (Equation 2. 6).
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Figure 5. 7. Probing metal binding properties of predicted EF-hand Ca2+ binding
motifs from Shr of Streptococcus pyrogenes (CD2.Shr.EF) and from the nsP1 of
Sindbis virus (CD2.Sin.EF).
A, the structural integrity of the engineered proteins are confirmed by the fluorescence
emission peaks at 315 nm and 330 nm. B, far ultra-violet circular dichroism spectra of
CD2 wild type and the engineered proteins. C and D, Tb3+-binding curves of the engineered
proteins CD2.Shr.EF and CD2.Sin.EF. The titration curve is fitted for a 1:1 binding
stoichiometry (Equation 2.6). All the fluorescence measurements were taken in 10 mM
PIPES,100 mM KCl at pH 6.8 with 2 to 5 µM proteins. All the CD measurements were
taken in 10 mM Tris-HCl,100 mM KCl at pH 7.2 with 8 to 10 µM proteins.
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Figure 5. 8. Monitoring Ca2+ dependent secondary structure changes of CD2.Cal1.EF
and CD2.Cal2.EF by far ultra-violet circular dichroism spectra.
A, the far-UV CD spectrum of CD2.Cal1.EF with (●) and without calcium (○). B, the far-UV
CD spectrum of CD2.Cal2.EF with (●) and without calcium (○). C, the secondary structure
prediction (DichroWeb) of CD2.WT and engineered proteins from calbindin D9k with and
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Beta sheet content. D, the calcium binding EF-hand loop 2 (brown) of calbindin D9k was
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proteins.2 mM EGTA or Ca2+ was added in the buffer to obtain apo or holo form of
engineered proteins.
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Figure 5. 9. Monitoring Ca2+ dependent secondary structure changes of CD2.Pox.EF and CD2.Shr.EF by far ultra-violet circular dichroism spectra.
A, the far-UV CD spectrum of CD2.Pox.EF with 2 mM (◆) or 4 mM (■) calcium and without calcium (□). B, the far-UV CD spectrum of CD2.Shr.EF with
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proteins.
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Figure 5. 10. Determination of the oligomeric state of CD2.Cal1.EF and CD2.Cal2.EF by PFG-NMR.
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Figure 5. 11. Determination of the oligomeric state of CD2.Cal1.EF by fluorescence anisotropy.
The fluorescence signal in different excitation and emission orientation was measured in 10 mM KCl, 50 mM Tris-HCl at pH 7.5 with 300 µM EDTA or 5
mM Ca2+ for 2 µM (A), 5 µM (B) and 10 µM (C) CD2.Cal1.EF. The fluorescence anisotropy was calculated by Equation 2.8. The fluorescence maximum
intensity was measured at λex = 282 nm and λem = 340 nm with an integration time of 15s.
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Figure 5. 12. Determination of the oligomeric state of CD2.Cal2.EF by fluorescence anisotropy.
The fluorescence signal in different excitation and emission orientation was measured in 10 mM KCl, 50 mM Tris-HCl at pH 7.5 with 300 µM EDTA or 5
mM Ca2+ for 2 µM (A), 5 µM (B) and 10 µM (C) CD2.Cal2.EF. The fluorescence anisotropy was calculated by Equation 2.8. The fluorescence maximum
intensity was measured at λex = 282 nm and λem = 332 nm with an integration time of 15s.
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Table 5. 1 The secondary structure prediction by DichroWeb.
Grafted
proteins

CD2.WT

CD2.Cal1.EF

CD2.Cal2.EF

Apo

Holo

Apo

Holo

α Helix (%)

7.6

10.7

8.6

18.0

14.7

ß Sheet (%)

40.3

33.2

37.8

28.8

31.7
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Table 5. 2 Hydro dynamic radii (Rhydro) and fluorescence anisotropy (r) of calbindin D9k grafted proteins.
Grafted
proteins

Rhydro (Å)

CD2.WT

19.4 ± 0.4

ra
rb

N.A.

rc
Dimer

No

CD2.Cal1.EF

CD2.Cal2.EF

Apo

Holo

Apo

Holo

21.1 ± 0.2

20.4 ± 0.3

N.A

27.4 ± 0.3

0.078 ± 0.003

0.077 ± 0.004

0.077 ± 0.005

0.077 ± 0.005

0.081 ± 0.003

0.079 ± 0.003

0.076 ± 0.003

0.084 ± 0.003

0.082 ± 0.002

0.083 ± 0.002

0.079 ± 0.002

0.086 ± 0.002

No

No

No

Yes
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Table 5. 3 The summary of Tb3+ dissociation constants (Kd) in grafted proteins.
Grafted
proteins

Kd (µM)

Folding

Negative charges in
the loop

CD2.Cal1.EF

174

Partial

3

CD2.Cal2.EF

1.2 ± 0.1

Yes

4

CD2.Shr.EF

25.1 ± 0.6

Yes

4

CD2.Sin.EF

16 .4± 0.1

Yes

4

CD2.Pox.EF

86.0 ± 2.0

Yes

3
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6. MASS SPECTROMETRY OF PROTEIN STUDY
6.1.

Introduction
Mass spectrometry has come a long way from the discovery of isotopes for many of the chemical

elements to the application to large, highly polar molecules such as proteins. Electrospray ionization mass
spectrometry (ESI-MS) and Matrix-assisted laser desorption and ionization mass spectrometry (MALDIMS) are two major techniques for protein-protein interaction study based on the mass of molecules. In
1985, Franz Hillenkamp, Michael Karas and their colleagues found that the alanine could be ionized more
easily by a pulsed 266 nm laser if it is mixed with tryptophan with aromatic group [265]. They were the
first to define the term Matrix-assisted laser desorption and ionization (MALDI). Later, Koichi Tanaka
from Shimadzu Corp. applied MALDI mass spectrometry to analyze biological macromolecules in 1988
and received the 2002 Nobel Prize in Chemistry because of this high-impact discovery [266]. MALDIMS is usually used to investigate protein-protein interaction due to its soft ionization technique without
the fragmentation. MALDI-MS is frequently used to identify proteins (protein ID) by peptide mass
fingerprinting after enzyme digestion and to search protein post translational modification sites such as
methylation and phosporylation because of its fast process and high-throughput screening. MALDI-MS is
a power technique for protein study with less sample consumption, tolerance to high salt concentration
and high detection limit for large protein complex. This chapter is focused on protein study using
MALDI-MS.
As shown in Fig. 6.1, MALDI-MS instrument includes five major parts: sample plate, laser
generator, flight tube, reflector and detector. In brief, samples with either a positive charge (Positive mode)
or a negative charge (Negative mode) for analysis are excited by laser and are ejected into the flight tube
through an electronic force. The speed of the samples depends on their mass over charge ratio. Detector
records the time of flight (TOF) of the samples which can be used to calculate their molecular weight
after standard calibration. For the smaller molecules, a reflector is used to increase the flight length of the
samples in order to improve the accuracy in the electron mode. For the larger molecule, linear mode can
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be used to improve the sensitivity. Reflectron mode and linear mode use different detectors, reflector
detector and linear detector, respectively. Reflectron mode is good for peptide (<5000 kDa) analysis with
internal calibration strand, especially for protein identification with the peptide mass fingerprinting. Liner
mode is suitable for identification of protein complex and protein oligomer.
The MALDI-MS samples have to be mixed with different matrixes based on the properties of
samples. The matrix refers to the crystallized molecule with UV abortion. Table 6.1 summarizes all of the
commonly used matrixes for protein study in MALDI-MS and words written in red indicate their major
applications in protein study. The MALDI-MS metal plate is pre-coated with isopropanol which forms an
organic thin layer on the surface. The sample is co-crystalized with matrix on the metal plate (Fig. 6.2).
As shown in Fig. 6.2, the matrix absorbs the UV laser light triggered by a laser beam during the
desorption process. The matrix not only passes the proton to samples, but also transfers the energy to
samples from laser during the ionization process. Charged samples are extracted into flight tube.
The protein sample preparation method in MALDI-MS can be the key to obtaining the spectrum
successfully. Proper sample preparation procedure is vital for improving the efficiency of MALDI-MS.
The formation of homogeneous, small and evenly distributed matrix/analyte co-crystal reduces the matrix
signal and yields a reproducible signal because the overall ionization process is facilitated.
Inhomogeneous crystallization could cause the “sweet spot” on the crystal surface which affects the spot-to-spot and the sample to sample reproducibility. Most of the common matrixes are not soluble in water
and should be prepared freshly in organic/aqueous solution mixture. Although MALDI-MS allows higher
salt concentration to exist in the sample than ESI-MS, a low quality spectrum is often produced when the
sample contains a low abundance of the analyte and a high concentration of the contaminants. It is
recommended to purify the sample before performing the MALDI-MS analysis. Once the samples are
spotted on the plate with high levels of contaminants, cold water should be used to carefully wash away
the contaminants such as salt on the crystal surface. The water soluble contaminant can be reduced by this
simple method because matrix/analyte co-crystal is only soluble in organic solvent. In order to obtain
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homogeneous co-crystallization for the low abundance analyte, matrix dissolved in highly volatile organic
solvent such as acetone can be sprayed on the plate before spotting the sample. Under microscope, it is
clear to see that matrix forms homogeneous and evenly distributed crystal surface in such a fast
crystallization process.
MALDI-MS provides a fast and accurate method for identification of protein modification sites.
Functional groups with certain properties are often introduced to protein for protein-protein interaction
and metal binding study through protein modification. The intrinsic fluorescence of CaM comes from
tyrosine and phenylalanine. The fluorescence from tyrosine and phenylalanine in CaM is weak and often
overlaps with the CaM binding peptide. Dansyl chloride was first introduced by C.Gros and B. Labouesse
in 1969 to study amino acids, peptides and proteins [267]. Later on, CaM was labeled with dansyl
chloride to study the binding of inhibitory ligands [151]. Dansyl groups majorly interact with free amine
group at N-termini of the protein at the physiological pH 7. However, more than one dansylation site have
been found in CaM by MALDI-MS study and the location of dansylation sites has been suggested in this
chapter. Therefore, IAEDANS dye for the specific labeling with the CaM mutant with additional cysteine
added into the end of C-termini of CaM, T34C and T110C was introduced to study the domain dependent
interaction between CaM and gap junction peptides. The condition of the reaction between IAEDANS
and cysteine in CaM was also improved based on the reaction efficiency obtained from MALDI-MS
spectrum.
6.2.

Dansylation of CaM and its variants
As shown in Fig. 6.3A, CaM has 8 potential reaction sites (7 lysines and N-termini highlighted in

grey color) with a free amine group in the structure. At pH 7.0, all the amine groups in the lysine are
protonated and no reaction occurs between these lysines and dansyl chloride. However, up to 4
dansylation sites were observed in MALDI-MS spectrum when 1 mM Ca2+-CaM was incubated with 5
molar excess of dansyl chloride at pH 7.0 at 4°C for overnight (Fig. 6.3B). This result indicates that at
least three lysines in CaM can be dansylated at pH 7.0 and major modified CaM are single site and double
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sites labeling. We kept all the condition the same but varied the initial protein concentration for
dansylation. Three sites of CaM were dansylated when protein concentrations were 0.5 mM (Fig. 6.3C)
and 0.25 mM (Fig. 6.3D). The peaks of CaM with three dansylation sites in these two reactions were
much smaller than the one in 1 mM high protein concentration. We further decreased the initial CaM
concentration to 0.125 mM (Fig. 6.3E), and the efficiency of the labeling was affected. The major protein
peak became the free CaM without label. The efficiency of the dansylation reaction depends on the initial
protein concentration and specific single label on N-termini is not available for CaM dansylation reaction.
The best initial CaM concentration we found is 0.25 mM with single label as major peak and less double
and triple labeling.
In order to locate the possible dansylation sites and to study the domain specific interaction
between CaM and CaM binding domain peptide, half CaM for both N-lobe (N-CaM, 1-75 aa) and C-lobe
(C-CaM, 75-148 aa) were engineered and produced. As shown in Fig. 6.4, both pH effect on the labeling
efficiency and half CaM labeling also have been tested at 6.5 and 7.0. The peak intensity of free CaM at
pH 6.5 (Fig. 6.4DE) is much higher than pH 7.0 (Fig. 6.4GH) for both CaM and N- CaM. Therefore, the
labeling efficiency at pH 7.0 is much higher than pH 6.5. As shown in Fig. 6.4FI, C-CaM is easier to
degrade than N-CaM because the major peak is the fragment of C- CaM which is the degradation product,
missing either FVQMMTAK (MW 955.20 Da) from C-termini or MKDTDSEE (953.97) from N-termini.
The labeling efficiency for C-CaM is almost 100% since the free CaM peak before reaction in Fig. 6.4F
almost disappeared in Fig. 6.4I after the reaction. In contrast, for N-CaM, the major product after
dansylation is still free N-CaM. The dansylation labeling efficiency of C-CaM is much higher than NCaM. According to the labeling efficiency by comparing the protein and reaction product intensity for
both entire CaM and two half CaM, it is highly possible that the first dansylation site in CaM is the same
as the one in C-CaM (> 90%) and second dansylation sites in CaM is the same as the one in N-CaM (<
50%). According to the results of MALDI-MS, the optimal initial CaM concentration in the reaction of
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dansylation on CaM is 0.25 mM and reaction at pH 7.0 has higher labeling efficiency. Even at pH 6.5,
dansyl labeling on lysine group still cannot be eliminated.
6.3.

IAEDANS dye labeling of CaM cysteine variants
CaM does not have a cysteine in its sequence and cysteine mutants were introduced into CaM at

the C-terminal end (CaM-Cys, Fig. 6. 5A) or to replace threonine at 34 (T34C, Fig. 6.5B) and 110
(T110C, Fig. 6.5B). The domain specific interaction between CaM binding peptide and these CaM
mutants can be studied by fluorescence after specific labeling with IAEDANS on the cysteine residues.
Similar to Dansyl groups, IAEDANS can be excited at 335 nm and have an emission wavelength with
maxima intensity at ~ 490 nm, an emission that is distinguishable from the intrinsic protein aromatic
group. In order to get maximum reaction efficiency, the CaM cysteine mutants were pre-incubated with
10 mM DTT, a reduced environment. The 10 mM DTT was removed by an Amicon concentrator with
Nitrogen gas pressure. The reaction took place in 10 mM Tris, 100 mM KCl, pH 7.4 (degassed to remove
all the oxygen) with 6 M urea for overnight incubation at 4 °C. The reaction bottle was filled with
nitrogen and kept dark during labeling. As shown in Fig. 6.5 DEGH, both CaM-Cys and T34C can be
labeled with IAESAN with almost 100% efficiency. However, T110C could be labeled possibly due to its
local environment (Fig. 6.5 FI). Since CaM is very stable and can be refolded back easily from a
denatured, linear condition in 6 M urea to facilitate the reaction rate and efficiency (Fig. 6.6).
The semi-quantitative analysis for dansylation and IAEDANS labeling efficiency is not very
accurate because both dansyl and IAEDANS groups have the same properties as the MALDI matrix. The
aromatic group in these two dyes can absorb the laser excitation energy at ~335 nm in the MALDI
instrument and facilitate the flight ability of the modified protein molecule. By the matrix effect of these
labeling dyes, the population of modified protein molecule could be overestimated because it is more
easily projected than the protein molecule without the label. Therefore, the dansyl label can be used to
raise the peptide detection limit with a low abundance in the sample by the improvement of its ionization
efficiency [268, 269].
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6.4.

Protein-protein interaction study of CaM with gap junction peptide.
MALDI-MS has been considered a “softly-soft” ionization mass spectrometry technique in the

protein-protein interaction study. The average dissociation energy of intermolecular non-covalent bond is
around 20 kJ/mole, which is almost 20 folds less than the energy required to cleave a covalent bond. The
properties of the soft ionization process make MALDI-MS an advanced technique to explore the protein
complex without breaking its weak non-covalent bond. MALDI-MS is more tolerant of buffers,
denaturants, detergents, salts and many other contaminates than the ESI-MS. MALDI-MS does not
require specific solvent combination to boost the signal in ESI-MS. MALDI-MS has become an attractive
approach to study protein-protein interaction because of its simplicity, low detection limits, low sample
consumption and low detection limits.
In Chapter 3 and 4, we have reported the interaction between α-gap junction Cx43/Cx50 peptides
with CaM by MALDI-MS. We also performed a quick test for the possibility of interaction between CaM
and γ-gap junction Cx45 peptide (Cx45p) from the second half of its intracellular loop. As shown in Fig.
6.7, both apo-CaM in 1 mM EGTA and holo-CaM in 1 mM CaCl2 form a complex with Cx45 peptide.
But the intensity of the complex in 1 mM Ca2+ (Fig. 6.7A) is more than two folds higher than the one in 1
mM EGTA (Fig. 6.7B) if we set the intensity of free CaM in each spectrum as a reference. Moreover,
although we only added peptide to CaM as 2 to 1 ratio, holo-CaM could form the complex with four
peptides but apo-CaM can only form with three peptides with lower intensity. As shown in Fig. 6.8, the
interaction between Cx45p and CaM was also confirmed by NMR HSQC spectrum in the presence of
calcium. The dramatic chemical shift changes for most of the amino acids of CaM were observed in the
overlay NMR HSQC spectrum. The data also suggests strong binding because of the slow exchange in
the spectrum. However, the binding ratio between Cx45p and CaM is not consistent with MALDI-MS
because the spectrum of the CaM stops changing after adding Cx45p at 1 to 1 ratio (Fig. 6.8). As
indicated in Fig. 6.9, the Cx45p binds to both lobes of CaM because the average chemical shift
perturbations were observed in the whole CaM. The conclusion of the interaction between CaM and
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Cx45p in the absence of calcium is difficult to make because of the insolubility of the Cx45p in 5 mM
EGTA. An NMR of apo-CaM binding domain study without addition of EGTA has to be explored
because most of the peptides do not dissolve well in the high concentration of EGTA. The interaction
between Cx45p γ-gap junction and Cx45 peptide in the intracellular region has been identified by both
MALDI-MS and NMR spectrum.
6.5.

Dimerization study of engineered proteins with grafted EF-hand motif.
It has been reported that 35% or more proteins in the cell are in oligomeric state [270]. And

average population of the oligomeric proteins is tetramer according to the calculation [271]. However, the
number of the protein in oligomeric state is quite low because of the difficulties to get crystal for the
oligomeric proteins [272]. In addition, the size of oligomeric protein is often too big to get high definition
solution structure information by NMR technique. MALDI-MS is a fast approach to study the oligomeric
protein. MALDI-MS also could provide the structure information in atomic level using hydrogendeuterium exchange mass spectrometry.
EF-hand motif has been reported for involving in dimerization of many calcium binding proteins
[263, 273-275]. We have reported calcium independent oligomerization of stromal interaction molecule 1
(STIM1) by the grafting approach. STIM1 is responsible for activating the Ca2+ release-activated Ca2+
(CRAC) channel [276]. The isolated EF-hand form STIM1was inserted into the host protein, domain 1 of
CD2 (CD2.D1, read Chapter 2 and 5 for more information about the grafting approach). As shown in Fig.
6. 10 and Fig. 6.11, in the presence of Calcium or EGTA, peaks of STIM1 in both dimer and trimer
molecule weight range were observed in MALDI-MS. The intensity of dimer peak is several folds
stronger than the trimer. However, in the control experiment, the oligomeric state of the host protein
CD2.D1 also was observed in the MALDI-MS spectrum but with less abundance (Fig. 6. 12&13). It is
very difficult to get the trimer peak of CD2.D1 by scanning many times for both calcium and EGTA
condition. Therefore, we conclude that inserted EF-Hand facilitates the dimer formation of CD2.D1 but
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calcium does not play a role for the oligomerization (Fig. 6. 14A). The data obtained by cross-linking
SDS-PAGE also confirmed the oligomeric stage of the grafted protein CD.STIM1.EF (Fig. 6. 14B).
6.6.

Determination of chemical PEGylation sites on protein based MRI contrast agent.
For the therapeutic protein based drug, polyethylene glycol polymer (PEG) chains are often

attached to lysine group of the protein drug through a covalent bond to reduce the immunogenicity from
the host immune system. This process is called PEGylation. In our protein based MRI contrast agent,
PEGylation also increases the protein solubility and the relativity. The determination of the PEGylation
sites in the MRI contrast agent could provide the structural information for improvement of the drug
design. HPLC-ESI-Nano spray was used in this study to locate the PEGylation sites of the contrast agent
protein (7E15) with much less sample consumption and better isolation.
As shown in Fig. 6. 15, 7E15 were PEGylated by different PEG with various chain length from
0.6 kDa to 5 kDa. Like other protein modification regents working on the lysine residues, more than one
PEGylation sites were observed for all PEG reactions (Fig. 6. 15) because most of the lysine residues in
the target protein are exposed to the solvent. 7E15 PEGylation product was digested by Trypsin which
cleaves the bond after lysine and argnine. The digestion in 0.05% SDS was taken at 37 °C for overnight.
The digestion solution was injected into Nano spray ESI-MS after 0.22 µm filtration. The peptide
fragments were separated by HPLC in a very low flow rate following ESI-MS detection. Later, the
peptide precursors were selected to perform tandem MS in order to get the peptide sequence information.
As shown in Fig. 6.16, only the peptide fragment sequence with underline can be detected in ESI-MS.
Peptide fragments of 7E15 containing K66 and K91 (Marine blue in Cartoon, PDB code: 1hng) cannot be
observed because 1) the fragment with PEG is difficult to be ionized in current condition; 2) the size of
the fragment with PEG is over the detection limit; 3) the PEGylation sites in 7E15 blocks the possible
Trypsin cleavage sites and reduces the enzyme activity. Therefore, K66 and K91 are two highly possible
PEGylation sites in the MRI contrast agent protein 7E15. In the future plan, Lysines in 7E15 will be
replaced by arginine to specify the PEGylation locations.
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6.7.

Summary
MALDI-MS is a powerful technique to study protein-protein interaction and modifications.

Dansylation and IAEDANS labeling on CaM have been studied by MALDI-MS. In the physiological pH,
not only N-termini of CaM can be dansylated, but also the lysine residues in CaM. Although dansylation
requires deprotonated lysine side chains and lysine has high pka (~10.5), we cannot get CaM dansylation
product from a single labeling at even lower pH (6.5) possiblely due to the special local environment of
certain lysine residues. The interaction of CaM and Cx45 gap junction peptide was also confirmed by
both MALDI-MS and NMR spectrum. The oligomeric stage of engineered protein with grated EF-hand
form STIM1 has also been demonstrated by MALDI-MS. The possible PEGylaiton sites on the protein
based contrast agent 7E15 has also been suggested by ESI-MS.
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Figure 6. 1 Voyager-DETM PRO workstation.
Figure is from Applied Biosystems.
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1. Sample (A) is mixed with excess
matrix (M) and dried
on a MALDI plate.
2. Laser flash ionizes matrix
molecules.
3. Sample molecules are ionized by
proton transfer from matrix:
MH+ + A  M + AH+.

Figure 6. 2 Desorption and Ionization processed in MALDI-MS.
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Figure 6. 3 MALDI-MS spectrum of CaM dansylation in various concentrations.
A, Cartoon of CaM structure with potential dansylation sites highlighted in light grey sphere. B, the CaM
dansylation product with 1 mM initial protein concentration. C, the CaM dansylation product with 0.5
mM initial protein concentration. D, the CaM dansylation product with 0.25 mM initial protein
concentration. E, the CaM dansylation product with 0.125 mM initial protein concentration.
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Figure 6. 4 MALDI-MS spectrum of CaM and variants dansylation at various pH.
Cartoon picture of CaM (A, 1-148 aa), N-CaM (B, 1-75 aa) and C-CaM (C, 76-148 aa) with potential
dansylation sites highlighted in brown sticks. The dansylation product of CaM (D) and N-CaM (E) at pH
6.5. The dansylation product of CaM (G), N-CaM (H) and C-CaM (I) at pH 7.0. F, the spectrum of CCaM without dansylation. C-CaMF stands for the major degradation fragment of C-CaM.
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Figure 6. 5 MALDI-MS spectrum of CaM variant IAEDANS labeling with cysteine mutation or
insertion.
Cartoon picture of CaM-Cys (A), T34C (B) and T110C (C) with IAEDANS labeling sites highlighted in
pink color. MS spectrum of CaM-cys (D), T34C (E) and T110C (F).MS spectrum of CaM variant with
IAEDANS dye modification for CaM-Cys (G), T34C (H) and T110C (I).
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Figure 6. 6 The effect of urea on CaM modification with IAEDANS dye.
A, MALDI-MS spectrum of reaction product without 6 M urea. B, MALDI-MS spectrum of reaction
product with 6 M urea. The efficiency of CaM chemical labeling in denature condition is much higher
than native solution.
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Figure 6. 7 MALDI-MS spectrum of CaM and C45 peptide complex.
The spectrum were obtained after 100 µM CaM with 200 µM Cx45p peptide was incubated in
10 mM Tris-HCl, 100 mM KCl (pH 7.4) at room temperature with either 1 mM CaCl2 (A) or 1
mM EGTA (B). The MALDI-MS spectrum of Cx45 peptide from the intracellular loop was
indicated in the inset of A. Both apo-CaM and holo-CaM forms complex with Cx45 peptide.
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Holo‐CaM
Holo‐CaM + Cx45p (1 : 1)

Figure 6. 8 Monitoring the interaction between CaM and Cx45 peptides (Cx45p) by (1H, 15N)-HSQC spectroscopy.
An overlay of HSQC spectra of holo-CaM (red) with the spectrum of the holo-CaM-Cx45p (green). The NMR spectrum was
obtained with 200 µM N15 CaM in 5 mM CaCl2, 10 mM Bis-Tris, 5 mM MES, 0.1% NaN3 at pH 6.5 and 20 µl 3 mM Cx45p
dissolved in DD H2O.
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Figure 6. 9 Chemical shift perturbation in CaM induced by addition of 2-fold molar excess of
Cx45p
A, The chemical shift change of the assigned CaM residues in 1H NMR spectrum. B, The chemical shift
change of the assigned CaM residues in 15N NMR spectrum. C, The weight average chemical shift change
(∆δ) was calculated using Equation 2.5.
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Figure 6. 10 MALDI-MS spectrum of CD2.STIM1.EF in the presence of CaCl2.
A, the monomer of CD2.STIM1.EF. B, the dimer of CD2.STIM1.EF. C, the trimer of CD2.STIM1.EF.
Sample of 50 µM CD.STIM1.EF with 500 µM CaCl2 in 10 mM Tris, pH 7.4 was incubated at room
temperature for 2 hours before spotting on the MALDI plate.
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Figure 6. 11 MALDI-MS spectrum of CD2.STIM1.EF in the presence of EGTA.
A, the monomer of CD2.STIM1.EF. B, the dimer of CD2.STIM1.EF. C, the trimer of CD2.STIM1.EF.
Sample of 50 µM CD.STIM1.EF with 500 µM EGTA in 10 mM Tris, pH 7.4 was incubated at room
temperature for 2 hours before spotting on the MALDI plate.
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Figure 6. 12 MALDI-MS spectrum of CD2.D1 in the presence of CaCl2.
A, the monomer of CD2.D1. B, the dimer of CD2.D1. C, the trimer of CD2.D1. Sample of 50 µM CD.D1
with 500 µM CaCl2 in 10 mM Tris, pH 7.4 was incubated at room temperature for 2 hours before spotting
on the MALDI plate.
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Figure 6. 13 MALDI-MS spectrum of CD2.D1 in the presence of EGTA.
A, the monomer of CD2.D1. B, the dimer of CD2.D1. C, the trimer of CD2.D1. Sample of 50 µM CD.D1
with 500 µM EGTA in 10 mM Tris, pH 7.4 was incubated at room temperature for 2 hours before
spotting on the MALDI plate.
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Figure 6. 14 Analysis of oligomer status of CD2.STIM1.EF by both MALDI-MS and crosslinking SDS-PAGE.
A, Semi-quantitative analysis of monomer and dimer population of CD2.STIM1.EF with additional calcium and EGTA in the MALDI-MS. B,
SDS-PAGE result of CD2.STIM1.EF after crosslinking with additional calcium and EGTA (data from Dr. Yun huang) . 100 μg proteins in 20
mM HEPES buffer (pH 7.5) with 0.2% (w/v) glutaraldehyde reacted at 37 ºC for 10 min.
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Figure 6. 15 MALDI-MS spectrum of MRI contrast agent 7E15 labeling with PEG.
The exposed lysine residues of 7E15 in solution were labeled with PEG0.6 (A, 0.6 kDa), PEG2.4 (B, 2.4 kDa) and PEG5 (C, 5 kDa).
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K91

K66

7E15-2T
calculated M.W. = 11290.65 Da
GS RDSGTVWGAL GHGIELNIPN FQMTDDIDEV
RWERGSTLVA EFKRKMKPFL KSGAFEIDAN
GDLDIKNLTR DDSGTYNVTV YSTNGTRILN
KALDLRILE
Figure 6. 16 The possible PEGylation sites determined by Nano spray ESI-MS.
Only the peptide fragment with underline can be observed in the mass spectrum. Red and green color
letters are the amino acids forming the calcium binding pocket in 7E15. All the lysine residues are in
purple color in the sequence. K66 and K91 (Marine blue in the cartoon) are the possible PEGylation
sties.
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Table 6. 1 UV MALDI Matrix list.
Common
names

Solvent

2,5-dihydroxy benzoic acid

3,5-dimethoxy-4-hydroxycinnamic
acid

Compound

α-cyano-4-hydroxycinnamic acid

Wavelength
(nm)

Applications

DHB
Gentisic acid

acetonitrile
water
methanol
acetone
chloroform

266
337
355

Peptides
Glycoproteins
Nucleotides
Oligonucleotide
Oligosaccharides

sinapic acid
sinapinic acid
SA

acetonitrile
water
acetone
chloroform

266
337
355

Peptides
Proteins
Lipids

CHCA

Acetonitrile
Water
ethanol
acetone

337
355

Peptides
Lipids,
Nucleotides

Structure
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7. MAJOR FINDING AND THE SIGNIFICANCE OF THIS DISSERTATION
The performed studies of this dissertation are divided in three major parts: 1) investigating CaM
regulation of gap junction proteins, 2) identifying EF-hand viral calcium binding proteins using grafting
approaches, and 3) probing protein modification by mass spectrometry.
7.1.

Investigating CaM regulation of gap junction proteins
Connexin 50 (Cx50), a member of the α family of gap junction proteins expressed in the lens of the

eye, has been shown to be essential for normal lens development. Working with Dr. Yubin Zhou in
Yang's lab, we have first reported a Ca2+-dependent regulation of Cx43, and Cx44, the sheep ortholog of
human Cx46 via the association of Ca2+-CaM at the intracellular loop domain of alpha-family gap
junction proteins [103, 104]. However, several major questions remain to be answered:
1. Is lens specific Cx50 also regulated by CaM via interacting at this cystosolic region of gap
junction protein?
2. If yes, does CaM bind to these alpha-family gap junction proteins with different affinities?
3. What are the CaM binding modes to the Cx?
4. Can CaM interact with Cx43 via multiple regions? If yes, what is the possible working model?
Chapters 3 and 4 of this dissertation addressed the above-unanswered questions. First, we have
predicted and identified a CaM-target sequence (CaMBD, residues 141-166) at the conserved second half
of the introcellular loop region of Cx50. Using a peptide model encompassing this predicted CaM region,
we have determined its strong ability to bind CaM using a variety of in vitro biophysical and
electrophysiological approaches. NMR and fluorescence spectroscopy further revealed that the peptide
stoichiometrically binds to Ca2+/CaM with an affinity of ~5 nM. The binding of the peptide expanded the
Ca2+ sensing range of CaM by increasing the Ca2+ affinity of the C-lobe of CaM, while decreasing the
Ca2+ affinity of the N-lobe of CaM. In addition, we have shown that elevations in intracellular Ca2+
concentration affected a 95% decline in junctional conductance (gj) of Cx50 in N2A cells that is likely
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mediated by CaM, because inclusion of the CaM inhibitor, calmidazolium, prevented this Ca2+-dependent
decrease in gj. The direct involvement of the Cx50 CaMBD in this Ca2+/CaM-dependent regulation was
further demonstrated by inclusion of a synthetic peptide encompassing the CaMBD in both whole cell
patch pipettes, which effectively prevented the intracellular Ca2+-dependent decline in gj. Overall, these
results demonstrate that the binding of Ca2+/CaM to the intracellular loop of Cx50 is critical for mediating
the Ca2+-dependent inhibition of Cx50 gap junctions in the lens of the eye.
Second, we have further shown that CaM exhibits the differential affinities for Cx43, 44, and Cx50 at
this conserved loop regions using peptide models. The observed CaM binding affinity order is consistent
with their helical propensity at the CaM binding regions of the Cxs.
Third, we have identified additional CaM binding sites on the first half of the intracellular loop and the Cterminal domain of Cx43 by biophysical studies. Our results indicate that in the presence of Ca2+,
synthesized Cx peptide fragments, Cx43-2p and Cx43-4p, encompassing predicted CaM binding regions
are able to bind with high affinity to CaM using NMR spectroscopy. Unlike Cx43-3p, the suggested
stoichiometry of these newly discovered peptides which bind with CaM is greater than one. The NMR
RDC result suggests that the CaM binding mode of Cx43-2p to CaM is similar as CaMBD in SK channel
in an extended mode.
Fourth, in addition, the conserved CaM binding region in the second half of the intracellular loop has also been
identified as a gamma-class of gap junction Cx45.

Based on our studies on CaM, it directly interacts with Cx43 at three predicted regions including two
cytosolic loop regions (Cx43-2p and Cx43-2p) and the C-terminal (Cx43-4p). Based upon dye transfer
studies via w.t Cx43 and mutations at the predicted CaM binding region, and the electrophysiological
studies using patch clamp and peptide competition, we propose the working model for CaM regulation of
alpha-gap junction proteins shown in Fig,. 4.11. The binding of CaM to the cytoslic region Cx43-3p is
the major regulation site. Upon response to the cytosolic calcium increase, CaM binds to the cytosolic
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loop to result in the conformational change of gap junction and close the channel. It is possible CaM
using Cx43-2p region as an anchor to locate close to the regulation site Cx43-3p to allow fast response.
Our observation of the direct interaction of Cx43-4p at the C-terminal domain using peptide model by
NMR is also interesting given the knowledge that this region is involved in trafficking, assembly and
regulations such as physorylation.

The significance and high impact of this research is multifaceted. First, our results elucidate the
molecular level of regulation of Cx43 by multiple CaM targeting regions and provide a proposed model
about how CaM regulate gap junction assemble, trafficking and gating. Second, a large number of
residues in the Cxs mutated in human diseases reside at the highly conserved CaM binding site in our
prediction. Our studies provide insights that define the critical cellular changes and molecular
mechanisms contributing to human disease pathogenesis as part of an integrated molecular model for the
calcium regulation of GJs. Third, our proposed1 model for Ca2+-dependent regulation of the alpha-class
of gap junction proteins could provide new therapies to manage and/or prevent human maturity onset
cataract (Cx46 and Cx50) and heart diseases (Cx43) by introducing CaM mutant with altered Ca2+ binding
affinities. The model of CaM interacts with multiple CaM binding sites in Cx43 will facilitate understanding of
mechanism underlying gap junction regulation, and thus provide a molecular basis of potential therapeutic
intervention of heart diseases related to malfunction of gap junction.
7.2.

Identification of continuous calcium binding sites by grafting approach.

We applied a powerful Calcium Pattern Search (CaPS) method to predict and identify continuous Ca2+
binding sites, EF-hand motifs, from linear protein sequences in bacteria and viruses. We have applied a
grafting approach to predict and identify EF-hand motifs from various biological systems. The calcium
binding sites identified in nonstructural protein 1 (nsP1) of Sindbis virus and Poxvirus, streptococcal
hemoprotein receptor (Shr) of Streptococcus pyrogenes provides not only novel insight into the roles of
Ca2+ and Ca2+-binding proteins in pathogens including bacteria and virus, but also a method to explore
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and define the role of Ca2+ in other biological systems. We have also shown that the metal binding
properties and dimerization study of two EF-hand motifs isolated from Calbindin D9k implicates the key
role of Ca2+ in protein oligomerization which is important for biological function of protein complex. The
developed algorithm and grafting approach provide a new way to understand the role of calcium in
channels and other biological systems.
7.3.

The study of protein-protein interactions by mass spectrometry.

MALDI-MS has been considered a “softly-soft” ionization mass spectrometry technique in the proteinprotein interaction study. The properties of the soft ionization process make MALDI-MS an advanced
technique to explore the protein complex without breaking its weak non-covalent bond. The interaction of
CaM and its targeting peptides fragments from gap junction has been proved by MALDI-MS in a fast,
efficient and costless manner. MALDI-MS also suggests a de novo application to study the
oligomerization of calcium binding proteins, and a fast and accurate method for identification of protein
modification sites. Functional groups with certain properties are often introduced to protein for proteinprotein interaction and metal binding study through protein modification. In this study, MALDI-MS was
used to improve the protein modification with dye labeling for the fluorescence study or with PEG for the
protein based contrast agent.
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